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Abstract 
Blood cell formation involves proliferation of hematopoietic stem cells coupled with 
progressive maturation and lineage commitment. There is a critical requirement to 
maintain stem cell numbers by self-renewal. The mechanisms which control both 
differentiation and the balance between self-renewal and differentiation are poorly 
understood. The focus of this thesis is on myeloid differentiation. Four myeloid 
differentiation pathways have been recognized: (1) steady state myeloid differentiation, 
which maintains the normal levels of mature myeloid cells, (2) cytokine-driven or 
inducible myelopoiesis which generates additional myeloid effector cells during 
infections or allergic responses, (3) All-trans retinoic acid (ATRA)-induced 
differentiation of promyelocytic leukemia cells and (4) CD44-driven differentiation of 
AML blasts. The aim of the thesis work was to gain a better understanding of IL-3-
driven myeloid differentiation. 
In Chapter 3, investigations of the hIL-3R system in the promyelocytic leukemia line 
NB4 are presented. NB4 is not only blocked in steady-state granulocytic differentiation 
but also in cytokine-induced differentiation driven by IL-3 or GM-CSF. The IL-3R 
system was present at low levels in NB4 but was otherwise normal. Elevation of hIL-3R 
levels by ectopic expression restored lL-3-induced differentiation, but differentiation 
was only partial indicating that the PML-RARa protein also interferes with the 
induction of IL-3-driven differentiation. SiRNA knockdown of h(3c did not affect 
ATRA-driven differentiation. 
In Chapter 4, studies relating to the CD44-induced differentiation pathway are 
presented. Although it is known that CD44 is a potent inducer of differentiation of 
promyelocytic leukemia cells, siRNA knockdown of CD44 did not affect ATRA-
induced differentiation of NB4 cells and also did not affect IL-3-induced differentiation. 
In Chapter 5, the development of a new in vitro model for studying the mechanisms of 
mIL-3-induced myeloid differentiation is presented which utilizes the conditionally 
immortalized GM progenitor SCF ER-Hoxb8. The data indicate that IL-3-induced 
differentiation results in significant upregulation of miR-223 and the transcription 
factors C/EBPE and C/EBPp. Additionally, the data show an important role for signaling 
via the IL-3Ra SP2 isoform in the differentiation of this immortalized GM progenitor. 
Collectively, the thesis results indicate that the mechanisms involved in the induction of 
differentiation via the IL-3-driven, steady state, ATRA-induced and CD44-induced 
pathways are separate but they likely invoke a common granulocytic differentiation 
pathway which involves upregulation of C/EBPs, C/EBPP and miR-223. The new IL-3 
differentiation model provides the foundation for future studies which could lead to 
miRNA directed strategies for controlling allergic inflammation and a better 
understanding of the pathogenesis of AML. 
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Chapter 1 
Introduction 
Chapter 1: Introduction 
The work described in this thesis relates to investigations of the mechanisms of IL-3-
induced myeloid differentiation. These are poorly understood at present but are relevant 
to allergic inflammation and to acute myeloid leukemia. In order to introduce this topic 
this Chapter gives an overview of hematopoiesis, the biology of IL-3 and GM-CSF and 
their receptors, the relevant signaling pathways and the mechanisms regulating myeloid 
differentiation. 
1.1 Hematopoiesis 
Hematopoiesis is the process by which blood cells are derived from multipotent stem 
cells that are found in the bone marrow in the adult. During foetal development, 
hematopoiesis begins in the blood islands of the yolk sac and then develops in the liver, 
spleen and lymph nodes before the bone marrow becomes the primary site for 
hematopoiesis throughout life (Gallicchio, 1998). Multipotent stem cells can proliferate 
in response to appropriate stimuli to produce large numbers of progenitor cells that 
become committed to one or another of the major cell lineages of the blood. In the 
steady state the numbers of progenitor cells is small, but this compartment can be 
rapidly expanded under conditions of increased demand, such as infection or bleeding, 
or during growth of the individual. Under these conditions, alternative sites of 
hematopoiesis may be utilised, including the liver and spleen. This process is referred to 
as extramedullary hematopoiesis (Gallicchio, 1998). 
Hematopoietic stem cells are referred to as multipotent because they have the ability to 
differentiate into mature cells of both the myeloid and lymphoid lineages, and are also 
capable of self-renewal (Spangrude et al., 1988; Spangrude, 1991). Importantly, 
hematopoietic stem cells are capable of engrafting into a myeloablated adult and 
reconstituting all lineages of the hematopoietic system (Spangrude et al., 1988; Moore 
and Sakamoto, 2005). While stem cells are multipotent, committed progenitor cells 
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differentiate into a limited number of different cell lineages. As progenitor cells undergo 
further commitment, their proliferative and lineage potential is reduced until they finally 
form one of the mature blood cell types. 
Although the mechanisms regulating hematopoiesis are poorly understood, it is well 
established that this process can be stimulated by cytokines. The colony-stimulating 
factors such as IL-3 and GM-CSF stimulate multilineages of hematopoietic cells, while 
IL-5, G-CSF, M-CSF, erythropoietin (EPO) and thrombopoietin (TPO) stimulate more 
restricted lineages (Heimfeld et al., 1991). IL-3 can positively regulate the proliferation 
and differentiation of hematopoietic stem cells. After binding to its receptor on target 
cells, IL-3 promotes proliferation and differentiation of hematopoietic stem cells and the 
survival of mature cells. 
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Figure 1.1: Schematic representation of hematopoiesis (adapted from Nabel, 2002). The 
cytokines stimulating stem cell self-renewal and lineage commitment are shown. 
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1.2 Basal versus inducible hematopoiesis 
In considering the role of cytokines in regulating hematopoiesis, it is important to 
distinguish basal or steady state hematopoiesis from inducible (or emergency) 
hematopoiesis. Steady state blood cell formation maintains the appropriate basal levels 
of blood cells under normal conditions and involves a balance between proliferation and 
terminal differentiation/death of committed progenitor cells. Hematopoietic stem cells 
(HSC) reside in the bone marrow and give rise to progenitors that become progressively 
restricted with respect to their cell lineages as they undergo maturation. HSC must 
undergo self-renewal to maintain their numbers. In addition to steady state 
hematopoiesis, there is the process of inducible hematopoiesis. For example, the 
numbers of particular cell types can be dramatically elevated in response to infections 
and this is regulated by the immune system via the production of cytokines such as IL-3, 
IL-5 and GM-CSF by activated T lymphocytes. These cytokines, particularly IL-3 and 
IL-5, are not critical for basal or steady state hematopoiesis but are important in 
inducible hematopoiesis. For example, IL-3 and IL-5 regulate basophil and eosinophil 
responses, respectively, during parasite infections (Lantz et al., 1998; Wang and Young, 
2007). IL-5 also regulates eosinophilic inflammation of the lung in asthma (Foster et al., 
1996; Kouro and Takatsu, 2009). IL-3 does not have a unique role in steady state 
hematopoiesis but it does in relation to basophils and, to a lesser extent, mast cells in 
inducible hematopoiesis as discussed in detail below. 
The control of differentiation versus self-renewal is not well understood but some 
general principles have been established. Hematopoietic stem cells (HSC) reside in the 
bone marrow and give rise to progenitors that become progressively restricted with 
respect to their cell lineages as they undergo maturation. Specific transcription factors 
are induced which control lineage determination during differentiation (Zhu and 
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Emerson, 2002) in conjunction with miRNAs which appear to provide an additional 
level of control (Fatica et al., 2008). In addition, the HSCs must undergo self-renewal to 
maintain their numbers. Hox homeodomain transcription factors promote self-renewal 
and expansion of hematopoietic progenitors and are down-regulated during 
differentiation and maturation (Owens and Hawley, 2002). They are commonly 
dysregulated in mouse and human acute myeloid leukemia (AML). The mechanisms 
which control both differentiation and the balance between self-renewal and 
differentiation are critical to maintaining normal blood cell development. Their failure 
leads to diseases like leukemia in which there is excessive self-renewal and defective 
differentiation. 
1.3 Leukemia 
Leukemia involves an uncontrolled proliferation of progenitor cells in the absence of 
differentiation. Uncontrolled proliferation can arise through changes that lead to an 
increased proliferative capacity of the progenitor cell and/or a block in differentiation 
(Kuby, 1997). A block in differentiation results in an accumulation of immature cells 
that fail to fully mature and subsequently die. Proliferating immature cells that are 
blocked in their differentiation and escape immune surveillance, eventually dominate 
the bone marrow and invade other tissues and organs leading to death (Kuby, 1997; 
Evans et al., 1998). 
While the processes of proliferation and differentiation are central to the development of 
leukemia, apoptosis is also involved in the control of leukemia. Homeostasis is 
maintained by balancing cell proliferation with cell death and an imbalance in either 
may result in cancer (Kuby, 1997). Cytokines can promote proliferation and tumour 
suppressor genes can inhibit proliferation. The regulation of apoptosis can occur by 
mutation of genes that either block or induce apoptosis. For example, in B-cell follicular 
Chapter 1: Introduction 
lymphoma a chromosomal translocation of the anti-apoptotic gene bcl-2 occurs leading 
to its over-expression and inhibition of apoptosis (Golub et al., 1999). Inhibition of 
apoptosis enables a leukemic cell to escape its usual programmed cell death and can 
enable the cell to live almost indefinitely. However, other events that enable the cell to 
proliferate and maintain its self-renewal capacity must also occur for immortalisation of 
a cell. As stated above, a block in differentiation can also lead to leukemia. In myeloid 
leukemias, chromosomal translocations occurring in genes involved in the regulation of 
transcription are a common mechanism leading to arrested differentiation (Warner et 
ah, 2004). Warner et al., (2004) suggest that "alterations in transcriptional regulation 
leading to aberrant myeloid differentiation may be a necessary step in 
leukemogenesis," but are not sufficient for progression to acute myeloid leukemia 
(AML) without additional events providing proliferative and survival advantages. 
In human leukemia, gross chromosomal changes occur quite frequently resulting in the 
fusion of unrelated genes creating chimeric proteins with altered functions (Brendel and 
Neubauer, 2000). In many cases, the disruption of each gene's normal function by the 
formation of the novel chimeric protein has been demonstrated to be responsible for the 
disease (Pandolfi, 2001). The mutations that cause leukemia fall into two broad groups. 
Mutations in the first group provide a proliferative or survival advantage on the 
hematopoietic cells by the aberrant activation of signal transduction pathways (Gilliland 
et al., 2004). In contrast, mutations in the second group inhibit differentiation or provide 
self-renewal properties to the hematopoietic cells during development through the 
mutation of transcription factors or transcription co-activators that mediate their effects 
on cell differentiation or self-renewal (Gilliland et al., 2004). 
It was shown that concomitant abnormal expression of the transcription factor Hoxb8 
and the hematopoietic growth factor IL-3 generates a rapid-onset transplantable myeloid 
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leukemia in mice (Ymer et al., 1985; Perkins et al., 1990). Hoxb8 appears to 
immortalize an early hematopoietic progenitor by blocking its differentiation. 
Continuous IL-3 dependent lines are readily created from Hoxb8-immortalized 
progenitors but require unusually high levels of IL-3 compared with other I n -
dependent cell lines. This property originally led to the suggestion that another form of 
the IL-3 receptor may exist in the immortalized progenitors but it has remained 
unexplained (Perkins and Cory, 1993). The special relationship between Hoxb8 and IL-
3 in the generation of AML in mice makes it critical to elucidate how Hoxb8 blocks 
differentiation and to uncover the special nature of IL-3 signaling in Hoxb8-
immortalized progenitors. 
1.4 Biology of IL-3, GM-CSF and IL-5 
The work described in this thesis is primarily concerned with IL-3-supported myeloid 
differentiation, but it is useful to compare the biology of IL-3 with the biology of the 
related cytokines, GM-CSF and IL-5 which share the same receptor system. In addition, 
GM-CSF is used in some of the studies for comparison of its signaling effects with 
those of IL-3. 
1.4.1 IL-3 biology 
IL-3, also referred to as multi-lineage-colony stimulating factor (Multi-CSF), is 
produced mainly by activated CD4+ T cells and mast cells. IL-3 acts on the most 
immature marrow progenitors (Metcalf, 1989) and is a multipotent cytokine which 
promotes myeloid progenitor cell self-renewal and differentiation, and the survival and 
activation of mature myeloid cells (Spivak et al., 1985; Metcalf et al., 1986; 
Wagemaker et al., 1990). IL-3 is a critical mediator of inflammation and immune 
responses to infections. IL-3-deficient mice show a defective capacity to elevate mast 
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cell and basophil numbers in response to parasite infections (Lantz et al., 1998). It is 
important to note that IL-3 does not play a critical role, however, in basal 
hematopoiesis. 
IL-3 can promote the growth and differentiation of CD34+ progenitor cells into 
basophils and mast cells, myeloid-derived dendritic cells and non-myeloid derived 
dendritic cells, and to a lesser extent, eosinophils and monocytes-macrophages (Lantz et 
al., 1998; Ebner et al., 2002; Strobl, 2003). This pattern of IL-3 responsiveness 
corresponds to the cellular expression of IL-3Ra (Yamada et al., 1998). IL-3, but not 
IL-5 or GM-CSF, prevents basophil apoptosis in vitro through the activation of PI3-K 
(Zheng et al., 2002). IL-3 also promotes stem cell factor-induced mast cell 
differentiation in a dose-dependent manner and enhances FceRl-dependent mediator 
release (Gebhardt et al., 2002). The role of IL-3 in relation to basophils and Th2-type 
allergic responses is discussed in more detail below. 
A potential role for IL-3 in the pathophysiology of inflammation in the central nervous 
system has been suggested (Araujo and Lapchak, 1994; Appel et al., 1995). Data to 
support this notion include the observation in rats that microglia can produce and 
respond to IL-3 and that Pc expression in the brain is restricted to the microglial cells, 
suggesting that IL-3 might function in an autocrine feedback loop (Appel et al., 1995). 
In vitro IL-3 stimulation of microglial cells induced their proliferation and the formation 
of multinucleated giant cells (Lee et al., 1993). The clinical relevance of these 
observations is suggested by the detection of IL-3 in postmortem brain tissue from 
patients with Alzheimer's disease (Araujo and Lapchak, 1994). Taken together, these 
data suggest that IL-3 might mediate increased activation of microglial cells and the 
subsequent development of neurodegeneration. 
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The role for IL-3 in modulating type 1 dendritic cells (DCs) function was also reported 
(Ebner et al., 2002). When the human type 1 dendritic cells were derived in vitro with 
IL-3 rather than GM-CSF, the dendritic cells preferentially induced Th2 responses. In 
contrast, type 1 dendritic cells derived with GM-CSF preferentially induced Thl 
responses. This difference was the consequence of decreased IL-12 production by IL-3-
derived type 1 dendritic cells. In addition, differentiation of type 2 dendritic cells 
requires IL-3, and these cells also produce low quantities of IL-12 and promote Th2 
responses (Ebner et al., 2002). Thus IL-3 might become an important molecule in the 
development of strategies to modulate Thl and Th2 immune responses. IL-3 is the key 
cytokine for generating DCs from high IL-3R expressing plasmacytoid precursor cells, 
by ensuring their proliferation and survival. However, IL-3Rs are also expressed, albeit 
at lower levels, in monocytes (Rissoan et al., 1999), and IL-3 has been reported to play 
a role in the generation of DCs when using blood monocytes as precursors. In particular, 
it has been demonstrated that IL-3 can replace GM-CSF and, combined with either IL-4 
or IFN-P, leads to the generation of DCs endowed with distinct functional properties 
(Buelens et al., 2002; Ebner et al., 2002). 
IL-3 released by infiltrating inflammatory cells in different pathological settings 
contributes to organ and tumor angiogenesis. IL-3 expands a subset of CD45 + 
circulating angiogenic cells clonally derived from the hematopoietic progenitors. 
Moreover, CD45+ cells exposed to IL-3 acquire arterial specification and contribute to 
the formation of vessels in vivo. In inflammatory microenvironments containing IL-3, 
angiogenic cells derived from hematopoietic precursors can act as adult vasculogenic 
cells (Zeoli et al., 2008). 
The expression of IL-3 Ra on a wide range of hematological malignancies is of potential 
importance as a marker of tumor load (Munoz et al., 2001). Although not normally 
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expressed by B cells, increased expression of IL-3Ra is observed in approximately 40% 
of patients with B cell-acute lymphocytic leukemia or acute myeloid leukemia. 
Furthermore, the increased expression of IL-3Ra is associated with enhanced blast 
proliferation, increased cellularity, and a poor prognosis (Testa et al., 2002). The IL-3R 
represents one of the target molecules involved in the stimulation of proliferation of 
AMLs, and the overexpression of the IL-3Ra chain may represent one of the 
mechanisms contributing to the development of a highly malignant leukemic phenotype 
(Testa et al., 2004). The studies on the IL-3Ra have indicated it is an important marker 
in leukemia and leukemic stem cells. The new anti-leukemic drugs targeting the IL-3Ra 
are now under development (Testa et al., 2004). 
1.4.2 IL-3, basophils and type 2 immunity 
Basophils are rare blood granulocytes that are generated in the bone marrow from their 
progenitors and enter the circulation as fully mature cells (Falcone et al., 2000). 
Basophil numbers are increased during parasite infections and in allergic inflammation 
(Luccioli et al., 2002). The role of IL-3 in allergic diseases is supported by its in vitro 
effects on eosinophils and basophils. Basophils are postulated to be the circulating 
effector cells of allergy. IL-3 has been shown to directly cause the release of histamine 
from basophils of allergic asthmatic subjects (Sugiyama et al., 1993). Furthermore, 
recruitment of basophils to sites of allergic inflammation may also be increased by IL-3, 
mediated via the up-regulation of the adhesion molecule CD l ib, the a-chain of the 
complement receptor type 3 (mac-1) (Bochner et al., 1990). 
The mechanisms involved in induced basophil generation are poorly understood but 
there is much evidence of an important role for IL-3. For example, incubating bone 
marrow cells with IL-3 in vitro promotes their differentiation into basophils (Yoshimoto 
et al., 1999; Gessner et al., 2005). In vivo, basophilia can be induced by IL-3 treatment 
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of mice and parasite-induced basophilia is due to increased endogenous production of 
IL-3 (Oh et al., 2007). Treating Nippostrongylus brasiliensis (Nb)-infected mice with 
neutralizing anti-IL-3 antibody partially diminished basophil accumulation in the 
periphery (Min et al., 2004). Voehringer et al., (2004) reported that administration of 
the IL-3 complex (IL-3 plus anti-IL-3 Ab) in vivo promoted the differentiation of GMPs 
into basophil lineage-restricted progenitors (BaPs) in a STAT5 signaling-dependent 
manner and increased the number of basophil/mast cell progenitors (BMCPs) in the 
spleen. IL-3 receptor expression was dramatically up-regulated in BaPs, but not in 
eosinophil lineage-restricted progenitors (EoPs). It has been shown that about 38% of 
BMCPs express the IL-3 receptor (Ohmori et al., 2009). IL-3 induces basophil 
expansion by promoting granulocyte-monocyte progenitors and basophil-mast cell 
progenitors to differentiate into basophil lineage progenitors (Ohmori et al., 2009; 
Arinobu et al., 2005). It has been reported that activated T cells are the major source of 
IL-3, which acts to enhance basophil generation in the bone marrow (BM) during 
parasite infection. Indeed, both basophil generation in the BM and basophil 
accumulation in the peripheral tissues are significantly impaired in mice deficient in IL-
3 (Shen et al., 2008). IL-3 plays an additional key role in recruiting circulating 
basophils into the lymphoid tissues (Kim et al., 2010). 
The above results strongly suggest that IL-3 plays an important role in the inducible 
formation of basophils. Interestingly, IL-3 does not seem to be necessary for basophil 
differentiation under homeostatic conditions, as IL-3-deficient mice have normal basal 
levels of basophils but are not able to mount a basophilia in response to parasite 
infections (Shen et al., 2008). IL-3 also has a unique capacity to augment the 
proinflammatory properties and phenotype of human basophils. It has been shown that 
basophils rapidly bind and utilize the IL-3 they produce, as evidenced by functional and 
phenotypic activity that is inhibited in the presence of neutralizing anti-IL-3 receptor 
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(CD 123) Abs (Schroeder et al., 2009). In vitro, IL-3 also enhances acute IL-4 
production in basophils (Valent et al., 1989; Le Gros et al., 1990). IL-3 stimulation can 
directly induce moderate IL-4 production in resting basophils (Hida et al., 2009). In 
addition, IL-3 has been described to have an important priming role in antibody-
dependent basophil activation and cytokine production (Le Gros et al., 1990; Brunner et 
al., 1993). Whereas IL-4 production can be detected after IgE crosslinking or protease 
activation of basophils, IL-3 pretreatment significantly increases IL-4 production (Hida 
et al., 2009). Interestingly, this IL-3-mediated priming effect seems to exert an effect 
through a different receptor complex than that inducing IL-3-mediated basophil 
development (Hida et al., 2009). This may be particularly relevant for basophil-T cell 
crosstalk in vivo as activated T cells produce IL-3 (Shen et al., 2008). When starved of 
IL-3, basophils will produce small amounts of IL-4 directly in response to subsequent 
IL-3 stimulation. This depends on the presence of the Fc receptor common y-chain 
(FcRy), as FcRy knockout mice are unable to produce IL-4 in response to IL-3 
stimulation. The FcRy chain interacts with the IL-3 receptor complex; IL-3R signaling 
through FcRy induces IL-4 production (Hida et al., 2009). FcRy is a constitutive 
component of the IL-3R and is essential, through its ITAM, in the IL-3-induced 
production of IL-4 and in supporting Th2 differentiation by basophils. The involvement 
of FcRy in IL-4 production is selective, as another function of IL-3, the promotion of 
basophil proliferation, was not affected by FcRy deficiency (Hida et al., 2009). 
It has been suggested that basophils play important roles in the development of type 2 
immunity (Mitre and Nutman, 2006). It has been demonstrated that basophils, defined 
as CD49b+ FCERI+ cells, promote differentiation of activated naive CD4 T cells into IL-
4-producing Th2 type effector cells by providing IL-4 necessary for Th2 differentiation 
(Oh et al., 2007). In vivo, CD4 T cells primed in the presence of elevated numbers of 
basophils preferentially differentiate into IL-4-producing effector cells (Oh et al., 2007). 
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Moreover, spontaneous Th2 immunity develops in mice deficient in interferon 
regulatory factor 2 where basophil generation is elevated (Hida et al., 2005). Basophils 
were also shown to induce IgE-mediated chronic allergic dermatitis and allergen-
induced Th2 differentiation (Sokol et al., 2008). In support of this, depletion of 
basophils dramatically abolished the development of inflammatory lesions, reduced 
infiltration of other effector cells (Obata et al., 2007) and abrogated the Th2 
differentiation induced by allergen immunization (Sokol et al., 2008). Thus, there is 
considerable evidence supporting the hypothesis that basophils are important 
immunoregulatory cells particularly in Th2 type immunity. Recent work has 
established important roles for basophils in initiating and augmenting Th2-type immune 
responses to allergen challenges and parasitic infection (Sokol et al., 2008; Min and 
Paul, 2008). 
1.4.3 GM-CSF biology 
The GM-CSFRa subunit is expressed on CD34+ progenitor cells and all myeloid 
lineages, as well as some myeloid leukemias and vascular endothelial cells (Gauvreau et 
al., 1998). GM-CSF is secreted by activated T lymphocytes, eosinophils, mast cells, 
basophils, macrophages, endothelial cells and bone marrow stromal cells. In addition to 
the promotion of myeloid differentiation, GM-CSF is a potent inhibitor of CD34+ 
progenitor cell differentiation into lymphoid progenitors or type 2 dendritic cells 
(Iwasaki-Arai et al., 2003). Likewise, GM-CSF inhibits the terminal differentiation of 
mast cells and decreases FceRl expression and tryptase production by mature mast cells 
(Welker et al., 2001). Recombinant human GM-CSF has been used clinically to 
promote myeloid cell recovery in myelosuppressed patients and is currently under 
investigation as an adjuvant for vaccines (Pichichero, 2008). The in vitro inhibition of 
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mast cell differentiation by GM-CSF also led to the use of GM-CSF as a treatment of 
systemic mastocytosis, although with limited benefit (Zuberbier et al., 2001). 
When the gene encoding Pc or the GM-CSF gene was deleted in mice, these animals 
had normal numbers of hematopoietic stem cells and progenitor cells but failed to 
accelerate production of granulocytes, macrophages, and eosinophils when challenged 
with infectious and inflammatory stimuli (Robb et al., 1995; Nishinakamura et al., 
1995). However, the GM-CSF null mice also revealed a totally unexpected phenotype 
and elucidated a new role for GM-CSF (Robb et al., 1995). These mice had pulmonary 
alveolar proteinosis (PAP), which is characterized by abnormal surfactant metabolism. 
A similar PAP phenotype occurred when the gene encoding Pc was deleted (Robb et al., 
1995; Nishinakamura et al., 1995). In the GM-CSF null or Pc null mice, as well as in 
human PAP, there is an accumulation of phospholipids and surfactant proteins within 
alveolar spaces. In addition, neutralizing auto-antibodies against GM-CSF were 
detected in adult patients with PAP (Bonfield et al., 2002) and disease activity appears 
to correlate with the anti-GM-CSF antibody titer (Bonfield et al., 2002). Very recently, 
it has been shown that PAP is caused by deletion of the GM-CSFR gene in the X 
chromosome pseudoautosomal region and new studies also identified three patients in 
whom PAP was caused by mutations in the gene encoding the ligand-binding a chain of 
the GM-CSF receptor (Notarangelo and Pessach, 2008). These data, together with those 
of the gene knock-out studies, strongly suggest that PAP is caused by a lack of GM-
CSF function, which is likely to be important for modulating pulmonary alveolar 
macrophage metabolic activity. 
GM-CSF has also been implicated in cellular transformation. Expression of both GM-
CSFRa and Pc has been detected in different types of malignancies, indicating that GM-
CSF can potentially transduce proliferative and survival signals to these transformed 
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cells (Baldwin et al., 1989). Examples of these malignancies include chronic myeloid 
leukemia, acute myeloid leukemia, juvenile myelomonocytic leukemia, small-cell lung 
carcinoma, melanoma, certain breast cancer cell lines and prostate cancer. The transient 
improvement of a patient with a GM-CSF responsive myelomonocytic leukemia treated 
with a recombinant GM-CSF that had been mutated at Glu21, to prevent (3c signaling 
suggests the potential to treat such diseases with GM-CSF antagonists or GM-CSFRa 
antagonists (Bernard et al., 2002). However, the effects claimed for E21R hGM-CSF 
could not be reproduced and the clinical trial was dropped (Jakupovic et al., 2004). GM-
CSF has also been shown to be involved in angiogenesis through the JAK2/STAT3 
pathway in vivo (Valdembri et al., 2002). Using chicken chorioallantoic membranes, 
GM-CSF stimulation was found to induce vessel sprouting from aortic rings without 
recruitment of inflammatory cells. Taken together, these data indicate that unregulated 
GM-CSF signaling can have physiological consequences leading to the promotion of 
malignant growth. 
1.4.4 Role of IL-3, IL-5 and GM-CSF in allergic inflammation of the 
airways 
IL-3, IL-5 and GM-CSF are related hematopoietic cytokines that are important for 
allergic inflammation. Allergic asthma is a chronic inflammatory disease of the airways 
(Braman, 2006). Inflammatory infiltrates in the asthmatic airways are complex, and a 
range of cells has been associated with disease progression. These include basophils, 
eosinophils, effector T lymphocytes, mast cells, macrophages, neutrophils, and, more 
recently, T regulatory and NK-T cells (Umetsu and Dekruyff, 2006). Th2 cytokines 
(including IL-3, IL-5 and GM-CSF) and eosinophils are thought to play critical roles in 
the induction of airway hyperreactivity (AHR) and the development of lesions that 
underpin chronic airway wall remodeling (Cohn et al., 2004). 
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Several lines of evidence indicate that IL-5 is important in the pathophysiology of 
allergic inflammation and asthma (Huang et al., 2003). Peripheral blood eosinophil 
counts increase within 24 hours of allergen challenge, and eosinophil infiltration of the 
lungs is a hallmark of asthma (Huang et al., 2003). Furthermore, eosinophil-derived 
mediators are both toxic to the bronchial epithelium and can cause bronchospasm. In 
addition, IL-5 levels, Th2 T cells, and eosinophils are all increased in the 
bronchoalveolar lavage fluid of asthmatic patients, and the levels correlate with the 
severity of disease. Similar increases of IL-5, Th2 cells, and eosinophils are found in the 
bronchial mucosa of patients with severe asthma (Huang et al., 2003). 
IL-3 and GM-CSF, which together with IL-5 are the only known mediators capable of 
inducing eosinophil differentiation from bone marrow progenitors, are central to the 
survival, migration, and activation of this granulocyte (Lopez et al., 1986; Rothenberg 
et al., 1988). IL-3 and GM-CSF, produced by activated T cells as well as in copious 
amounts by lung epithelial cells in the case of GM-CSF, share a common P receptor 
chain (0c) with IL-5. Indeed, signaling redundancy between these cytokines may be the 
critical pathway that promotes the development and recruitment of eosinophils 
independently of IL-5 at sites of allergic inflammation. Interestingly, limited 
suppression of pulmonary eosinophil numbers and AHR has been documented in a rat 
model of allergic asthma following partial (~60%) attenuation of the Pc using antisense 
oligonucleotides (Allakhverdi et al., 2002). 
IL-5-deficient (IL-5 ) mice have proved extremely valuable in definition of the 
biological roles of IL-5 and eosinophils in host defence, bronchoconstriction, and 
allergic inflammation (Kopf et al., 1996). In IL-5-deficient mice, the eosinophilia, lung 
damage, and airways hyperreactivity normally resulting from aeroallergen challenge 
were abolished. IL-5 and eosinophils are central mediators in the pathogenesis of 
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allergic lung disease (Foster et al., 1996). Pc-deficient (0c - /~) mice were used in an 
acute model of allergic airways inflammation to show that the 0c receptor chain is not 
only essential for eosinophil accumulation in tissues, but also plays a critical role in the 
development of hallmark features of asthma, including production of Ag-specific IgE, 
mucus hypersecretion, and AHR, by limiting the functional capacity of Th2 cells in the 
lung. Thus, Pc plays a novel role in allergic disease by regulating multiple effector arms 
associated with the allergic inflammatory response (Asquith et al., 2008). 
Signaling through the Pc by IL-3 and GM-CSF is also important in the development and 
function of other immune cells that play central roles in allergic inflammation. This 
includes dendritic cells (Storozynsky et al., 1999), which play an integral role in the 
immune response to inhaled allergens (Lambrecht et al., 2000). Importantly, IL-3 is also 
a critical molecular switch for the differentiation, survival, and effector function of mast 
cells and basophils, whereas GM-CSF is a strong activator of neutrophil and 
macrophage function (Lantz et al., 1998). Thus, the central role of the Pc in regulating 
the function of a range of immune effector cells suggests that this molecule may be a 
pivotal regulator of allergic inflammation. 
1.5 IL-3 and GM-CSF receptors 
One of the characteristic features of cytokines is their functional pleiotropy, i.e. a 
particular cytokine can exhibit a wide variety of biological actions on various tissues 
and cells. Such functional pleiotropy and redundancy was initially thought to be a 
consequence of the structural characteristics of the cytokines themselves, though the 
critical role of cytokine receptors is now recognized. The overlapping nature of the 
downstream signaling proteins recruited by the receptors to elicit the cytokine stimulus 
can account for the functional pleiotropy and redundancy of cytokines. Most cytokine 
receptors consist of a multi-subunit protein complex: a unique and specific ligand 
18 
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binding subunit, and a signal transducing subunit, which may be structurally similar to 
other members of the cytokine receptor superfamily (Hunter, 1993; Stahl and 
Yancopoulos, 1993; Kishimoto et al, 1994; Taniguchi, 1995). The signal transducing 
subunit can be regarded as the 'work-horse' of the cytokine receptor complex. Not only 
does it receive signals initiated upon cytokine binding, but it is also responsible for 
propagation of the signals to downstream target proteins. The signal transducing subunit 
recruits cytoplasmic proteins, which results in changes in protein-protein interactions as 
well as changes in the phosphorylation status of certain proteins. 
IL-3, IL-5 and GM-CSF receptors conform to the shared cytokine receptor model 
outlined above having cytokine-specific a-subunits (Gearing et al., 1989; Kitamura et 
al., 1991; Tavernier et al., 1991; Murata et al., 1992; Takaki et al., 1993) and a shared 
Pc-subunit (Hayashida et al., 1990). Both the a- and Pc-subunits are members of the 
class I cytokine receptor superfamily, a family of receptors characterized by 
ectodomains, which contain a functional unit known as the cytokine-receptor homology 
module (CRM). The CRM is formed by two barrel-like domains, each composed of 
seven P-strands, with approximate fibronectin type-Ill topology. The hallmark of the 
class I cytokine receptors' CRM is a conserved arrangement of disulfide bonds in the N-
terminal fibronectin type-Ill domain and the conserved WSXWS motif (where, W = 
tryptophan, S = serine, and X = any amino acid) in the C-terminal domain. On the basis 
of these conserved sequence elements in receptor ectodomains, Bazan (1990) described 
the superfamily of class I cytokine receptors or hematopoietin receptors. Notably, the 
cytoplasmic domains of these receptors lack any catalytic activity (Sakamaki et al., 
1992), but when the cytokine ligands bind to the oligomeric receptor, the receptor 
subunits are orientated so that the Janus Kinases (JAKs) that are constitutively 
associated with the receptor cytoplasmic domains are able to transactivate one another 
and initiate signaling. The signaling pathways that may be initiated in this manner are 
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extensive and include the Ras/MAPK (mitogen-activated protein kinase), PI-3K 
(phosphatidylinositol-3-kinase), and JAK/STAT (signal transducers and activators of 
transcription) pathways (de Groot et al., 1998). 
There have been many models proposed for activation of class I cytokine receptors, i.e. 
ligand-induced receptor dimerization, ligand-induced receptor aggregation and a ligand-
induced conformational change resulting in signal transduction. More recent studies 
using full length GHR have shown that the receptor is found as a dimer on the surface 
of the cell in the absence of GH demonstrated by FRET and BRET, spectral techniques 
which allow one to measure protein association in live cells and membranes (Gent et al., 
2002; Brown et al., 2005). This current model of GH signaling is not unique to GHR as 
other recent studies have also suggested a similar activation mechanism for the close 
related EPOR (Seubert et al., 2003; Lu et al., 2006). Recent evidence indicates that 
surface EPOR exists as a dimer in the absence of EPO, and that EPO binding likely 
activates the EPOR through defined conformational changes (Constantinescu et al., 
2001; Seubert et al., 2003). The EPOR transmembrane and juxtamembrane segments 
play key roles in properly orienting the EPORs in both its active liganded and inactive 
unliganded states, and these studies suggest an activation mechanism that might 
similarly be utilized by other class I cytokine receptors. 
1.5.1 IL-3 receptor 
IL-3 signaling in human cells involves an IL-3-specific a receptor and a P common (pc) 
receptor shared with IL-5 and GM-CSF (Kitamura et al., 1991). Signaling through the 
Pc receptor requires the formation of a high affinity complex involving each cytokine 
and its respective a subunit. Whereas the a subunits bind their ligands with low affinity, 
Pc does not measurably bind any of the ligands alone. In mouse cells, there is a shared 
PC receptor but also an IL-3-specific P receptor (Pil-3)-
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All of the biological effects of IL-3 are mediated via the IL-3 receptor, a member of the 
gpl40 group of the type I cytokine receptor superfamily. In contrast to the homodimeric 
receptors of M-CSF and G-CSF and similar to the heterodimeric GM-CSF receptor 
discussed above, the IL-3 receptor is composed of two distinct chains, a and p. The a 
chain is the primary binding chain that binds IL-3 with low affinity (Kd 50-100 nM) 
and has rapid dissociation kinetics. The (3 chain, although it does not display intrinsic 
binding affinity for IL-3 alone, is necessary for signal transduction and mediates the 
high affinity binding of IL-3 together with the a receptor (Kd 100-300 pM) in a 
complex that displays slow dissociation kinetics (Metcalf et al., 1995). Pil-3 differs from 
the mpc subunit in its ability to bind mIL-3 directly, although the presence of the mlL-
3Ra subunit is absolutely required for signaling (Hara and Miyajima, 1992; Murphy et 
al., 2004). 
1.5.1.1 IL-3 receptor a-chain 
The IL-3 receptor a-subunit (CD 123) is a type I transmembrane glycoprotein belonging 
to the cytokine receptor superfamily, as are the related IL-5Ra and GM-CSFRa to 
which it displays 54 and 43% sequence homology, respectively (Lindemann and 
Mertelsmann, 1995). The IL-3Ra gene encodes for a protein of 41.3 kDa (Moretti et al., 
2001). Cleavage of the 18 amino acid signal peptide yields a mature polypeptide of 360 
amino acids containing a 288 amino acid extracellular domain that plays a significant 
role in receptor binding to IL-3, a 20 amino acid transmembrane domain, and a short 
cytoplasmic domain of 52 amino acids. The extracellular domain consists of an N-
terminal region of about 100 amino acids that share significant sequence homology to 
similar regions in the GM-CSF and IL-5 receptor a-chains, followed by a cytokine 
receptor domain containing four conserved cysteine residues and a WSXWS motif 
common to other members of this receptor family (Nicola, 1991). The extracellular 
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domain contains six potential N-glycosylation sites, and the presence of N-linked 
oligosaccharides is essential to both ligand binding by the a-subunit as well as signaling 
by the IL-3 receptor (Yang, 1997). N-glycosylation at these sites appears responsible for 
the observed molecular weight of 70 kDa. The cytoplasmic domain contains a short 
proline-rich motif similar to Box 1 of the common 0-chain, but displays no intrinsic 
enzymatic activity. 
The role of IL-3 in the promotion of hematopoietic progenitor cell survival and 
proliferation is well documented. However, the role of IL-3 in differentiation of 
hematopoietic cells is not very clear. Evans et al., (1999) transfected the murine 
multipotential hematopoietic progenitor cell line FDCP-mix with chimeric receptor 
subunits consisting of the extracellular domain of the IL-3Ra and the intracellular 
domain of the GM-CSFRa subunit. This chimeric receptor promoted differentiation in 
response to IL-3, demonstrating the role of the a subunit in conferring specificity and 
determining cell fate via distinct signal transduction events. The IL-3Ra subunit 
(CD 123) is overexpressed on leukemic stem cells and blasts suggesting a role in 
leukemia pathogenesis (Jordan et al., 2000; Munoz et al., 2001; Testa et al., 2002). The 
increased expression of IL-3Ra is associated with enhanced blast proliferation, 
increased cellularity, and a poor prognosis (Testa et al., 2002). 
Our group recently identified a new alternatively spliced isoform of the IL-3Ra receptor 
in mouse (GI: 5599968; from a placental library) and human (GI: 19018027; from an 
RPE and choroids library) cells amongst the mRNA sequences in the NCBI EST 
databases. The new isoform (designated SP2) is depicted in Fig. 1.2 (Chen et al., 2009) 
and lacks domain 1 of the extracellular portion of the original IL-3Ra receptor 
(designated IL-3Ra SP1). The ability of the IL-3Ra SP2 and SP1 to promote 
differentiation of the multi-potential hematopoietic cell line FDCP-mix and the mouse 
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myeloid leukemia line Ml has been investigated in our laboratory. In this study, the 
human IL-3Ra SP2 together with h|3c was shown to promote the differentiation of 
multi-potential FDCP-mix cells into basophil-like cells in contrast to the IL-3Ra SP1 
isoform which promoted self-renewal. Human IL-3Ra SP2 also directed the 
differentiation of the myeloblasts Ml leukemia line into monocytes whereas IL-3Ra 
SP1 did not (Chen et al., 2009). The ability of the two structural isoforms of the IL-3a 
receptor to achieve different signaling outcomes with respect to differentiation and self-
renewal indicates greater complexity in the modes of receptor activation and signaling 
than previously recognized. More recently, our group has obtained evidence that the 
mIL-3Ra SP2 isoform plays an important role, not only in the formation of basophils 
from bone marrow progenitors in mice, but also in their maturation and ability to 
produce IL-4 after IL-3 stimulation (J. Chen and I. Young, unpublished). 
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IL-3Ra SP1 IL-3RCCSP2 
-Domain 1 
-Domain 2 
I—Domain 3 
Class I 
cytokine receptor 
homology module 
m c t B t i t c m m c a c i m c c c t 
B 
hIL-3Ra 
SP2 
mIL-3Ra 
SP2 
ATGGTCCTCCTTTGGCTCACGCTGCTCCTGATCGCCCTGCCC 
M V L L W L T L L L I A L P 
XGXCXCCTGCAAACGAAGGAA-^-gGTGGGAAGCCTTGGGCA 
C L L Q T K E J J G G K P W A 
Deletion 234 bp 
ATGGCCGCCAACCTGTGGCTCATCCTGGGGCTCCTGGCATCC 
M A A N L W L I L G L L A S 
CACTCTTCACATCT£-t:-GATGGCGACCACGAGGCCGCAGCC 
H S S D L l j D G D H E A A A 
Deletion 279 bp 
Figure 1.2: Structure of the SP2 isoform of mouse and human IL-3Ra (adapted from 
Chen et al., 2009). A, Schematic models of IL-3Ra SP1 and SP2 isoforms showing the 
structural domains; B, DNA and protein sequence covering the N-terminal region of 
human and mouse IL-3Ra SP2 showing the position of the deletion of exons 3 and 4, 
which encode domain 1 of the extracellular region (indicated by the arrows). The start 
of the mature protein sequence (predicted by SignalP 3.0) is shown bold and underlined. 
The full-length nucleotide sequences for the SP2 isoforms are found in GenBank™ with 
accession numbers of FJ550346 for mouse IL-3Ra SP2 and FJ550347 for human IL-
3Ra SP2. 
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1.5.1.2 IL-3 receptor [i chain 
In human cells the IL-3Ra subunit shares a common p chain with GM-CSFRa and IL-
5Ra. A second p chain is present in mice that associates exclusively with the IL-3Ra 
chain and is therefore called Pil-3- Both Pc and Pil-3 subunits form similar high-affinity 
IL-3Rs with IL-3Ra SP1 (Hara and Miyajima, 1994). However, Pil-3, but not Pc, forms 
a high affinity receptor complex with IL-3Ra SP2 (Chen et al., 2009). Pil-3 is able to 
bind mIL-3 directly with low affinity (Itoh et al., 1990), although the presence of the IL-
3Ra subunit is absolutely required for signaling to occur upon stimulation with mIL-3 
(Hara and Miyajima, 1992). 
Our group reported a crystal structure of the complete Pc extracellular domain (Carr et 
al., 2001). The pc structure revealed an interdigitating homodimer with an arch-like 
conformation (Fig. 1.3). The pc interlocking homodimer structure is also distinct from 
that of monomelic cytokine receptors like GHR and EPOR. Because the cytoplasmic 
domains of the homodimeric Pc are too far apart to activate each other for signaling, Pc 
activation would require proximate association with a ligand- bound IL-3Ra, IL-5Ra, or 
GM-CSFRa (Carr et al, 2001; Murphy and Young, 2006). The crystal structure of pc, 
together with mutagenesis studies (Murphy et al., 2004), led to the proposition that the 
cytokine-binding site is composed of D1 of one chain and D4 of the partner chain in the 
Pc homodimer that join in an antiparallel fashion. 
Hansen et al., (2008) reported the crystal structure of the human GM-CSF/GM-CSF 
receptor ternary complex and its assembly into an unexpected dodecamer or higher-
order complex. These authors showed through mutagenesis of the GM-CSF receptor at 
the dodecamer interface that dodecamer formation is required for receptor activation 
and signaling. It was proposed that this unusual form of receptor assembly likely applies 
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also to IL-3 and IL-5 receptors, providing a structural basis for understanding their 
mechanism of activation and for the development of therapeutics (Hansen et al., 2008). 
Recently our group reported the identification of residues clustering around the highly 
conserved A-helix residue, Glu (23), in the mIL-3 A- and C-helices as critical for 
receptor binding and growth stimulation via the PIL-3 and mIL-3Ra SP2 subunits, 
whereas an overlapping cluster was required for binding and activation of PIL-3 in the 
presence of mIL-3Ra SP1. Similarly, our studies of human IL-3 indicate that two 
different modes of Pc binding are utilized in the presence of the hIL-3Ra SP1 or SP2 
isoforms, suggesting a possible conserved mechanism by which the relative orientations 
of receptor subunits are modulated to achieve distinct signaling outcomes (Mirza et al., 
2010a). Our group also described a role for the domain 1 D-E loop disulfide of hpc and 
PIL-3 in maintaining the precise positions of ligand-binding residues necessary for 
normal high affinity binding and signaling (Mirza et al., 2010b). 
Structure/function studies using the common P-chain of IL-3 have shown that the 
cytoplasmic domain of this chain can be divided into two distinctive functional domains 
(Woodcock et al., 1999). The membrane proximal intracellular portion of the receptor 
till amino-acid number 589, that includes the Box 1 region, was shown to be necessary 
and sufficient for DNA synthesis mediated by several of these cytokines including IL-3 
(Tian et al., 1996). This region was also found to be required for the induction of 
proliferation-associated genes such as c-myc, pim-1 and oncostatin M. The membrane 
distal domain of the receptor, spanning amino acids 589-881, was shown to be required 
for growth inhibition that can be induced by some of the cytokines. More importantly, 
this region appears to be necessary for the promotion of viability of hematopoietic cells 
(Inhorn et al., 1995). 
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IL-3, GM-CSF, and IL-5 share a common p subunit for the formation of their high 
affinity receptors and subsequent activation of downstream signaling pathways 
(Martinez-Moczygemba and Huston, 2003). Generally, these receptors are differentially 
expressed among cells of the hematopoietic system. However, cross-competition 
between the cytokine ligands for the Pc chains results in the formation of a hierarchy of 
Pc binding in those cells expressing the appropriate a chains as well as the Pc chain 
(Lopez et al., 1991; Lopez et al., 1992). GM-CSF shows the greatest ability to recruit 
Pc, followed by IL-3 and IL-5. As such, affinity for the Pc subunit may induce 
differential biological activities even in the presence of more that one of the cytokine 
ligands and/or their specific a-chains. 
P chains are widely expressed throughout the hematopoietic system. Despite them being 
able to associate with an array of adaptors and signaling molecules, it is important to 
recognize that the patterns of expression of these proteins differs depending on the cell 
type, maturation stage, and the proliferation and/or activation signals that the cell is 
exposed to. As such, the end-result is intimately dependent not only on a functional 
receptor that can transduce extracellular signals, but also in the intracellular 
environment that must provide the necessary cytoplasmic signaling proteins to generate 
a downstream response. 
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Figure 1.3: The structure of the human 0c ectodomain (adapted from Carr et al., 2001). 
Left panel: the intertwined chains of the (3c homodimer are colored orange ( " A " chain) 
and blue ( " B " chain) and the component domains of each chain are labeled in orange 
or blue text, respectively. N-linked glycosylation chains are shown as sticks at N34 and 
N167 (carbons are colored green; nitrogens, blue; and oxygens are colored red). The 
loops that contribute residues to the functional epitope for IL-3, IL-5, and GM-CSF 
binding are labeled in black text. Right panel: expanded view of the domain B1-A4 
interface. The color scheme is as for the left panel, except the side chains of the 
functional epitopes residues are shown in green and are labeled with black text. The 
coordinates for Pc are available from the Protein Data Bank (accession 1GH7). 
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1.5.2 GM-CSF receptor 
The GM-CSF receptor, first identified on cells of the myelomonocytic lineage by 
ligand-binding studies (Walker and Burgess, 1985), is a heterodimer that comprises a 
major binding subunit (GMRa) (Gearing et al., 1989) and a shared signaling subunit 
(Pc) (Hayashida et al., 1990). The receptor subunits are always coexpressed on the 
surface of leukocytes, with Pc being expressed at lower levels than GMRa. Certain 
nonhemopoietic cell types have also been reported to express the GM-CSF receptor 
(Baldwin et al., 1989) and to respond to GM-CSF stimulation in vitro (Rivas et al., 
1998), although the in vivo significance of these observations remains uncertain. The 
closely related IL-3 and IL-5 receptors (IL-3R and IL-5R) also use a ligand-specific a-
chain and share Pc with the GM-CSF receptor. Although Pc is absolutely required for 
signaling in cells expressing GM-CSF, IL-3, or IL-5 receptors, there is evidence that the 
functional specificity of signaling may be fine-tuned by the presence of different a-
chains. The GM-CSF receptor can signal an astonishing variety of cellular functions, 
including protection from apoptosis, entry and progression through the cell cycle, early 
commitment to myelopoiesis, differentiation/maturation of committed progenitors, and 
multiple activation and motility functions in mature cells (Metcalf, 2008). 
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and the related cytokines 
IL-3 and IL-5 regulate the production and functional activation of hematopoietic cells, 
with GM-CSF acting on monocyte/macrophages and all granulocytes (Metcalf, 2008). 
GM-CSF also controls dendritic cell and T-cell function (Mellman and Steinman, 
2001), thus linking innate and acquired immunity. Because of the widespread 
expression of the GM-CSF receptor in hematopoietic cells, it was assumed that both 
GM-CSF and its receptor were key players in the regulation of steady-state functions. 
Whereas this turned out to be true in terms of lung physiology (Dranoff et al., 1994), 
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deletion of either the GM-CSF gene or its receptor showed no obvious deficiency in 
myeloid cell numbers or production. Rather, a growing body of evidence now suggests 
that GM-CSF plays a key role in signaling emergency hematopoiesis (predominantly 
myelopoiesis) in response to infection, including the production of granulocytes and 
macrophages in the bone marrow and their maintenance, survival, and functional 
activation at sites of injury or insult (Hamilton and Anderson, 2004; Fleetwood et al., 
2005). 
1.6 IL-3 induced signal transduction pathways 
IL-3 induces three types of biological effects in target cells, consisting of the induction 
of survival, proliferation and cell differentiation. These different biological effects 
require the activation of several signal transduction pathways, resulting in the 
reprogramming of gene expression. The first event in the mechanism of induction of a 
cell response to IL-3 is represented by the binding of this cytokine to its specific 
membrane receptor; the initial binding of IL-3 to the IL-3Ra chain results in the 
recruitment of a P-chain homodimer with the consequent formation of a high-affinity 
heterodimeric complex, culminating in initiation of cell signaling. The intracellular 
cell signaling originated by activation of the IL-3R involves three main known signaling 
transduction pathways: the Janus kinase (JAK)/signal transducer and activator of 
transcription (STAT) pathway, the mitogen-activated protein kinase (MAPK) 
pathways and the phosphatidylinositol 3-kinase (PI3-kinase) pathway (Fig. 1.4). 
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Figure 1.4: IL-3 signaling (from Steelman et al., 2004). IL-3 receptor activation induces 
the JAK/STAT, Raf/MEK/ERK and PI3K/Akt pathways. The JAK/STAT pathway 
induces the expression of anti-apoptotic genes such as Bcl-XL and also CIS and SOCS 
proteins, which serve as negative feedback regulators. The Ras/Raf/MEK/ERK pathway 
phosphorylates transcription factors that promote cell proliferation. Akt can 
phosphorylate many targets (Bad, IKK, caspase-9, GSK3p, Foxo3), which have effects 
on apoptosis and cell cycle progression. IL-3 also induces tyrosine phosphorylation of 
Gab2, a docking molecule, which associates with the Shp-2 phosphatase, Grb-2 and 
PI3PI3K. Gab2 can regulate PI3K and Ras activities. IL-3 regulates expression of 
phosphatases such as Shp2 and SHIP1, which regulate these pathways. Dotted lines 
indicate potential interactions between the pathways. Solid lines indicate direct paths of 
signal transduction. 
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1.6.1 JAK/STAT pathway 
The JAK/STAT pathway is used by many cytokines as a signal transduction mechanism 
for transmitting extracellular signals generated by the activation of their membrane 
receptors to promoters of target genes (Darnell, 1997; Bromberg and Darnell, 2000). To 
date, four mammalian members of the JAK family (JAK1, JAK2, JAK3 and TYK2) 
have been discovered. JAKs are constitutively associated with membrane-proximal 
intracellular domains of cytokine receptors and become phosphorylated after ligand 
binding and dimerization or oligomerization of the respective receptor chains. Activated 
JAKs constitutively phosphorylate tyrosine residues at the distal part of receptor chains, 
thereby generating docking sites for STATs and other intracellular signaling molecules 
(Darnell, 1997; Bromberg and Darnell, 2000). STATs recruited to specific 
phosphotyrosine-containing motifs located in the cytoplasmic tails of the receptors are 
in turn phosphorylated by activated JAKs at distinct tyrosine residues. After this 
modification, STATs either homodimerize or heterodimerize, leave the receptor 
complex, enter the nucleus and bind to response elements of target genes, thus 
influencing their transcriptional activity (Darnell, 1997; Bromberg and Darnell, 2000). 
Gene targeting experiments have provided clear evidence that JAK2 is strictly required 
for both the development of the hematopoietic system (Neubauer et al., 1998) and for 
the response to cytokines, including IL-3 (Parganas et al., 1998). 
Although JAK2 is the kinase predominantly activated by IL-3, members of the Src 
family of kinases, such as Fyn, Lyn, Syk, Btk and Hck, have also been reported to be 
activated by IL-3. JAK activation results in the phosphorylation of the p-chain at six 
tyrosine residues: Tyr577, Tyr612, Tyr695. Tyr750, Tyr806 and Tyr866 (Geijsen et al., 
2001). Three of these tyrosine residues, Tyr612, Tyr695 and Tyr750, serve as docking 
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sites for the Src homology 2 (SH2) domains of two members of the STAT family: 
ST ATI and STAT5. These two STATs are recruited to the receptor complex by their 
SH2 domains, become tyrosine-phosphorylated on critical residues in their 
carboxytermini and then homodimerize or heterodimerize by means of reciprocal SH2 
and phosphotyrosine interactions. 
The two STATs that play the most relevant role in mediating the biological effects of 
IL-3/IL-3R are STAT5 and STAT3. As discussed above, STAT5 activation is 
dependent on the P-chain, while STAT3 activation is mainly dependent on the 
cytoplasmic tail of the IL-3Ra-chain (Piu et al., 2002). The target genes of STAT3 and 
STAT5 are represented by a set of genes involved in survival, proliferation and 
differentiation. In this complex, a remarkable activating effect is exerted by STAT5 on 
retinoic acid receptors (RARs). These receptors regulate the growth and differentiation 
of primitive myeloid precursors in vitro and knockout mice deficient in RARa/RARy 
display a block in granulocytic differentiation (Labrecque et al., 1998). IL-3 markedly 
stimulates RAR expression through a STAT5-dependent mechanism; 
interestingly, activated STAT5 and RARs physically interact, forming a heterodimer 
(Si and Collins, 2002) 
1.6.2 MAPKPathways 
The MAPK pathways include three main signaling cascades: the extracellular signal-
regulated kinase (ERK), c-jun amino-terminal kinase (JNK) and p38. These pathways 
are key mediators of a large number of important cellular responses that play a major 
role in the control of cell survival and proliferation. These important signaling pathways 
are activated in response to many cytokines and growth factors. All three signaling 
pathways are activated by IL-3. 
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JNK is a member of the MAPK family and was identified as a stress-activated protein 
kinase that phosphorylates c-jun on two sites in the Nth-terminal activation domain. 
The upstream pathway leading to JNK activation is complex and involves as an end step 
the dual phosphorylation of the motif Thr-Pro-Tyr located in the activation loop 
(Manning and Davis, 2003). JNK phosphorylation is mediated by two MAPKs, 
MAP2K4 and MAP2K7, that cooperatively activate JNK. JNK activation leads to the 
phosphorylation of a number of transcription factors, most notably the c-jun component 
of AP-1 and cellular proteins, mainly those associated with the control of cell apoptosis. 
This last mechanism, in particular, is responsible for the anti-apoptotic mechanism 
induced by IL-3 via JNK activation. In fact, JNK is responsible for the phosphorylation 
and consequent inactivation of the proapoptotic Bcl-2 family protein Bad; 
phosphorylated Bad becomes unable to bind the anti-apoptotic molecule BC1-XL ( Y U et 
al., 2004). IL-3 withdrawal is associated with inactivation of JNK, which leads to 
dephosphorylation of Bad, which determines its potent activity (Yu et al., 2004). 
The activation of the ERK pathway by IL-3 starts with the phosphorylation of the P-
chain at the level of residue Tyr 5 7 7 , induced by JAK2 activation. This tyrosine residue, 
once phosphorylated, becomes a docking site for the cellular substrate SHC (Src 
homology and collagen), which then in turn becomes phosphorylated, allowing it to 
interact with the SH2 domain of the growth factor receptor-bound adaptor protein Grb2 
and the nucleotide exchange factor SOS (Ravichandran, 2001). The SHC/Grb2 
interaction leads to an association with the nucleotide exchange factor for Ras, which in 
turn leads to the sequential activation of Ras, Raf-1, MEK and ERK. Using (3-chain 
mutants in which a single tyrosine residue is left intact. It was shown that either Tyr 5 7 7 , 
Tyr 6 1 2 or Tyr 6 9 5 was sufficient to promote SHC phosphorylation, Grb2 association and 
MAPK activation (Kinoshita et al., 1995). 
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The downstream targets of activated ERK are represented by genes involved in the 
control of apoptosis and transcription factors that control the expression of genes 
involved in regulating proliferation. Concerning apoptosis genes, IL-3 is a stimulator of 
Bcl-2 and BC1-XL expression through an ERK-dependent mechanism (Kinoshita et al, 
1995). In addition to the upregulation of anti-apoptotic factors, the ERK pathway also 
inhibits apoptosis through inactivation of pro-apoptotic factors, such as Bad, via 
phosphorylation. Concerning the stimulatory effect on cell proliferation, the ERK 
pathway induces the transcription factors activating transcription factor 2 (ATF2) and 
ternary complex factor (TCF), which are capable of activating the proliferation- related 
genes c-Fos and c-Jun (Perkins et al., 1996). 
The tyrosine phosphatase Src homology protein tyrosine phosphatase 2 (SHP2) appears 
to be a positive regulator of the cell signaling originated by the common P-chain. In 
fact, the catalytic activity of SHP2 is strictly required for both JAK2 and ERK 
activation, but not for PI3-kinase induction (Yu et al., 2003). 
The activation of the MAPK p38 pathway by IL-3 is related to the induction of anti-
apoptotic mechanisms. In fact, the antiapoptotic mcl-1 is an immediate-early gene 
activated by IL-3 through a transcriptional mechanism involving the phosphorylation of 
PU. 1 and subsequent transcriptional activation of the mcl-1 gene by this phosphorylated 
transcription factor (Wang et al., 2003). 
1.6.3 PI3-Kinase Pathway 
While P-chain tyrosine phosphorylation is required for the activation of STAT and 
MAPK signaling cascades, PI3-kinase activation requires phosphorylation of the P-
chain at the level of Ser5 5. The phosphorylation of Ser585 results in recruitment of the 
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adaptor molecule 14-3-3 (Stomski et al., 1999). Mutation at this amino acid position 
causes a block in PI3-kinase activation by IL-3 (Guthridge et al., 2000). 
PI3-kinase is a heterodimeric lipid kinase composed of a regulatory subunit (p85) and a 
catalytic subunit (pi 10). Following IL-3 stimulation, activated PI3-kinase 
phosphorylates phosphatidylinositol lipids at the level of the inositol residues present in 
the cell membrane, thereby allowing the production of phosphatidylinositol-3,4,5-
triphosphate (PIP3), a second messenger that interacts with proteins through pleckstrin 
homology domains and induces a variety of biological effects (Cartley, 2002). 
One important target of PIP3 is the serine/threonine kinase Akt. This kinase plays a key 
role in the survival signals originating from PI3-kinase activation. Thus, the activation 
of Akt in response to IL-3 produces phosphorylation of Bad, resulting in 14-3-3 binding 
and sequestration in the cytoplasm, with consequent cell survival (Zha et al., 1996). In 
the absence of IL-3, PI3-kinase and Akt are not activated and Bad remains 
unphosphorylated, allowing it to translocate to mitochondria where it can bind the 
antiapoptotic proteins Bcl-2 and BC1-XL and induce cell death. 
More recently, it was observed that Akt could promote cell survival by acting as an 
inducer of nuclear factor-icB (NF-KB). Under normal conditions, NF-KB is maintained 
in an inactive, latent state in the cytoplasm by the inhibitor protein IKB. Akt 
phosphorylates IKB kinase ( IKK), which in turn phosphorylates IKB (Ramaskova and 
Makorov, 1999). Phosphorylated IKB is then targeted for degradation by the 
proteosome, allowing NF-KB to translocate to the nucleus and regulate gene expression. 
NF-KB is able to regulate the expression of a large set of genes, particularly the 
antiapoptotic genes Bcl-2, Bcl-XL and Al. Recent studies provided clear evidence that 
this pathway is involved in the stimulatory effect exerted by IL-3 on Bcl-2 gene 
expression (Guthridge et al., 2004). 
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The PI3-kinase pathway is involved not only in mediating the antiapoptotic effects of 
IL-3, but also in the control of cell proliferation by IL-3 via induction of the c-Myc 
protein. 
1.6.4 Pim-2 gene 
Anti-apoptotic mechanisms are induced by IL-3 not only via signal transduction 
pathways, but also via transcriptional stimulation. This is the case for the Pim-2 protein, 
a member of a family of serine/threonine kinases consisting of three members (Pim-1, 
Pim-2 and Pim-3), the expression of which is markedly stimulated by IL-3. In 
particular, in an IL-3-dependent lymphoid cell line, it was shown that Pim-2 gene 
expression was downregulated to the greatest extent following IL-3 deprivation. The 
activity of Pim-2 as an anti-apoptotic factor appears to be related to phosphorylation and 
consequent inactivation of the pro-apoptotic proteins Bad and Bim (Fox et al., 2003). 
The effects of Pim-2 on cell survival are similar to those displayed by Akt; however, 
Pim-2 does not appear to act through Akt. 
1.6.5 Negative control of IL-3R signaling 
Excessive uncontrolled signaling through IL-3R, as well as through other cytokine 
receptors involved in the stimulation of cell proliferation, could have deleterious effects 
and lead to uncontrolled cell growth. Therefore, several biochemical mechanisms limit 
in both extent and time the signaling originating from activation of IL-3 R. 
One mechanism is based on the activity of the suppressors of cytokine signaling 
(SOCS) family of small SH2-containing proteins. These proteins inhibit STAT 
signaling through two different mechanisms: one related to inactivation of JAK2 by 
blocking the access of STAT5 to receptor binding sites (Endo et al., 1997), and the 
other to ubiquitination of JAK2 with subsequent degradation (Ungureanu et al., 2002). 
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The inhibitory effect of SOCS-1 on STAT5 activity is potentiated by Pim-1, a 
serine/threonine kinase induced by IL-3. Pim-1 acts by phosphorylating SOCS-1, an 
event that stabilizes the interaction of this protein with STAT5 (Peltola et al., 2004). It 
is therefore evident that both Pim-1 and SOCS-1 are components of a negative feedback 
mechanism that allows STAT5 to attenuate its own activity. 
A second mechanism of attenuation of the STAT signaling originating from activation 
of IL-3R is related to the activation of cytosolic tyrosine phosphatases that control the 
level of phosphorylation of cellular substrates of activated tyrosine kinases. The tyrosine 
phosphatase SHP1 is involved in the negative control of IL-3R signaling, as shown by 
the observation that its overexpression resulted in a complete loss of IL-3 induced 
effects. SHP1 interacts directly with the IL-3R common (3-chain at the level of Tyr612, 
after phosphorylation (Bone et al., 1997). 
A third mechanism common to several membrane receptors is represented by receptor 
internalization, with subsequent degradation. In fact, for the majority of membrane 
receptors, including the IL-3R, ligand binding promotes the internalization of the 
receptor/ligand complex into clathrin-coated vesicles. These vesicles then fuse with 
early endosomes, where receptors are either resorted for receptor recycling back to the 
cell membrane or are targeted into late endosomes and finally degraded in lysosomes. 
Two lines of evidence suggest that this mechanism plays a role in the termination and 
modulation of IL-3R signaling: 1) prolonged IL-3R signaling is observed in the 
presence of proteosome inhibitors (Callus and Mathey-Prevot, 1998); and 2) 
biochemical studies indicate that during IL-3R internalization, the IL-3R common (3-
chain, but not the IL-3R a-chain, is proteolytically degraded at the level of the 
cytoplasmic domain (Martinez-Moczygamba and Huston, 2001). 
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1.7 Role of transcription factors and microRNAs in regulating 
differentiation 
HSCs (hematopoietic stem cells) reside in the bone marrow and give rise to progenitors 
that become progressively restricted to several or single blood cell lineages (Iwasaky 
and Akashy, 2007). These progenitors are devoted to the production of mature blood 
cells. All the non-lymphoid lineages of the blood are indicated as myeloid lineages. 
However, in its most common usage 'myeloid cells' refers to granulocytes (neutrophils) 
and monocytes/macrophages. Granulocytes (neutrophils) and monocytes/macrophages 
develop by progenitors that include CMPs (common myeloid progenitors) and, 
subsequently, GMPs (granulocyte/macrophage progenitors) in a process known as 
myelopoiesis. The production of these two alternative lineages depends on the unique 
combination and relative expression levels of key transcription factors that promote 
competing specific genetic programmes (Rosenbauer and Tenen, 2007). In particular, 
the co-ordinated development of myeloid cells depends on reciprocal inhibitory effects 
and adjustment of the concentration of key transcription factors that are responsible for 
the reduction in cell proliferation, induction of apoptosis and the expression of lineage-
specific myeloid genes. Among master transcription factors for myelopoiesis are 
C/EBPs (CCAAT/enhancer-binding proteins), PU.l, GFI1 (growth-factor independent 
1), IRFs (interferon-regulatory factors), SCL (stem-cell leukemia factor; also known as 
TALI) and RUNX1 [runt-related transcription factor 1; also known as AML1 (acute 
myeloid leukemia 1)]. A remarkable feature of the transcription factors in the myeloid 
system is that in human AML (acute myeloid leukemia) the majorities of them are 
involved in chromosomal translocations or contain somatic mutations (Tenen, 2003; 
Rosenbauer and Tenen, 2007). 
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miRNAs (microRNAs) provide an additional level of control beyond the transcription 
factors. They modulate a variety of developmental and physiological processes by 
regulating translation and stability of specific mRNAs (Bartel, 2004). A single miRNA 
can control the levels of hundreds of different target genes. Beyond its mere presence or 
absence, the concentration at which a given factor is expressed may influence lineage 
choice and differentiation. For this reason, it has been hypothesized that miRNAs 
deeply contribute to the large network of factors that dictate hematopoietic cell lineage 
specification. Indeed, several miRNAs are highly expressed in specific hematopoietic 
lineages and manipulation of their levels has been correlated with changes in cellular 
properties or differentiation (Chen et al., 2004; Shivdasani, 2006). 
1.8 Myeloid differentiation pathways 
Four myeloid differentiation pathways have been recognized: (1) steady state myeloid 
differentiation, which maintains the normal levels of mature myeloid cells, (2) cytokine-
driven (inducible or emergency) myelopoiesis which generates additional myeloid 
effector cells during infections or allergic responses, (3) ATRA-induced differentiation 
of PML cells and (4) CD44-driven differentiation of AML blasts. 
1.8.1 Steady state myeloid differentiation 
Studies of steady state myeloid differentiation have mainly focussed on granulopoiesis 
and particularly on the differentiation of neutrophils. C/EBPa is a master myeloid 
transcription factor and absolutely required for neutrophil differentiation (Rosenbauer 
and Tenen, 2007). The activity or expression of C/EBPa is commonly affected in AML 
(Mueller and Pabst, 2006). C/EBPa "7" mice are blocked in the formation of GM 
progenitors and C/EBPa does not appear to be required for later steps in neutrophil 
differentiation (Zhang et al., 1997). Although most attention has been given to the role 
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of C/EBPa in granulocyte differentiation, fetal liver from C/EBPa t mice lacks mature 
macrophages and macrophage progenitors (Heath et al., 2004). Progenitors from 
C/EBPa mice are still able to differentiate in response to IL-3 and GM-CSF (Zhang et 
al., 2002) indicating the existence of a cytokine-induced differentiation pathway in the 
progenitors which is not affected by the absence of C/EBPa. When C/EBPa is 
introduced into the C/EBPa progenitors, the G-CSFR, C/EBPp, C/EBPe and miR-223 
are upregulated and the cells differentiate into neutrophils (Zhang et al., 2002). 
1.8.2 Cytokine-induced myeloid differentiation 
Experiments with C/EBPa progenitors indicate that IL-3 and GM-CSF induce 
differentiation of these cells to neutrophils and upregulate C/EBPp and C/EBPe ( Zhang 
et al., 2002). ATRA does not induce the differentiation of C/EBPa progenitors. 
Evidence has also been presented that C/EBPp is important for cytokine-induced 
emergency granulopoiesis (Hirai et al., 2006). IL-3- and GM-CSF-driven myeloid 
differentiation appears commonly to be blocked in AML. However, at the 
commencement of the work described in this thesis there was little known of the 
mechanisms regulating IL-3- and GM-CSF-driven differentiation. 
1.8.3 ATRA-induced differentiation of promyelocytic leukemia cells 
Acute promyelocytic leukemia has been characterized as a differentiation arrest at the 
promyelocyte stage due to t (15; 17) reciprocal chromosomal translocation that 
generates a PML-retinoic acid (RA) receptor a (RARa) fusion protein (de The et al., 
1991; Kakizuka et al., 1991). All-trans retinoic acid (ATRA) induces the differentiation 
and elimination of APL clones (Yamanaka et al., 1997). The NB4 cell line was derived 
from a promyelocytic leukemia patient and carries the t (15; 17) translocation resulting 
in the joining of the promyelocytic leukemia-associated protein (PML) oncogene to the 
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gene encoding the RARa (Lanotte et al., 1991). Previous studies have demonstrated that 
NB4 cell line can be differentiated into granulocytes by ATRA (Tohda et al., 1992; 
Clark et al., 2004). Induction of differentiation by ATRA results in upregulation of the 
G-CSFR, C/EBPp, C/EBPe and miR-223 (Park et al., 1999; Duprez et al., 2001; Fatica 
et al., 2008). Interestingly, NB4 does not differentiate in response to IL-3 or GM-CSF. 
However, it has been shown that the combined neutralization of hIL-3, hGM-CSF and 
hG-CSF inhibits ATRA-induced differentiation of NB4 (Matsui et al., 2005) suggesting 
a possible involvement of the hpc receptor system in the process. 
1.8.4 CD44-induced differentiation ofAML blasts and NB4 
Differentiation of a variety of sub-types of AML cells can be induced by antibody 
ligation of the cell surface receptor CD44 (Charrad et al., 1999). Indeed, CD44 ligation 
is even more efficient than ATRA in lowering the levels of the PML-RARa protein in 
AML3 blasts (Charrad et al., 1999). Although the efficiency of differentiation varies 
with the AML sub-type, successful differentiation of AML primary cells or AML cell 
lines using anti-CD44 monoclonal antibodies has raised the exciting prospect of CD44 
as a new target for anti-leukemia differentiation therapy. The anti-CD44 monoclonal 
antibodies of H90, A3D8 and HI44a can induce differentiation and apoptosis of human 
acute myeloid leukemia cells (Charrad et al., 2002; Song et al., 2004), Further, H90 has 
the capacity to eradicate human AML stem cells (Jin et al., 2006). Little is currently 
known of the mechanisms in myeloid differentiation induced via CD44, but induction of 
expression of G-CSF and M-CSF mRNAs has been detected in some cases (Charrad et 
al., 1999). It has also been shown that autocrine/paracrine secretion of GM-CSF is 
required for AML5 blast differentiation by ligated CD44 (Delaunay et al., 2008) 
suggesting the involvement of the Pc receptor system. 
Work presented in the thesis 
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The promyelocytic leukemia line NB4 is not only blocked in steady-state granulocytic 
differentiation but also in cytokine-induced differentiation driven by IL-3 or GM-CSF. 
In Chapter 3, the hIL-3R system is investigated in NB4 cells. The IL-3R system was 
present at low levels in NB4 but was otherwise normal. Elevation of hIL-3R levels by 
ectopic expression restored IL-3-induced differentiation, in the absence of ATRA, but 
differentiation was only partial indicating that the PML-RARa protein also interferes 
with the induction of IL-3-driven differentiation. SiRNA knockdown of hpc did not 
affect ATRA-driven differentiation. In Chapter 4, the expression of CD44 and its ligand 
osteopontin in differentiating myeloid cells was investigated. Although it is known that 
CD44 is a potent inducer of differentiation of promyelocytic leukemia cells, siRNA 
knockdown of CD44 did not affect ATRA-induced differentiation of NB4 cells and also 
did not affect IL-3-induced differentiation. A major goal of the thesis work was the 
establishment of a new in vitro model for mIL-3-induced myeloid differentiation which 
would enable detailed molecular studies of the mechanisms involved with the potential 
for further investigations to be carried out in vivo. This work is addressed in Chapter 5. 
The recent development of conditional Hoxb8 (ER-Hoxb8) provides a way of reversibly 
immortalizing early myeloid progenitors. The activity of Hoxb8 is controlled by the 
level of estrogen in the medium. Growth factor-dependent immortalized myeloid 
progenitors can be isolated as continuous cell lines which grow without differentiation 
in the presence of estrogen and differentiate in its absence (Wang et al., 2006). Thus 
ER-Hoxb8 potentially provides an excellent model for study of the mechanisms 
regulating the switch between growth and differentiation. It is shown in Chapter 5 that 
the SCF-dependent line SCF ER-Hoxb8 shows IL-3-driven differentiation when grown 
in the absence of estrogen and some initial studies of the mechanisms involved are 
presented in this Chapter. The data indicate significant upregulation of miR-223 and the 
43 
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transcription factors C/EBPE and C/EBPp in the induction of differentiation and indicate 
that this model has great potential for future detailed studies. Interestingly, data using a 
mIL-3 mutant developed in our group which is specific for signaling via IL-3Ra SP1 
establishes an important role for signaling via the IL-3Ra SP2 isoform in the 
differentiation of this conditionally-immortalized GM progenitor. 
Collectively, the data suggest that the mechanisms involved in the induction of 
differentiation via the IL-3-driven, steady state, CD44-induced and ATRA-induced 
pathways are separate but they likely invoke a common granulocytic differentiation 
pathway which involves upregulation of C/EBPs, C/EBPp and miR-223. 
Chapter 2 
Materials and methods 
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2.1 Materials 
2.1.1 Chemicals 
All reagents were of analytical grade, or were of the highest grade obtainable. 
2.1.2 A ntibiotics 
Penicillin Sigma 
Streptomycin Sigma 
Gentamicin sulphate Sigma 
Puromycin Sigma 
Gentamicin (G418) Sigma 
2.1.3 Antibodies 
Rat anti-mouse IL-3Ra monoclonal antibody (5B11) BD Pharmingen 
Rat anti-mouse Pil-3 /pc monoclonal antibody (AIC2) MBL 
Monoclonal Anti-human IL-3 Ra Antibody (MAB301) R&D Systems) 
Purified Mouse Anti-Human CDw 131 (hpc) (3D7) BD Pharmingen 
Rabbit anti-mouse IL-3Ra (sc-681) Santa Cruz 
Goat anti-rabbit IgG HRP (sc-2004) Santa Cruz 
Monoclonal anti-P actin (AC-74) Sigma 
Rat anti- mouse F4/80 antigen-FITC 
Rat Anti-mouse CD1 lb (Mac-1 a chain) -PE 
Rat anti-mouse Gr-1 mAb-FITC 
Phycoerythrin (PE) anti-mouse FceRIa (Mar-1) 
Mouse Anti-Human CD1 lb (Mac-l)-PE 
Purified Mouse Anti-Human CD 15 - FITC 
Phospho-Jak2 (Tyr1007/1008) (C80C3) Rabbit mAb 
Jak2 (D2E12) Rabbit mAb 
Phospho-Stat5 (Tyr694) (CI 1C5) Rabbit mAb 
Stat5 Antibody 
Phospho-Akt (Ser473) (D9E) Rabbit mAb 
Akt (pan) (C67E7) Rabbit mAb 
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Serotec 
BD Pharmingen 
Caltag Laboratories 
eBioscience 
BD Pharmingen 
BD Pharmingen 
Cell signaling 
Cell signaling 
Cell signaling 
Cell signaling 
Cell signaling 
Cell signaling 
Phospho-p44/42 MAPK (Erk 112) (Thr202/Tyr204) Rabbit mAb Cell signaling 
p44/42 MAPK (Erkl/2) (137F5) Rabbit mAb 
Goat anti-rabbit IgG HRP 
Cell signaling 
Cell signaling 
2.1.4. Kits 
RNeasy Mini Kit 
QIAshredder 
Qiagen 
Qiagen 
Omniscript RT Kit 
HotStarTaq Master Mix Kit 
HotStar HiFidelity Polymerase Kit 
miRNeasy Mini Kit 
miScript Reverse Transcription Kit 
miScript SYBR Green PCR Kit 
QIAGEN Plasmid Midi and Maxi Purification Kits 
QIAprep Spin Miniprep Kit 
NucleoSpin Extract II Kit (PCR clean-up Gel extraction) 
pGEM-T Easy Vector Systems Kit 
KAPA HiFi PCR Kit 
Illustra Templiphi 100 Amplification kit 
EZ-Vision one, DNA Dye as Loading Buffer, 6X 
Platinum Taq DNA Polymerase High Fidelity 
NuPAGE 4-12% Bis-Tris 1.0 mm 10 well gel 
SuperSignal West Pico Chemiluminescent Substrate 
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Qiagen 
Qiagen 
Qiagen 
Qiagen 
Qiagen 
Qiagen 
Qiagen 
Qiagen 
Macherey-Nagel 
Promega 
KAPA Biosystems 
GE Healthcare 
Amresco 
Invitrogen 
Invitrogen 
Thermo Scientific 
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2.1.5. Oligonucleotides 
Table 2.1: Primers used for RT-PCR and quantitative real time PCR 
Gene Primer sequence 
mIL-3Ra SP1 or SP2 F 5 '-ATGGCCGCCAACCTGTGGCTC-3' 
R 5 '-GC AGG ACCG AGCCGC AC ATC A-3' 
hIL-3Ra SP1 and SP2 F 5 '-CTGTCTCCTGCAAACGAAGG-3' 
R 5 '-GTTGACGCCTGTTGGCAACG-3' 
Mouse P-actin F 5 '-GTGGGCCGCTCTAGGC ACC A-3' 
R 5 '-CGGTTGGCCTT AGGGTTC AGGGGGG-3' 
Human P-actin F 5 '-CCTCGCCTTTGCCGATCC-3' 
R 5 '-GGATCTTCATGAGGTAGTCAGTC-3' 
Mouse GATA-1 F 5 '-C ATTGGCCCCTTGTGAGGCC AG-3' 
R 5 '-CGCTCC AGCC AG ATTCG ACCC-3' 
Mouse GATA-2 F 5 '-CGAC AC ACC ACCCG AT ACCC ACCT AT-3' 
R 5 '-CGCCTACGCCATGGCAGTCACCATGCT-3' 
Mouse PU.l F 5 '-GAGTTTGAGAACTTCCCTGAG-3' 
R 5 '-TGGTAGGTCATCTTCTTGCGG-3' 
Mouse c-Myb F 5 '-GAGCTTGTCCAGAAATATGGTCCGAAG-3' 
R 5 '-GGCTGCCGC AGCCGGCTG AGGG AC-3' 
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Mouse AML1 F 5'-CCAGCAAGCTGAGGAGCGGCG-3' 
R 5 '-CCGACAAACCTGAGGTCGTTG-3' 
Mouse Ikaros F 5 '-C ACT ACCTCTGGAGC AC AGC-3' 
R 5'-TCTGAGGCATAGAGCTCTTA-3' 
Mouse Idl F 5 '-TC AGG ATCATGAAGGTCGCCAGTG-3' 
R 5 '-TG AAGGGCTGGAGTCC ATCTGGT-3' 
Mouse C/EBPa F 5 '-TGCGTCTAAGATGAGGGAGT-3' 
R 5 '-GATTAGGAGCCCTCC ACCTC-3' 
Mouse C/EBPp F 5 '-CGCCCGCGCACCACGACTTCCTCT-3' 
R 5 '-CGTCGCTC AGCTTGTCC ACCGTCTT-3' 
Mouse C/EBP5 F 5 '-CGGGC AGAGGGCGGGTCGTTCC-3' 
R 5 '-GCCGGCCGCTTTGTGGTTGCTGTT-3' 
Mouse C/EBPe F 5 '-TGTGGCGGTGAAAGAGGAGCCT-3' 
R 5 '-GGCTC AGCTGC AGCCCCC-3' 
Mouse NFYA F 5 '-TGCAGCCTCTGATTGGGTTTCG-3' 
R 5' -TCCTCCTG AGTTG ACC AC ATTCC-3' 
Mouse UBC F 5'-AAG AG AATCC AC AAGGAATTG AATG-3' 
R 5 '-C AAC AGG ACCTGCTG AAC ACTG-3' 
Mouse HPRT F 5 '-CACAGGACTAGAACACCTGC -3' 
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R 5 '-GCTGGTGAAAAGGACCTCT -3' 
Mouse NFI-A 
F 5 '-AACCGGCCCCAATTTTTCTCT 3' 
R 5'-AGGCTGCTGG ATG ATGGGTG AC- 3' 
Mouse Gfi-1 F 5 '-CCTTGGCCTGGGAACCTACC-3' 
R 5'-GGGGGCCTCCAAAAGTCCTC-3' 
Mouse G-CSFR F 5 '-GCTCCAGCGCTGCATCTAAAG-3' 
R 5 '-TGGGCTGGGTCTGGCACATC-3' 
Mouse M-CSFR F 5'-A ATGGC AGTGTGG A ATGGG ATGG-3' 
R 5 '-GTGGGGGCTCTGGGTGGACTC-3' 
Human P common F 5'-GCACCGGCTACAACGGGATCT-3' 
R 5 '-TCCCCGAATCCTACAGGGAAC-3' 
Mouse CBAP F 5 '-TTCGCTCTACTCGGTCTGGTTCAC-3' 
R 5 '-GGGACTCTCTTTGCTATGGGTTTG-3' 
Human CBAP F 5 '-CCAAGGACTTTGTCTTCTCTTTGC-3' 
R 5' - ACTTTCTTCGCTCTCCGTTCG-3' 
Mouse OPN F 5'-TGATGAACAGTATCCTGATGCCAC-3' 
R 5 '-GCTTTGGAACTTGCTTGACTATCG-3' 
Human OPN F 5 '-TGCAGCCTTCTCAGCC AAAC-3' 
R 5 '-TT AC AGGG AGTTTCC ATGAAGCC-3' 
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Mouse CD44 F 5'-CCAGAAGGCTACATTTTGCACAC-3' 
R 5'-TGGAGTCCTTGGATGAGTCTCG-3' 
Human CD44 F 5 '-GGGTTC AT AG AAGGGC ATGTGG-3' 
R 5 '-TCTCCTTTCTGGAC ATAGCGGG-3' 
Mouse Pc F 5'-TATGTGCTAAAAGGTAGTGTTTGC-3' 
R 5 '-TGTGCTCAATGAATGAGTAAGCC-3' 
Mouse Pil-3 F 5'-ATGTGTGCT AAAAGATT ACCTCTAT-3' 
R 5'-AAAGTGTGATC AATGTATTTGGGT-3' 
Mouse GM-CSF Ra F 5'-AGG AAGCCCCCTGTCTC AG-3' 
R 5 '-CCTTCCTGTCAGTC ACGTTG-3' 
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2.2 Methods 
2.2.1 Cell culture 
Unless otherwise stated, the cytokines used for cell growth were produced in insect cells 
(see below) and not further purified. Previous work in our laboratory verified that the 
unpurified preparations of the cytokines used had the same biological activities as 
purified preparations. The SCF used was conditioned medium from the CHO (SCF) cell 
line (see below). 
2.2.1.1 Expression of cytokines 
The flashYSAC system (Oxford Expression Technologies Limited) was used for the 
production of recombinant baculoviruses. Baculoviruses are insect viruses, 
predominantly infecting insect larvae of the order Lepidoptera (butterflies and moths) 
(van Regenmortel, 2000). A baculovirus expression vector is a recombinant baculovirus 
that has been genetically modified to contain a foreign gene of interest, which can then 
be expressed in insect cells under control of a baculovirus gene promoter. The most 
commonly used baculovirus for foreign gene expression is AcMNPV (Smith and Crook, 
1993). Recombinant baculoviruses were produced by cotransfection of Sf9 cells with 
flashYSAC Gold™ plus the transfer vector pBacPAK8 containing the gene encoding the 
protein to be expressed. Briefly, the pBacPAK8 plasmid DNA was diluted in TioEi 
buffer to 100ng/|il and 2 |il of this DNA was added to 400 (il of serum free medium, 2 
jil of flashBKC Gold DNA and 2 |j.l of transfection reagent. The solution was kept at 
RT for 30 minutes after gentle mixing. Two 4.5cm2 wells in a 6 well plate were seeded 
with 0.75xl05 Sf9 cells growing in TNM-FH with 10% FBS. After the cells adhered to 
the surface, they were washed twice in serum-free TNM-FH. The DNA mixture was 
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added gently and immediately to the cells. After incubating the plates for 5 hours, 1 ml 
of fresh TNM-FH with 10 % FBS was added to each well to give a final concentration 
of 5% FBS. Incubation of the plates was then continued at 27°c for 5 days, and the 
medium containing the virus collected and any cells removed by centrifugation at 1000 
rpm for 20 minutes. The virus titre was then amplified by several more passages using 
Sf9 cells in serum containing medium. 
The virus stock was then used to infect Hi5 cells (Invitrogen) for the production of 
expressed protein. Cells (5xl07) were seeded into 175-cm flasks in Ex-Cell™ 405. 10 
ml of virus in serum-containing TNM-FH medium was added and the cells incubated 
with virus for 1 hour, after which time the virus was drained off and the cells washed 
three times to remove traces of serum. 35 ml of Ex-Cell™ 405 medium was added and 
incubation continued for a further 72 hours. The supernatant containing the secreted 
recombinant protein was centrifuged at 1000 rpm for 20 minutes and stored frozen in 
aliquots. 
SCF-conditioned media was produced by culturing the CHO (SCF) cell line (kindly 
provided by Prof. M.P. Kamps) in OptiMEM medium supplemented with 10% v/v FBS, 
penicillin-streptomycin-glutamine solution and 2-mercaptoethanol. The cells are 
adherent and grow quickly. The media has to be changed every day. SCF-conditioned 
media stock was harvested and stored frozen in aliquots at -80 °c. 
2.2.1.2 Cell lines and cell culture 
Cells were grown in the following media: CTLL-2, RPMI 1640, 10% FCS, 2 mM L-
glutamine, 0.05 mM 2-mercaptoethanol, 0.1% v/v mIL-2; B4.1 (Hox-2A mouse 
myelomonocytic cells), DMEM, 10% FCS, 2% v/v mIL-3; FDCP-mix, Iscove's MEM, 
20% horse serum, 2% v/v mIL-3, 0.3% w/v NaHCCb, osmolarity adjusted to 0.32 
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osmol/L; FDCP-1, RPMI 1640, 10% FCS, 0.1% v/v mIL-3, 2 mM L-glutamine, 10 mM 
NaCl, 1 mM sodium pyruvate, 0.124 mM monothioglycerol; GB2, high glucose 
DMEM, 10% FCS, 0.05 mM 2-mercaptoethanol, 0.1 mM L-asparagine; WEHI-3B 
D+/D", Ml and HL60, DMEM, 10% FCS; TF1, RPMI 1640, 10% FCS, 4 mM L-
glutamine, 0.1% v/v hIL-3; NB4, RPMI 1640, 10% FCS, 2 mM L-glutamine; GM-CSF 
ER-HoxB8 progenitors, RPMI1640, 10% FBS, 1% Pen-Strep-Glut (PSG, Gibco) 1% 
v/v GM-CSF, 1 jiM P-estradiol (Sigma); SCF ER-HoxB8 progenitors, OptiMem I 
medium containing 10% FBS, 1% PSG, 1% v/v SCF (stem cell factor), 30uM beta 
mercaptoethanol, and 1 ^ M P-estradiol (Sigma). 
Cells were cultured in 5% CO2, except for GB2, WEHI-3B D+/D- and Ml cells which 
were cultured in 10% CO2. The growth medium for all cell lines was supplemented with 
60 ng/ml benzylpenicillin, 100|ig/ml streptomycin and 10 (ig/ml gentamycin. 
2.2.1.3 Stable transfection 
Stable transfections were used to derive cell lines expressing relevant receptors. cDNAs 
encoding mouse and human IL-3Ra SP1 and SP2 were cloned into the pEFIRES-N 
(G418) expression vector and cDNAs for mpc, mPiL-3 or hpc cloned into pEFIRES-P 
(puromycin). Restriction digestion was used to linearise 30 jig of a pEFIRES DNA 
construct, and DNA was purified by phenol/chloroform extraction, precipitated with 
ethanol and washed twice with 70% ethanol before air-drying. The DNA pellet was 
dissolved in 50 |xl plain medium and mixed with approximately 107 cells resuspended in 
320 |il growth medium before electroporation. Transfection of expression constructs 
into cells was done with a Bio-Rad Gene Pulser Xcell Electroporation System with 
settings of 290 V and 950|iF capacitance for Ml, NB4 cells and 260 V and 1050 fiF for 
FDCP-mix cells. Electroporated cells were allowed to stand for 10 minutes before being 
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transferred to 30 ml growth medium. 2 days after transfection, selection was carried out 
using 0.4 mg/ml G418 (Ml, FDCP-mix), 0.25 mg/ml G418 (NB4) and/or puromycin at 
0.006 mg/ml (Ml), 0.0005mg/ml (NB4) and 0.001 mg/ml (FDCP-mix). As many as 
possible stable transfectants were recovered yielding polyclonal populations of cells. 
2.2.1.4 Long term storage and thawing of cells 
Cell lines were stored in liquid nitrogen according to standard techniques. Cells growing 
in logarithmic phase were centrifuged (1500 rpm for 5 minutes at 4 °C) and resuspended 
at (>lxl06) in cold freezing medium (70% medium, 10% v/v dimethyl sulfoxide 
(DMSO), 20% FBS). 1 ml aliquots were dispensed into sterile pre-chilled cryotubes. 
The cryotubes were placed into a NALGENE Cryo Freezing Container (Nalge Nunc), 
an isopropanol rate cooling device, and placed at -80 °C for at least 24 hours before the 
vials were transferred to liquid nitrogen storage tanks. For recovery, stored cells were 
thawed rapidly in a 37 °C waterbath and transferred to a 15 ml sterile polypropylene 
tube. The cell suspension was mixed with 9 ml of growth media added dropwise over 5 
minutes whilst mixing. Cells were centrifuged at 1500 rpm for 5 minutes at room 
temperature and resuspended in 10 ml fresh growth medium. 
2.2.2 RNA Isolation and RT- PCR 
2.2.2.1 RNA Isolation 
Total RNA was prepared using a Qiagen RNeasy mini kit. Briefly, up to 1 x 107 cells, 
depending on the cell line, were disrupted using Buffer RLT. One volume of 70% 
ethanol was then added to the lysate, creating conditions that promote selective binding 
of RNA to the RNeasy membrane. The sample was then applied to the RNeasy Mini 
spin column and the RNA bound to the membrane. The column was washed with Buffer 
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RPE to remove contaminants and the high-quality RNA eluted in RNase-free water 
(Qiagen). All binding, washing, and elution steps were performed by centrifugation in a 
microcentrifuge. 
2.2.2.2 cDNA synthesis 
cDNA was synthesized using a Qiagen Omniscript RT kit with anchored Oligo(dT)20 
primers. Anchored Oligo (dT)2o Primer (Invitrogen) is a mixture of 12 primers, each 
consisting of a string of 20 deoxythymidylic acid (dT) residues followed by two 
additional nucleotides represented by VN, where V is dA, dC, or dG and N is dA, dC, 
dG or dT. The VN "anchor" allows the primer to anneal only at the '5 end of the poly 
(A) tail of mRNA, providing more efficient cDNA synthesis. 
Briefly, a fresh master mix was prepared (Table 2.2) and kept on ice. The primers used 
are listed in Table 2.1. The reaction mixture was carefully vortexed for no more than 5 
seconds, then centrifuged briefly and stored on ice. The template RNA was added and 
mixed carefully by vortexing for no more than 5 seconds. The reaction mixture was 
centrifuged briefly and incubated for 60 minutes at 37°C. 
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Table 2.2: Reverse transcription reaction components 
Component Volume/reaction Final concentration 
Master mix 
lOxBuffer RT 2|il 
dNTPMix (5mM each dNTP) 2^1 
Oligo-dT primer (10|iM) 2jj.\ 
RNase inhibitor (10 units/|_tl) 1 |il 
Omniscript Reverse Transcriptase 1 |al 
RNase-free water Variable 
Template RNA 
Template RNA 
0.5mM each dNTP 
lj iM 
10 units (per 20fxl reaction) 
4 units (per 20^1 reaction) 
Variable Up to 2 |ig (per 20jxl reaction) 
* This amount corresponds to the entire amount of RNA present, including any 
rRNA, mRNA, viral RNA, and carrier RNA present, and regardless of the primers used 
or cDNA analyzed. 
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2.2.2.3 Polymerase Chain Reaction (PCR) 
The prerequisite for a PCR to be used for quantification is that PCR product is measured 
within the exponential phase of the PCR reaction, where the amount of amplified target 
is directly proportional to the input amount of target. Therefore, quantification of gene 
expression by semi-quantitative RT-PCR was carried out during the exponential (log) 
phase of the PCR reaction and the plateau phase was avoided. The exponential phase of 
the PCR reaction was determined empirically by amplifying equivalent amounts of 
cDNA over different number of PCR cycles. The kinetic analysis was performed by 
amplifying PCR products over different number of PCR cycles and showed that PCR 
reaction was exponential between cycles 25 and 30. 
PCR was performed using a Qiagen HotStarTaq Master mix kit. Briefly, the HotStarTaq 
Master Mix was mixed by vortexing briefly and then dispensed into PCR tubes. The 
appropriate volume of the diluted primer mix was distributed into the PCR tubes 
containing the Master Mix. The primers used are listed in the Table 2.1. Template DNA 
(<1 (ig/50 |il reaction) was added to the individual PCR tubes. The conditions used for 
PCR were 30 cycles of 94 °C for 30 seconds, 50-68 °C (approximately 5 °C below the 
Tm of the primers) for 45 seconds and 72 °C for 1 minute using a PTC-200 Peltier 
thermal cycler (MJ Research, Watertown MA). 
2.2.3 MiRNA preparation and real-time PCR 
2.2.3.1 MiRNA preparation 
miRNA was prepared using a miRNeasy Mini kit (Qiagen) (Fig.2.1). Briefly, cell 
samples were disrupted by adding QIAzol Lysis reagent and were homogenized using a 
QIAshredder homogenizer. After the addition of chloroform, the homogenate was 
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separated into aqueous and organic phases by centrifugation. The RNA partitioned to 
the upper, aqueous phase, while the DNA partitioned to the interphase and proteins to 
the lower, organic phase or the interphase. The upper, aqueous phase was collected, and 
ethanol added to provide appropriate binding conditions for all RNA molecules from 18 
nucleotides (nt) upwards. The sample was then applied to the RNeasy Mini spin 
column. The RNA bound to the membrane and phenol and other contaminants were 
efficiently washed away. High-quality RNA was then eluted in RNase-free water 
(Qiagen). 
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miRNeasy 
Min i Procedure 
Cells/ t issue 
i 
i 
Lyse a n d homogenize 
A d d ch lo ro fo rm 
a n d shake 
Transfer aqueous 
phase to fresh tube 
A d d e thano l to 
aqueous phase 
Bind tota l RNA 
inc luding smal l RNAs 
Total RNA inc luding 
smal l RNAs 
Figure 2.1: miRNeasy mini procedure. 
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2.2.3.2 Quantitative real-time RT-PCR 
The detection and quantification of miRNAs was carried out by quantitative real time 
RT-PCR using the miScript reverse transcription kit, miSript primer assays and 
miScript SYBR green PCR kit (Qiagen) according to the manufacturer's instructions. 
Qiagen's Omniscript RT kit and miScript SYBR green PCR kit were employed in 
quantification of transcription factors. Quantitative RT-PCR was conducted with the 
7500 Real time PCR system (Applied Biosystems). 
2.2.3.2.1 Reverse-transcription step 
The miScript Reverse Transcription Kit includes miScript Reverse Transcriptase Mix 
and miScript RT Buffer. MiScript Reverse Transcriptase Mix is an optimized blend of 
enzymes comprising a poly (A) polymerase and a reverse transcriptase. MiScript RT 
Buffer has been developed specifically for use with miScript Reverse Transcriptase 
Mix. This buffer system enables maximum activity of both enzymes. MiScript RT 
2+ 
Buffer also contains Mg , dNTPs, oligo-dT primers, and random primers. Briefly, the 
reverse-transcription master mix was prepared on ice. This contains all components 
required for first-strand cDNA synthesis except template RNA. Template RNA was 
added to each tube containing reverse-transcription master mix and the reactions 
incubated for 60 minutes at 37°C. The reactions were heated for 5 minutes at 95°C to 
inactivate miScript Reverse Transcriptase Mix, placed on ice and then used for real-time 
PCR (Fig.2.2). 
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miScript Reverse Transcription Procedure 
Mix RNA, 
5x miScript RT Buffer, 
RNase-free water, and 
miScript Reverse Transcriptase Mix 
I 
I 
Incubate at 37°C for 60 min 
Incubate at 95°C for 5 min 
Use the cDNA to set up 
real-time PCRs 
F i g u r e 2 . 2 : M i S c r i p t R e v e r s e T r a n s c r i p t i o n p r o c e d u r e . 
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2.2.3.2.2 Real-time PCR step 
The cDNA serves as the template for real-time PCR analysis using the miScript Primer 
Assay in combination with the miScript SYBR Green PCR Kit (Fig.2.3). MiRNAs are 
amplified using the miScript Universal Primer, which primes from the universal tag 
sequence, together with the miRNA-specific primer (the miScript Primer Assay). A 
single cDNA preparation is sufficient to interrogate multiple miRNAs by real-time PCR 
using different miRNA-specific primers. 
The PCR conditions used were: initial activation step 95 °C 15 minutes, denaturation 94 
°C 15 seconds, annealing 55 °C 30 seconds, extension 70 °C 1 minute (extension 
temperature for transcription factors quantitative RT-PCR was 72 °C), 40 cycles. The 
miScript primer assays used in the miRNA experiments were: Mm_miR-15a_l, 
Mm_miR-16_l, Mm_miR-21_l, Mm_miR-142-3p_l, Mm_miR-155_l, Mm miR-
181a_l, Mm_miR-223_l, Mm_miR-292-3p_l, Mm_miR-23a_l, Mm_miR-27a_l, 
Mm_miR-24-2_l and Mm_miR-424_l. Hs_RNU6B_l was used as a reference gene 
compatible with both human and mouse samples. Mouse UBC and HPRT were 
employed as reference genes for the quantitative real time RT-PCR of transcription 
factors. Details of the primers used for reference genes and transcription factors are 
listed in Table 2.1. The data were analyzed using the comparative C T method ( A A C T 
method). To calculate the changes for SCF ER-hoxb8 cells undergoing differentiation, 
the fold-difference of miRNA or transcription factor expression was calculated for cells 
grown without estrogen (differentiating) relative to cells grown with estrogen (non-
differentiating). 
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miScr ipt Rea l -T ime P C R Procedure 
7 Prepare reaction mix 
/ Add template 
cDNA to wells 
a s u s t 
Add reaction 
mix to wells 
Cycle in real-time cycler 
F i g u r e 2 . 3 : M i S c r i p t r e a l - t i m e P C R p r o c e d u r e . 
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2.2.4 MiRNA microarrays 
MiRNA was prepared using a miRNeasy Mini kit (Qiagen). RNA quality was assessed 
by the Agilent 2100 Bioanalyzer prior to running microarrays. The sample profiles were 
analyzed by the software to generate an RNA Integrity Score (RIN). Up to 12 samples 
were run on a single RNA Nanochip. Each sample submitted for analysis was in 3 |il of 
RNase-free water (Qiagen) and at a concentration of about 200 ng / j_il. The Affymetrix 
miRNA Arrays were performed by the Adelaide Microarray Centre. These arrays 
required only 1 (xg of total RNA per sample. The Affymetrix miRNA microarray 
analyzed the expression of 609 mouse miRNAs in ER-Hoxb8 cells cultured with mIL-3 
or mGM-CSF for 2 days without and with estrogen. Microarray data was analyzed using 
the Partek Genomics Suite. Raw data were normalized after background subtraction 
using the global median of the intensities. 
2.2.5 Western blotting 
2.2.5.1 Deglycosylation 
For the Western blot, total protein or membrane protein fractions were prepared with 
CelLytic-M Mammalian Cell Lysis/Extraction Reagent (Sigma C2978) or CelLytic 
MEM protein extraction kit (Sigma CE0050) according to the manufacturer's 
instructions. Briefly, for deglycosylation, 80 jag of membrane protein fraction in 19.5 |il 
lx incubation buffer (20 mM sodium phosphate, 0.02% NaN3), was treated with SDS 
(0.1% final) and P-mercaptoethanol (50 mM final), and the proteins denatured by 
heating at 100 °C for 5 minutes. When cool, NP-40 (0.75% final) and 3U of N-
Glycosidase F (PNGase F, Roche) were added and the mixture incubated for 3 hours at 
37 °C. 
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2.2.5.2 Western blot analysis 
Western blotting was performed using an Invitrogen 4-12% NuPAGE Novex pre-cast 
gel system according to the manufacturer's instructions. Rabbit anti-mouse IL-3Ra (sc-
681) antibodies and goat anti-rabbit IgG HRP (sc-2004) were used (both from Santa 
Cruz) at a 1:1000 dilution for primary antibody and a 1:20,000 dilution for secondary 
antibody. Monoclonal anti-P actin (AC-74, Sigma) was used at a 1:5000 dilution. The 
membranes were washed 5 times in TBS containing 0.1% tween-20. Protein bands were 
detected using ECL Plus Chemiluminescent substrate according to the manufacturer's 
instructions. 
2.2.5.3 BCA protein assays 
The BCA Working Reagent was prepared by mixing 50 parts of Bicinchoninic Acid 
Solution with 1 part of Copper (II) Sulfate Solution. Mixing was continued until the 
BCA Working Reagent was light green in color. BSA protein standards ranging from 
0.2mg/ml to 8.0mg/ml were prepared and 2 ml of the BCA Working Reagent were 
added to 0.1 ml of each BSA protein standard, blank, and unknown sample. The 
samples were vortexed gently for thorough mixing and incubated at 37 ° C for 30 
minutes. The absorbance of the solution at 562 nm was measured by NanoDrop ND-
1000 spectrophotometer. Protein concentrations were determined from the standard 
curve for the BSA protein standards. 
2.2.5.4 Gel staining 
GelCode Blue Stain Reagent stains only protein and allows bands to be viewed directly 
on the gel for the use of total protein stains as loading control. After electrophoresis, 
gels were washed in ultrapure water with gentle shaking for 15 minutes. GelCode Blue 
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Stain Reagent was added and the gel was observed for approximately 1 hour to monitor 
protein band development. To destain the gel, the GelCode Stain Reagent was replaced 
with ultrapure water which was changed several times over 1-2 hours. Protein bands 
were visualized using the Fuji luminescent image analyser (Las-1000 plus, Fujifilm). 
2.2.5.5 Analysis of signal transduction pathways 
The phosphorylated and total Jak2, STAT5, Akt and Erkl/2 were investigated in SCF 
ER-Hoxb8 and BaF3 cells. All the antibodies used were from Cell Signaling (mouse 
anti-phosphorylated Jak2Tyrl007/1008, STAT5Xyrt>94, AktSer473, Erkl/2™r202Aryr204 and anti-
Jak2, STAT5, Akt, Erkl/2). SCF ER-Hoxb8 and BaF3 cells were treated with 1% mlL-
3 or mutant mIL-3 at the indicated times. The cells were harvested and washed once 
with cold PBS with ImM Na3VC>4. Then the cell lysates were prepared with the cold 
RIP A buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP40, 0.5% sodium 
deoxycholate, 0.1% SDS, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 
1 mM p-glycerophosphate, 10 mM Na3VC>4, 10 (ig/ml leupeptin, 10 (xg/ml aprotinin, 10 
|xg/ml pepstain A, 10 mM NaF, 1 mM PMSF, 4mM AEBSF, 250^M Cathepsin G 
inhibitor I ) at 4 °C 0.5 hour and the lysates were cleared by centrifugation for 10 
minutes at 4 °C and 100,000xg. The cleared lysates were subjected to SDS-PAGE using 
Invitrogen's Norvex Nupage reducing gel system. The Western blot for phosphorylated 
and total Jak2, STAT5, Akt, Erkl/2 was conducted according to the protocol provided 
by Cell Signaling. After probing with the phosphorylated-antibodies, the same blot was 
stripped and re-probed for detection of total proteins. 
2.2.5.6 Antibody stripping 
The Millipore Re-Blot Plus Western Blot Antibody Stripping Solution is effective for 
removal of antibodies from Western blots that have been developed with 
Chapter 2: Materials and methods 
chemiluminescence and was used in the work described in this thesis. Mild or Strong 
Antibody Stripping Solution lOx was diluted 10-fold with distilled water to obtain a lx 
solution. Blots were submerged in stripping solution in a plastic tray and incubated with 
gentle mixing for 15 minutes at room temperature. Blots were washed twice for 5 
minutes with blocking buffer before reprobing with antibodies. 
2.2.6 Flow cytometry 
Approx 10 cells were harvested and washed with ice-cold FACS buffer (2% FCS, 
0.02% NaN3 in PBS). For surface staining, cells were stained for 30 min in the dark at 
4°C. The following antibodies were used: Serotec, anti-mouse F4/80-FITC; BD 
Pharmingen, anti-mouse Mac-l-PE; Caltag Laboratories, anti-mouse Gr-l-FITC; 
eBioscience, anti-mouse Mar-l-PE (FceRIa); BD Pharmingen, anti-Human CD l i b 
(Mac-l)-PE; BD Pharmingen, anti-Human CD15-FITC; 7-AAD. Data were acquired on 
a FACSort cytometer and analyzed using FlowJo software. Two steps of flow cytometry 
were used to detect the ectopically expressed human IL-3Ra SP1 or SP2 with human 0c 
in NB4 cells, as well as mouse IL-3Ra SP1 or SP2 with mouse P i l - 3 , or mpc in Ml cells. 
Cells were harvested and washed with cold PBS, and then cells were incubated with 
1:200 dilution of primary antibody in FACS incubation buffer (0.2% BSA, 5% FBS in 
cold PBS) for 1 hour. After 3 washes with FACS washing buffer (0.2% BSA in cold 
PBS), the cells were then incubated with secondary antibody (1: 500 dilution of the 
relevant isotype of IgG or IgM in FITC or PE, 1:2000 dilution of SA-PE) for 0.5hour. 
Cells were washed three times with FACS washing buffer before being subjected to 
FACS. The same concentration of the relevant isotypes of immunoglobin of primary 
antibodies was used as the negative control. The primary monoclonal antibodies used 
were: MAB301 (for detection of hIL-3Ra SP1 and SP2, R&D Systems), 3D7 (CDwl31, 
for detection of hpc, BD Pharmingen), 5B11 (for detection of mIL-3Ra, BD 
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Pharmingen), and AIC2 (for detection of mouse |3IL-3, or mpc, MBL Medical and 
Biological Laboratories). 
2.2.7 Morphological analysis 
Ml or NB4 cells were cultured using a Lab-Tek II chamber slider system (Nalge Nunc) 
in growth medium for 4 days with and without mIL-3 or hIL-3. SCF ER-Hoxb8 cell 
was cultured with mIL-3, mGM-CSF or SCF using a Lab-Tek II chamber slider system 
for 4 days with or without estrogen. May-Grunwald-Giemsa staining was used. This 
staining method is based on the electrostatic interaction between dye and target 
molecules. The staining solutions contain methylene blue (a basic dye), related azures 
(also basic dyes) and eosin (an acidic dye). Briefly, the fixed slide was stained for 5 
minutes in May-Grunwald stain diluted with an equal volume of distilled water. The 
slide was transferred without washing into Giemsa stain diluted with 9 volumes of 
distilled water for 30 minutes, then washed in distilled water and allowed to dry. After 
May-Grunwald-Giemsa staining, cell morphology was examined under a lOOx oil 
objective using light microscopy. 
2.2.8 Proliferation assays 
Growth responses of SCF ER-Hoxb8 and Ba/F3 cells to mIL-3 or mIL-3 E23A were 
measured in triplicate by [ 3H] incorporation. The proliferation was measured after 2 
days incubation. Briefly, a two-fold serial dilution of a cytokine (mIL-3 or mIL-3 
E23A) was performed in triplicate in round-bottomed 96-well plates. The cells were 
washed four times with factor-free growth media and 50|xl of 4x l0 5 cells /ml were 
added into each well of the 96-well plate. The cells were incubated in a 95% CO2 
incubator at 37 °C for 44 hours. 0.5|xCi of tritiated thymidine was added to each well 
and the incubation continued for a further 4 hours. The cells were then harvested on to 
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glass fibre filters and the filters were washed three times with distilled water, dried, 
covered with lOO i^l of scintillation fluid and counted using a Packard Tri-Carb 1900CA 
liquid scintillation counter. 
2.2.9 RNA interference 
RNA interference (RNAi) is a highly evolutionally conserved process of post-
transcriptional gene silencing (PTGS) by which double stranded RNA (dsRNA), when 
introduced into a cell, causes sequence-specific degradation of homologous mRNA 
sequences. On entering the cell, long dsRNAs act as a trigger of the RNAi process. 
They are first processed by the RNAse III enzyme Dicer in an ATP-dependent reaction. 
Dicer processes dsRNAs into 21-23 nt short interfering RNA (siRNA) with 2-nt 3' 
overhangs. siRNA can also be synthesized outside the cell and then introduced into 
cells. The siRNAs are incorporated into the RNA-inducing silencing complex (RISC) 
which consists of an Argonaute (Ago) protein as one of its main components. Ago 
cleaves and discards the passenger (sense) strand of the siRNA duplex leading to 
activation of the RISC. The remaining guide (antisense) strand of the siRNA guides 
RISC to its homologous mRNA, resulting in the endonucleolytic cleavage of the target 
mRNA (Fig.2.4). 
The procedure used for RNA interference in the present work is described below. Three 
million log phase NB4 cells were washed twice and resuspended in 500 pi of 
electroporation buffer containing 0.5 nmol (final concentration l|iM) of hCD44 siRNAs 
(Ambion), hpc siRNAs (Ambion) or negative siRNA control in a 4-ram gap cuvette. 
The mixture was then electroporated with settings of 260 volts and 1050 pF using a 
Gene Pulser Xcell electroporation apparatus (Bio-Rad). Twenty-four hours after 
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transfection, cells were treated with 1 (iM ATRA. The cells were harvested for real-time 
RT-PCR to check the mRNA expression of target genes. 
Using the electroporation condition described above, a transfection efficiency of 80% or 
higher was consistently achieved without significant reduction of viability. After NB4 
cells were treated with ATRA for 4 days, the expression of surface markers were 
measured by FACS. 
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Figure 2.4: The mechanism of RNA interference. 
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2.2.10 Recombinant DNA techniques 
2.2.10.1 Preparation of bacterial cells 
2.2.10.1.1 E. coli Topi OF' 
The main bacterial cell used in this thesis was E. coli Topi OF' (Grant et al., 1990). This 
strain was from Invitrogen, USA and is a derivative of Hanahan's strain, DH5 
(Hanahan, 1985). The /acZAM15 locus contains a partial deletion of the p-galactosidase 
gene that enables a-complementation between the portion of the p-galactosidase gene 
carried on a pUC or M13-based plasmid and the portion of the chromosome of the host 
bacterial cell, allowing the blue-white screening of clones. The presence of the recAl 
allele increases the stability of inserts, and endAl improves the quality of plasmid DNA 
purified from this strain. The F' episome contains a tetracycline resistance marker, 
allowing Topi OF' to be maintained on rich media, such as LB or SOB, containing 
tetracycline, without the loss of F' episome. 
2.2.10.1.2 Chemically-heat shock-competent bacterial cells 
To select for the F' episome, an overnight culture of Topi OF' was grown in a small flask 
in the presence of tetracycline at 15|ig/ml. Next day, 1/100 dilution of the culture was 
made in LB without tetracycline. The cells were grown until the culture reached an 
optical density (OD) between A6oo 0.4 - 0.6. The cells were collected by centrifugation 
at 3700 rpm for 8 minutes at room temperature and resuspended gently in half the 
original volume, of ice-cold 50mM CaC^. The cells were centrifuged again and 
resuspended in 1/10 original volume, of 50mM CaCl2. Sterile glycerol was added to a 
final concentration of 15% v/v. Chemically-competent bacterial cells were frozen in 
liquid nitrogen in 100 or 200 |il aliquots and stored at -70°C until required. 
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2.2.10.1.3 Transformation of chemically heat-shock competent cells 
A 50 |j.l aliquot of Topi OF' chemically-competent bacterial cells was thawed on ice and 
incubated for 30 minutes with 5-10 of plasmid DNA. The bacterial sample was heat 
shocked for 45 seconds at 42°C, cooled on ice for 2 minutes and incubated for 45-60 
minutes at 37°C with preheated 200 (il LB media with gentle shaking at 160 rpm. Then 
the bacteria were spread onto LB-agar plates containing an appropriate antibiotic for 
selection of the plasmid and incubated overnight at 37°C. 
2.2.10.2 Mini preparation ofplasmid DNA 
DNA was prepared using the QIAprep DNA Miniprep kit (Qiagen), according to the 
manufacturer's instructions. Briefly, a single colony was inoculated into LB medium 
supplemented with the appropriate antibiotic (usually ampicillin at 50-100 |ig/ml) and 
the culture grown overnight at 37 °C with shaking at 250rpm. The cells were harvested 
by centrifugation, and lysed by alkaline lysis. The lysate was neutralised and the cellular 
debris removed by centrifugation. The supernatant was passed through an anion-
exchange resin containing positively-charged DEAE groups that bind the negatively-
charged DNA molecules. The DNA was subsequently eluted using TioEo.i buffer 
(lOmM Tris-HCl, 0.1 mM EDTA, pH8.0). 
2.2.10.3 Glycerol stock preparation 
A single colony of bacterial cells was used to inoculate 10 ml of LB medium 
supplemented with 50-100|j.g/ml ampicillin and grown for 16 hours at 37°C with 
shaking at 250 rpm. Glycerol stocks were prepared by adding 850 |il of overnight 
culture to 150 of sterile glycerol, and were stored at -70°C. 
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2.2.10.4 Large scale preparation of plasmid DNA 
Large amounts of DNA were prepared using the Qiagen midiprep or maxiprep kits 
according to the manufacturer's instructions. Briefly, bacterial cells from glycerol stocks 
were streaked on LB-agar plates at 37°C for single colonies. A single colony was 
inoculated into 50 ml or 200 ml of LB medium supplemented with 50-100 |ig/ml 
ampicillin for DNA midipreps or maxipreps, respectively, and grown for 16 hours at 
37°C with shaking at 270 rpm. Cells were harvested by centrifugation at 5000 rpm and 
lysed by alkaline lysis. After removal of the cell debris by centrifugation or filtration, 
the crude DNA was applied to an anion-exchange resin under low salt conditions. RNA, 
proteins and low molecular weight components were removed by a medium salt wash. 
The plasmid DNA was eluted by a high salt buffer, concentrated and desalted by 
isopropanol precipitation. The DNA precipitate was pelleted by centrifugation at 15000 
x g at 4°C and washed with 70% ethanol. The pellet was dried at room temperature and 
resuspended in TioEo.i buffer or milliQ water. 
2.2.10.5 Quantitation of nucleic acids 
The concentration of DNA was quantitated using a Nanodrop Spectrophotometer. The 
ratio between the OD readings at 260 nm and 280 nm (OD26O/OD28O) was used to 
estimate the purity of the DNA preparation. Pure preparations have OD26O/OD28O 
ratios of 1.8, with lower readings indicating protein or phenol contamination. 
2.2.10.6 Restriction enzyme digestion of DNA 
Restriction endonucleases were supplied by New England Biolabs, Promega or MBI 
Fermentas. DNA digestion was performed according to the manufacturer's protocols 
and in the buffer specified for each enzyme. The DNA concentration in the final 
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reaction was kept at 50 to 100 ng/jj.1 and glycerol was kept to below 5% (w/v) to 
minimise non-specific endonuclease activity. Bovine serum albumin (BSA) was 
routinely included in the reaction at 0.1 mg/ml. 
2.2.10.7 Agarose gel electrophoresis 
Electrophoresis was performed using agarose gels composed of 0.8- 2% (w/v) agarose 
dissolved in lxTAE (Tris-Acetate electrophoresis buffer containing 40 mM Tris-acetate, 
1 mM EDTA pH 8.0). The gels were submerged in a tank (Bio-Rad, USA) containing 
lxTAE buffer and were electrophoresed at up to 100 V. AMRESCO's EZ-VISION 
fluorescent DNA reagent was used for band visualization. En VIS ION DNA dye 6X 
Loading Buffer was diluted with 5 parts DNA sample and mixed. The samples were 
loaded and electrophoresis was carried out. The gel was removed and placed on a UV 
transilluminator to visualize bands. Gels were photographed using the Gene Genius Bio 
imaging system (Syngene). 
2.2.10.8 Purification of DNA fragments 
After agarose gel electrophoresis, the DNA fragment of interest was excised from the 
gel and purified using NucleoSpin Extract II Kits (Macherey-Nagel) according to the 
manufacturer's instructions. Briefly, the DNA was bound in the presence of chaotropic 
salt to a silica membrane. The binding mixture was loaded directly onto NucleoSpin 
Extract II columns. Contaminants such as salts and soluble macromolecular components 
were removed by a washing step with ethanolic buffer NT3. Pure DNA was finally 
eluted under low ionic strength conditions with slightly alkaline buffer NE (5 mM Tris-
Cl, pH 8.5). 
2.2.10.9 Dephosphorylation of DNA termini 
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Following digestion with restriction enzyme endonucleases, dephosphorylation buffer 
was added to the DNA solution to give a final composition of 50 mM Tris-HCl pH 8.5, 
0.1 mM EDTA. One unit of calf intestinal alkaline phosphatase (CIP; Roche) per 2 
pmol of DNA ends was added, and then the mixture incubated for 3 minutes at 37°C. 
An equal amount of CIP was added and incubation at 37°C continued for a further 30 
minutes. The reaction was terminated by freezing the solution to -20 °C. The digested 
DNA was then subjected to agarose gel electrophoresis and purified using illustra™ 
GFX™ PCR DNA and Gel Band Purification kit (GE HealthCare, UK) according to 
manufacturer's protocols. The DNA was then ready for ligation. 
2.2.10.10 DNA ligation 
Generally, a 5-fold molar excess of insert DNA to vector DNA was used in cohesive-
end ligation reactions. Ligation reactions were carried out in a 10 jxl volume using a 
rapid ligation kit (Promega). The rapid ligation kit was used according to manufacturer's 
instructions, with ligation reactions containing 3 Weiss units of T4 DNA ligase 
(Promega) incubated at 20-25 °C for between 1 and 3 hours before transformation into 
TOPI OF' competent cells. 
2.2.10.11 Transformation 
Transformations were carried out using chemically-competent cells. The entire ligation 
was added to 200^1 of competent cells and incubated on ice for 30 minutes followed by 
a heat shock step at 47 °C for 90 seconds. The transformation mixture was then 
transferred to ice for a further 5 minutes. 500(4.1 of LB was added to the mix and 
incubated at 37 °C for 30 minutes. The cells were then plated on an LB agar plate 
containing 100ng/ml ampicillin and incubated overnight at 37 °C. 
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2.2.10.12 Clone Screen PCR 
Colonies were picked and transferred to 20 of milliQ water with a sterile toothpick 
and the suspensions boiled for 5 minutes to lyse the bacterial cells. Each colony was 
also used to inoculate a numbered grid on an LB agar plate containing 50-100 ng/ml 
ampicillin. 3 of lysate was amplified in a 20 |xl reaction containing 10 pmol of each 
of two flanking primers (sense primer on the vector sequence; anti-sense primer on the 
inserted DNA), 2 mM dNTPs, 25 mM MgCL2, Perkin Elmer buffer II, 0.1 units of 
AmpliTaq DNA polymerase. The PCR reaction was performed in a Thermal cycler 
PTC-200 (MJ Research) using the following conditions: denaturation at 94 °C for 15 
seconds, annealing at 53 °C for 15 seconds, and extension at 72 °C for 1 minute/kilobase 
of predicted product fragment. This cycling was repeated 35 times, and at the end of the 
procedure, the PCR products were analyzed by agarose gel electrophoresis. 
2.2.10.13 Templiphi 
Templiphi can be used as a faster and easier alternative to DNA mini-preps for 
screening colonies when quite large numbers are involved, for example analysis of 
splice variants and checking for successful mutants in mutagenesis experiments. The 
reactions were performed using illustra TempliPhi 500 amplification kit according to 
the manufacturer's protocol (GE Healthcare UK limited, UK). Briefly, 2^1 of sample 
buffer was dispensed into PCR tubes. The sample buffer contains random hexamers that 
prime DNA synthesis nonspecifically and is used to resuspend bacterial cells from a 
colony or cell culture or any other input DNA. A pin was stuck lightly into the colony to 
be tested, then put into the sample buffer. After all the colonies were picked, the pins 
were removed and the samples were heated at 95 °C for 3 minutes in a PCR machine. A 
master mix containing 2.0^1 reaction buffer (salts and deoxynucleotides) and 0.08jal 
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enzyme mix (029 DNA polymerase and random hexamers in 50% glycerol) per reaction 
was prepared. 2.0^1 of master mix was added to the cooled sample tubes and the 
reactions were incubated at 30 °C overnight in the PCR machine. The DNA was then 
used directly for sequencing. 
2.2.11 DNA Sequencing 
The sequencing reaction contained: Big Dye terminator mix, l.Ojil; 5x Buffer, 1.5|il; 
primer (lpm/^1), 1.6|il; template + H20, 5.9|ul in a 10 |il volume. Reactions were 
performed in a thermal cycler (Bio Rad) using 25 cycles of 96 °C for 20 seconds, 50 °C 
for 10 seconds and 60 seconds for 4 minutes. This was followed by a 4 seconds holding 
step. DNA reaction products were precipitated by the addition of 5|*1 125mM EDTA, 
60^1 100% EtOH, and lOjal H20. Samples were centrifuged at 14000 rpm for 20 
minutes and the supernatant was discarded. The pellets were washed with 70% ethanol 
to carefully remove all supernatant and air dried for around 5 minutes. DNA sequencing 
was performed using the ABI Big Dye terminator cycle sequencing system following 
the manufacturer's instructions with analysis using an ABI 3730 sequencer. The 
sequencer was operated by the Biomolecular Resource Facility, John Curtin School of 
Medical Research at ANU. 
2.2.12 Statistical analysis 
A student's two-tailed non-paired Mest was used to determine the statistical 
significance. 
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3.1 Introduction 
The IL-3-driven myeloid differentiation pathway, which is the focus of the work 
described in this thesis, has so far received little attention and remains poorly 
understood. The properties of cytokine-deficient mice have shown that hematopoiesis 
driven by IL-3, GM-CSF and IL-5 (de Groot et al., 1998) can be disrupted with minimal 
effects on steady-state blood cell formation. Thus steady state hematopoiesis and 
cytokine-driven hematopoiesis involve separate mechanisms. As previously discussed 
in Chapter 1, the concept of two differentiation pathways is also supported by studies of 
progenitors from C/EBPa mice (Zhang et al., 2002). In terms of cytokine-driven 
differentiation, there remains controversy as to whether cytokine signaling has an 
instructive role or whether cytokines merely provide support for stochastic 
differentiation processes (Robb, 2007). 
Studies on IL-3Ra indicate that it is a marker of leukemic stem cells and suggest that it 
may be involved in the pathogenesis of AML. However, its role, if any, is not currently 
understood. IL-3Ra (CD123) is over-expressed in 45% of AML patients (Graf et al., 
2004), 40% of B- lineage ALL patients (de Waele et al., 2001) and 70% of immature T-
lineage ALL patients (Lhermitte et al., 2006). The elevated expression of CD 123 in 
acute leukemia is associated with enhanced leukemic blast cell proliferation, increased 
cell cycle activity, and poorer prognosis (Testa et al., 2002). Up-regulation of CD 123 
was also discovered in human acute myelogenous leukemia stem cells (Jordan et al., 
2000). New anti-leukemic drugs targeting the IL-3 receptor are now under development 
(Testa et al., 2004). 
Our group has recently identified a new splice variant of IL-3Ra (lL-3Ra SP2) which is 
active in myeloid differentiation (Chen et al., 2009). Ectopically expressed hIL-3Ra 
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SP2 plus hpc allowed hIL-3-driven differentiation of multi-potential FDCP-mix and 
myeloblasts Ml cells (Chen et al., 2009). The expression of hIL-3Ra SP2 was detected 
in various human leukemia cell lines, including NB4, KGla, THP-1 and MEG-01 cells. 
However, the levels of the individual hIL-3Ra isoforms in AML patients have not yet 
been determined. 
Analysis of IL-3 binding to AML blasts showed that over 80% had high affinity IL-3 
receptors (Alexandera et al., 2001) even though IL-3 did not induce differentiation as it 
does with normal myeloid progenitors. Also, a naturally occurring isoform of hpc (hPu) 
which possesses a truncated defective cytoplasmic region has been identified. Increased 
expression of PIT was found in the majority of AML patients tested (Gale et al., 1998). 
Collectively, this data suggests that AML blasts are commonly blocked in both the 
steady state and IL-3-induced myeloid differentiation pathways. 
The leukemic cell line, NB4 isolated from a promyelocytic leukemia patient (Lanotte et 
al., 1991), has been studied extensively because it can be differentiated along the 
granulocytic or monocyte/macrophage pathways by various differentiation inducers 
including ATRA (Tohda et al., 1992; Clark et al., 2004). Acute promyelocytic leukemia 
is characterized by maturation arrest at the promyelocytic stage of development caused 
by a novel fusion protein resulting from the reciprocal translocation involving the 
retinoic acid receptor alpha (RARa) on chromosome 17 with the promyelocytic 
leukemia gene (PML) on chromosome 15 (Melnick and Licht, 1999). The PML-RARa 
fusion protein blocks steady state myeloid differentiation (Benoit et al., 2001). NB4 also 
does not differentiate in response to hIL-3 or hGM-CSF (Hsu et al., 1996) indicating 
that the cytokine-induced differentiation pathway is blocked in these cells. However, 
interestingly, the combined neutralization of hIL-3, hGM-CSF and hG-CSF inhibits all-
trans retinoic acid (ATRA)-induced differentiation of NB4 (Matsui et al., 2005) 
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suggesting the possibility that IL-3 and/or GM-CSF signaling might be involved in the 
ATRA-induced differentiation pathway. 
In the results presented in this Chapter, the IL-3 receptor system in NB4 promyelocytic 
leukemia cells is studied, hIL-3-driven differentiation is partially restored by ectopic 
expression of the receptor and the possible involvement of the IL-3 receptor system in 
ATRA-induced differentiation is investigated. 
3.2 Results 
The human IL-3 receptor system is composed of an IL-3 receptor a subunit (hIL-3Ra; 
CD 123) and the pc subunit (CD 131). The pc subunit is shared with IL-5 and GM-CSF 
receptors. h(3c cannot detectably bind any of the three cytokines directly but complexes 
with the respective a subunits and the ligands to form high-affinity receptors, hpc is 
thought to be responsible for the majority of the signaling through the IL-3/IL-5/GM-
CSF receptors (Hayashida et al., 1990; Kitamura et al., 1991; Tavernier et al., 1991; 
Takaki et al., 1993). The hIL-3R system was investigated in NB4 promyelocytic 
leukemia cells. 
3.2.1 The common beta-associated protein (CBAP) 
A potentially important new lead relevant to Pc function in growth and differentiation is 
the recent identification of a novel transmembrane protein, common P-chain associated 
protein (CBAP) (Kao et al., 2008), which can induce apoptosis in factor-dependent cells 
via a mitochondrial pathway. Its expression in NB4 cells was investigated as it might 
potentially be relevant to myeloid differentiation. 
3.2.1.1 Expression of CBAP in NB4 cells undergoing differentiation 
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CBAP mRNA levels were determined before and after induction of differentiation. NB4 
cells were treated with ATRA for different times as indicated in Figure 3.1. The 
expression of human CBAP mRNA was increased only very slightly in NB4 cells 
induced by ATRA (Fig.3.1), but was clearly expressed in un-induced cells. The 
expression of CBAP in NB4 cells means it could potentially play a role in myeloid 
differentiation. 
Figure 3.1: The levels of hCBAP mRNA in NB4 cells before and after induction of 
differentiation by ATRA was measured by RT-PCR as described in Chapter 2. ATRA 
was dissolved in DMSO and included in the medium at a final concentration of ljxM. 
NB4, indicates untreated cells; DMSO, indicates cells treated with DMSO alone; the 
times of induction are indicated in the figure. P-actin was used as an internal standard. 
Results represent one of at least two independent experiments. 
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3.2.1.2 Expression of CBAP in mouse cell lines undergoing IL-3-
dependent growth or differentiation 
To further test for a possible role in growth or differentiation, the levels of CBAP 
mRNA were tested in a number of mouse cell lines. Some were undergoing mIL-3-
dependent growth and others undergoing hIL-3-induced differentiation enabled by 
ectopic expression of the hIL-3R. Surprisingly, the expression of CBAP mRNA was 
detected only in WEHI-3BD+ cells (Fig.3.2). This sub-line is capable of differentiation 
in G-CSF (Wu et al., 1989), but was grown in the absence of cytokine in this 
experiment. The sequence of the CBAP cDNA isolated from these cells confirmed its 
identity (see below) and the validity of this analysis. The results indicate that CBAP is 
not required for hIL-3-driven differentiation or mIL-3-driven growth of a number of 
mouse cell lines. The role of CBAP in IL-3-induced differentiation was therefore not 
investigated further. 
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Figure 3.2: The levels of CBAP mRNA in mouse cell lines measured by RT-PCR. 
FDCP-mix, B4.1, FDCP1 were undergoing IL-3-dependent growth and CTLL-2 was 
undergoing IL-2-dependent growth. FDCP-mix and Ml cells ectopically expressing 
hIL-3Ra SP2/hpc were undergoing hIL-3-driven differentiation. RNase-free water was 
used as PCR control. Results represent one of at least two independent experiments. 
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3.2.1.3 Sequence ofCBAPfrom WEHI-3B D+ 
Expression of CBAP mRNA was only detected in the WEHI-3B D+ cell line. WEHI-3B 
D+ is a leukemic cell line which constitutively expresses mIL-3 and will differentiate in 
response to G-CSF (Li et al„ 1993). The full length mCBAP cDNA from WEHI-3B D+ 
cell line was isolated and sequenced. The amino acid translation is shown in Figure 3.3 
aligned with the mouse CBAP standard from pregnant adult female mice. The identity 
of the CBAP cDNA was confirmed (Fig.3.3). Three amino acid substitutions were 
detected compared to the reference sequence. 
mCBAP_WEHI-3BD+ 
Standard mouse mCBAP 
mCBAP_WEHI-3BD+ 
Standard mouse mCBAP 
mCBAP_WEHI-3BD+ 
Standard mouse mCBAP 
mCBAP_WEHI-3BD+ 
Standard mouse mCBAP 
mCBAP_WEHI-3BD+ 
Standard mouse mCBAP 
MASTVWGGAPWWGPPPPAPAEPLTDIDFCSGAQLQELTQLIQELGVQESW 50 
MASTVWGGAPWWGPPPPAPARPLTDIDFCSGAQLQELTQLIQELRVQESW 50 
SEGPKPGADLLRAKDFVFALLGLVHRQDPRFPPQAELLLLRGGIREGSLD 100 
SEGPKPGADLLRAEDFVFALLGLVHRQDPRFPPQAELVLLRGGIREGSLD 100 
LGHAPLGPYSRGPHYDAGFTLLVPVFSLDGTGPELLLDLESCSAWLRLPE 150 
LGHAPLGPYSRGPHYDAGFTLLVPVFSLDGTGPELLLDLESCSAWLRLPE 150 
LMRGILVREAWQDCLGPPVPEESDMTHQTHSKESPTDRENSVDPSHDYVP 200 
LMRGILVREAWQDCLGPPVPEESDMTHQTHSKESPTDRENSVDPSHDYVP 200 
EPEPHMSLQKSSSDLSESQSSYKDITNPETPEPLETLSSDALDADESQVP 250 
EPEPHMSLQKSSSDLSESQSSYKDITNPETPEPLETLSSDALDADESQVP 250 
Figure 3.3: Alignment of amino acid sequences of mouse CBAP derived from WEHI-
3B D+ cells with the reference CBAP sequence (Kao et al., 2008). The full length 
mCBAP cDNA from WEHI-3B D+ cell line was isolated and the DNA sequencing was 
performed using the ABI Big Dye terminator cycle sequencing system with analysis 
using an ABI 3730 sequencer. 
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3.2.2 Expression of hfic, hIL-3Ra SP1 and hGM-CSFRa in NB4 cells 
undergoing differentiation 
NB4 cells can differentiate to neutrophils in the presence of ATRA (all-trans retinoic 
acid) but do not differentiate in response to hIL-3 or hGM-CSF. RT-PCR was used to 
investigate the levels of expression of endogenous hIL-3Ra SP1, hGM-CSFRa and hpc 
mRNAs in NB4 cells before and after induction of differentiation with ATRA. All were 
readily detectable in un-induced NB4 cells. The expression of h(3c was found to be 
increased significantly in NB4 cells undergoing differentiation induced by ATRA. The 
expression levels of IL-3Ra SP1 and GM-CSFRa showed no significant change in NB4 
cells with or without ATRA (Fig.3.4). 
Figure 3.4: The levels of IL-3Ra SP1, GM-CSFRa and h0c mRNA in NB4 cells before 
and after induction of differentiation by ATRA was measured by RT-PCR. ATRA was 
dissolved in DMSO and included in the medium at a final concentration of 1 (iM. NB4, 
indicates untreated cells; DMSO, indicates cells treated with DMSO alone; the times of 
induction are indicated in the figure, p-actin was used as an internal standard. Results 
represent one of at least two independent experiments. 
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3.2.3 DNA sequences of endogenous hIL-3 receptor sub units in NB4 
cells 
Since hIL-3 does not induce differentiation of NB4, in contrast to its action on normal 
myeloid progenitors, it was of interest to verify the sequence of the endogenous IL-3 Ra 
mRNAs to verify the absence of mutations which might affect function. Sequence 
analysis of full length hIL-3Ra cDNA clones isolated from NB4 cells showed the 
presence of approximately equal numbers of clones of the IL-3Ra SP1 and IL-3Ra SP2 
(211-444 base deletion) isoforms before and after treatment with ATRA. These clones 
had no amino acid substitutions compared with the reference sequence (Chen et al., 
2009). Also detected was a cDNA with a 211-329 base deletion (Fig.3.5). This clone is 
missing the first exon encoding domain 1 which results in the deletion of approximately 
half of domain 1 and causes premature termination. The data indicate expression of 
normal mRNAs encoding both hIL-3Ra isoforms in NB4 cells. 
Chapter 3: IL-3-driven differentiation of NB4 promyelocyte leukemia cells 
Single exon deletion 
hIL-3Ra SP2 
hIL-3Ra SP1 
Wild type hIL-3Ra 
MVLLWLTLLLIALPCLLQTKE' 
MVLLWLTLLLIALPCLLQTKE' 
21 
21 
MVLLWLTLLLIALPCLLQTKEDPNPPITNLRMKAKAQQLTWDLNRNVTDI 50 
MVLLWLTLLLIALPCLLQTKEDPNPPITNLRMKAKAQQLTWDLNRNVTDI 50 
Single exon deletion 
hIL-3Ra SP2 
hIL-3Ra SP1 
Wild type hIL-3Ra 
SEQ- 24 
S 22 
ECVKDADYSMPAVNNSYCQFGAISLCEVTNYTVRVANPPFSTWILFPENS 100 
ECVKDADYSMPAVNNSYCQFGAISLCEVTNYTVRVANPPFSTWILFPENS 100 
hIL-3Ra SP2 
hIL-3RaSP1 
Wild type hIL-3Ra 
GKPWAGAENLTCWIHDVDFLSCSWAVGPGAPADVQYDLYLNVANRRQQYE 72 
GKPWAGAENLTCWIHDVDFLSCSWAVGPGAPADVQYDLYLNVANRRQQYE 150 
GKPWAGAENLTCWIHDVDFLSCSWAVGPGAPADVQYDLYLNVANRRQQYE 150 
hIL-3Ra SP2 
hIL-3Ra SP1 
Wild type hIL-3Ra 
CLHYKTDAQGTRIGCRFDDISRLSSGSQSSHILVRGRSAAFGIPCTDKFV 122 
CLHYKTDAQGTRIGCRFDDISRLSSGSQSSHILVRGRSAAFGIPCTDKFV 200 
CLHYKTDAQGTRIGCRFDDISRLSSGSQSSHILVRGRSAAFGIPCTDKFV 200 
hIL-3Ra SP2 
hIL-3Ra SP1 
Wild type hIL-3Ra 
VFSQIEILTPPNMTAKCNKTHSFMHWKMRSHFNRKFRYELQIQKRMQPVI 172 
VFSQIEILTPPNMTAKCNKTHSFMHWKMRSHFNRKFRYELQIQKRMQPVI 250 
VFSQIEILTPPNMTAKCNKTHSFMHWKMRSHFNRKFRYELQIQKRMQPVI 250 
Figure 3.5: Alignment of amino acid sequences of hIL-3Ra derived from NB4 cells 
before and after treatment with ATRA. The full length hIL-3Ra cDNA clones were 
isolated from NB4 cells and the DNA sequencing was performed using the ABI Big 
Dye terminator cycle sequencing system with analysis using an ABI 3730 sequencer. 
Previous work by others in our group had shown that the hpc mRNAs expressed by 
NB4 cells were largely abnormal. Using flanking primers, seven clones were obtained 
and sequenced. Only one normal cDNA clone out of seven was obtained, with the rest 
having deletions (Y. Wu, J. Chen and I. Young, unpublished). After induction of 
differentiation with ATRA, six out of eight clones were normal. This suggests that a low 
level of normal h0c mRNA is present in NB4 cells prior to induction with ATRA. 
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3.2.4 Protein expression levels of hIL-3 receptor subunits in NB4 cells 
The endogenous levels of hIL-3Ra and hpc were measured by flow cytometry. The 
levels of hIL-3Ra and hpc were detectable but very low in NB4 parental cells. The 
endogenous expression levels of hIL-3Ra and h|3c in NB4 cells did not change 
significantly after NB4 cells were treated with ATRA (Fig.3.6). The antibody used 
detects both IL-3Ra SP1 and SP2 so the levels of the individual isoforms could not be 
established by flow cytometry. However, our group has previously measured the 
expression of both isoforms in NB4 by Western blotting (Chen et al., 2009) and shown 
that SP2 protein is expressed in NB4 cells together with the SP1 protein which is the 
major isoform. 
isotype 
NB4 parental 
NB4+ATRA 
104 10° 102 
hpc 
10 4 
Figure 3.6: The levels of hIL-3Ra and hpc endogenous expression in NB4 cells were 
measured by FACS. The red line histograms denote non-specific fluorescence obtained 
with the isotype control antibodies and are overlaid with the green and blue line 
histograms obtained after labeling with both the primary anti-receptor subunit antibody 
and secondary reagent. MAB301 is a mouse anti-human IL-3Ra (CD123) monoclonal 
antibody and 3D7 is a mouse anti-human hpc (CDwl31) monoclonal antibody. Results 
represent one of at least two independent experiments. 
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3.2.5 Ectopic expression of hIL-3Ra and hfk subunits in NB4 cells 
Since the endogenous levels of the hIL-3R subunits were very low in NB4 cells and 
there was some doubt about the amount of fully functional hpc, it was of interest to 
increase the levels of expression of the IL-3R. cDNAs encoding human IL-3Ra SP1 
and SP2 were cloned into the pEFIRES-N (G418) expression vector and a cDNA 
encoding h(3c cloned into pEFIRES-P (puromycin). Double stable transfections of 
expression constructs into NB4 cells were carried out and selection made using G418 
and/or puromycin. After the stable transfectants were recovered, the levels of 
ectopically expressed hIL-3Ra SP1 or SP2 and hpc in NB4 cells were measured by flow 
cytometry. Ectopic receptor expression was confirmed using a 2-step antibody labeling 
procedure. Dual transfectants expressing both the hIL-3Ra together with hpc were 
assessed by using 2-color analysis with FITC- and PE-conjugated secondary antibodies, 
respectively. The green line histograms denote non-specific fluorescence obtained with 
the isotype control antibodies and are overlaid with the red line histograms obtained 
after labeling with both the primary anti-receptor subunit antibody and secondary 
reagent. MAB301 is a mouse anti-human CD 123 monoclonal antibody and 3D7 is a 
mouse anti-human CDwl31 (hpc) monoclonal antibody. The results indicate good 
expression of the hIL-3Ra and hpc subunits (Fig.3.7). The levels of the receptors were 
considerably higher than the endogenous levels (see above). 
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antibody isotype control 
hIL-3Ra SPl/hpc hIL-3Ra SP2/hpc 
MAB301 3D7 MAB301 3D7 
Figure 3.7: The levels of ectopically expressed hIL-3Ra SP1 or SP2 and hpc in NB4 
cells were measured by FACS. Dual transfectants expressing both the hIL-3Ra together 
with hpc were assessed by using 2-color analysis with FITC- and PE-conjugated 
secondary antibodies, respectively. The green line histograms denote non-specific 
fluorescence obtained with the isotype control antibodies and are overlaid with the red 
line histograms obtained after labeling with both the primary anti-receptor subunit 
antibody and secondary reagent. MAB301 is a mouse anti-human IL-3Ra (CD123) 
monoclonal antibody and 3D7 is a mouse anti-human hpc (CDwl31) monoclonal 
antibody. Results represent one of at least two independent experiments. 
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3.2.6 Differentiation ofNB4 cells ectopically expressing hIL-3Rs in 
response to hIL-3 
NB4 cells ectopically expressing the two different hIL-3Rs were cultured in growth 
medium for 4 days with and without hIL-3. Morphological changes were examined by 
light microscopy after staining with May-Grunwald Giemsa. NB4 cells ectopically 
expressing hIL-3Ra SPl/h^c or SP2/hpc gave partial differentiation (about 15%) driven 
by hIL-3, in the absence of ATRA (Fig.3.8A). ATRA gave strong neutrophilic 
differentiation (about 70%) of NB4 cells as expected (Lee et al., 2002, Zhang et at., 
2008). hIL-3 was shown not to induce differentiation of NB4 parental cells (Fig.3.8B) in 
agreement with previously published data (Hsu et al., 1996). Thus over-expression of 
the IL-3R system resulted in a partial bypass of the differentiation block in NB4 cells. 
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hIL-3Ra SPl/hpc 
fc* N— 
hIL-3Ra SP2/hpc 
NB4 NB4+hIL-3 NB4+ATRA 
Figure 3.8: Morphological changes in A: NB4 cells expressing the hIL-3R system after 
4 days culture with hIL-3 (220U/ml); B: NB4 parental cells plus ATRA (lpM) or hIL-3 
(220U/ml). Morphological examination was made by light microscopy after May-
Grunwald-Giemsa staining. NB4 cells ectopically expressing hIL-3Ra SPl/hpc or 
SP2/hpc gave partial differentiation to neutrophil-like cells driven by hIL-3 and ATRA 
gave strong neutrophilic differentiation of NB4 cells. N, neutrophil. Scale bar =10 |im. 
Results represent one of three independent experiments. 
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3.2.7 hIL-3-induced expression of CDllb and CD15 in NB4 cells 
ectopically expressing hIL-3Rs 
NB4 cells expressing the two different hIL-3Rs were cultured with or without hIL-3 for 
4 days. The levels of expression of the surface markers C D l l b and CD 15 were 
measured by flow cytometry as an indicator of differentiation. hIL-3Ra SP2/hpc gave 
detectable increases in C D l l b and CD15 expression. hIL-3Ra SPl/hpc induced an 
increase in C D l l b but little increase in CD 15 expression. As expected, hpc alone gave 
no significant increase in either C D l l b or CD 15 expression indicating the critical role 
of IL-3Ra subunit in IL-3R signaling (Fig.3.9A). While the levels of CD1 lb and CD15 
were increased significantly in NB4 cells treated with ATRA, NB4 parental cells treated 
with hIL-3 gave no change in CD1 lb and CD 15 expression (Fig.3.9B). These results are 
in good agreement with the morphological changes observed with NB4 cells ectopically 
expressing hIL-3R described above. Overall the data indicates that the block in IL-3-
induced differentiation of NB4 can be partially overcome by increased expression of 
wild type receptors but full differentiation is not achieved presumably due to 
interference from the PML-RARa protein. 
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hIL-3 No addition 
CDllb CD15 
NB4 cells ectopically expressing the hIL-3R system were cultured with or without hlL-
3 (220U/ml) for 4 days. Expression of CD 1 lb and CD 15 in NB4 cells was measured by 
FACS. B: FACS analysis of expression of CDllb and CD15 in parental NB4 cells 
treated with ATRA (l|iM) or hIL-3 (220U/ml). Results represent one of three 
independent experiments. 
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3.2.8 MiRNA expression in NB4 cells undergoing differentiation induced 
by ATRA or hIL-3 
MicroRNAs (miRNAs) are small, non-protein-coding RNAs of 19-25 nucleotides that 
regulate gene expression by targeting messenger RNAs (mRNA) in a sequence-specific 
manner inducing translational repression or mRNA degradation (Bartel, 2004). 
MiRNAs play important roles in the development, differentiation, metabolism, cell 
growth and death in animals and plants (Poy et al., 2004; Cheng et al., 2005; Dresios et 
al., 2005). There is also evidence that supports a role for miRNAs in hematopoiesis. The 
miRNA gene expression profile of the NB4 cell line treated with ATRA was previously 
reported. miR-15a, miR-15b, miR-16-1, let-7a-3, let-7c, let-7d, miR-223, miR-342 and 
miR-107 were upregulated, whereas miR-181b was downregulated (Garzon et al., 
2007). 
Real-time PCR was used to measure the relative fold change of four miRNAs in NB4 
cells undergoing differentiation induced by ATRA or hIL-3. In agreement with previous 
findings (Garzon et al., 2007), miR-15a, miR-16, miR-223 and miR-342 were elevated 
in NB4 cells treated with ATRA with miR-223 being elevated 5-fold. In contrast, only 
slight increases were detected in NB4 cells expressing hIL-3 Ra SP1 or SP2/h|3c after 
treatment with hIL-3 (Fig.3.10) consistent with the incomplete differentiation observed. 
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Figure 3.10: Relative fold change of four miRNAs in NB4 cells undergoing 
differentiation induced by ATRA or hIL-3 was measured by real-time RT-PCR. NB4 
cells expressing the hIL-3R system were cultured with hIL-3 for 4 days. And NB4 
parental cells were treated with or without ATRA for 4 days. Expression of each 
component was presented as the fold-expression ratio of the level in differentiated cells 
over the level in NB4 untreated cells. U6B small nuclear RNA was used as reference 
gene. Results were verified in at least three independent experiments. 
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3.2.9 Investigation of possible synergistic effects between hIL-3 or hGM-
CSF and ATRA in the induction of differentiation 
The experiments described above showed that over-expression of the hIL-3R partially 
overcame the block in differentiation in NB4 cells. It was of interest to see if any 
synergism could be detected between IL-3 or GM-CSF signaling through their 
endogenous receptors and ATRA. In order to detect synergistic effects, preliminary 
experiments were carried out to establish suitable sub-optimal levels of ATRA. It was 
established that O.OOSjxM ATRA gave a small but detectable increase in C D l l b 
expression indicating slight differentiation (Fig.3.11A). No synergistic increases in 
CD1 lb expression were detected with ATRA (0.005JIM) in combination with hIL-3 or 
hGM-CSF (Fig.3.11B) indicating that separate mechanisms are involved in the 
induction of differentiation via the ATRA and cytokine-driven pathways. 
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Figure 3.11: Investigation of possible synergistic effects between hIL-3 or hGM-CSF 
and sub-optimal levels of ATRA. A: NB4 cells were treated with different 
concentrations of ATRA (0.005|liM, 0.1 |iM, 1 |iM) for 4 days and the levels of CD1 lb 
expression determined by FACS. B: NB4 cells were treated with a sub-optimal level of 
ATRA (0.005jiM) and hIL-3 (220U/ml) or hGM-CSF (290U/ml) for 4 days and CD1 lb 
expression measured by FACS. Results represent one of three independent experiments. 
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3.2.10 Effect ofsiRNA knockdown of hpc on ATRA-inducedNB4 
differentiation 
It was previously shown that simultaneous treatment with neutralizing antibodies 
against IL-3, GM-CSF and G-CSF inhibited ATRA differentiation of NB4 (Matsui et 
al., 2005). It was therefore of interest to test siRNA knockdown of endogenous hpc on 
differentiation of NB4 induced by ATRA. Knockdown of hpc would simultaneously 
inhibit signaling by IL-3 and GM-CSF. Real-time PCR showed that siRNA treatment 
reduced hpc expression by 90% and 75% respectively, 1 and 4 days after siRNA 
treatment in NB4 (Fig.3.12). The effect of siRNA knockdown on ATRA induced 
differentiation of NB4 was measured by CD1 lb expression, but no effect was detected 
(Fig.3.13). Thus the mechanisms involved in the induction of differentiation via the IL-
3-driven and ATRA-induced differentiation pathways appear to be independent. 
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Figure 3.12: siRNA knockdown of h0c mRNA in NB4 cells by hpc siRNA. NB4 cells 
were treated with hpc siRNA and a negative siRNA control. The levels of hpc mRNA in 
NB4 cells treated with hpc siRNA for 1 and 4 days was measured by real-time RT-PCR 
and compared with NB4 cells treated with negative siRNA control. Results were 
verified in three independent experiments. Data are mean, error bars are standard 
deviations. *,/?<0.001; **,/?<0.01 by student's t test. 
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Figure 3.13: The effect of hpc siRNA knockdown on ATRA induced differentiation of 
NB4 was measured by CD l ib expression. NB4 cells were treated with 1 |iM ATRA 
and/or hpc siRNA or negative siRNA control for 4 days. Expression of CD1 lb in NB4 
cells was measured by FACS. Results represent one of three independent experiments. 
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3.3 Discussion 
In the results described in this Chapter, the hIL-3R system was investigated in NB4 
cells, hIL-3-driven differentiation was partially restored after elevation of the IL-3R 
levels by ectopic expression and the possible involvement of the IL-3 receptor system in 
ATRA-induced differentiation was investigated. 
Common P-chain associated prbtein (CBAP) (Kao et al., 2008), is a novel 
transmembrane protein which can induce apoptosis in factor-dependent cells via a 
mitochondrial pathway. The expression of CBAP was shown in NB4 cells undergoing 
ATRA-induced differentiation. The possible involvement of CBAP in either IL-3-
dependent growth or differentiation had not previously been investigated. Its expression 
in differentiating NB4 cells was potentially interesting, but the mRNA levels of CBAP 
were also tested in mouse cells undergoing IL-3-dependent growth or IL-3-dependent 
differentiation. Surprisingly, CBAP was only expressed in WEHI-3 D+ and was absent 
in all strains undergoing IL-3-dependent growth or differentiation. It is therefore clear 
that CBAP does not play a critical role in IL-3-dependent growth or differentiation in 
mouse cells and it is reasonable to conclude that it would also not play a critical role in 
IL-3-driven differentiation of human myeloid cells. 
The IL-3R system was investigated in NB4 cells. It was shown by DNA sequencing that 
the sequences of the endogenous IL-3Ra isoforms were normal. Previous work in our 
group had shown by Western blotting that normal levels of protein of the two isoforms 
are expressed in NB4 cells (Chen et al., 2009). Flow cytometry demonstrated low but 
detectable levels of IL-3Ra and h(3c in NB4 cells. The levels of the IL-3R were 
considerably elevated by ectopic expression. Interestingly, hIL-3-driven differentiation 
was restored in NB4 cells ectopically expressing hIL-3Ra SPl/hpc or hIL-3Ra SP2/h(k 
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as shown by morphological analysis and surface marker expression but the 
differentiation was only partial. This indicates that the block in IL-3-induced 
differentiation of NB4 can be partially overcome by increased expression of wild type 
IL-3 receptors. However, full differentiation could not be restored, probably due to the 
dominant negative effects of the PML-RARa fusion protein, which are only fully 
overcome by ATRA. 
MiRNAs play important roles in the differentiation, development, cell growth and 
hematopoiesis (Cheng et all 2005; Dresios et al., 2005). It has been reported that miR-
223 is a key member of a regulatory circuit involving C/EBPa and NFI-A that control 
granulocytic differentiation in ATRA-treated APL cell lines (Fazi et al., 2005). In 
agreement with previous findings (Garzon et al., 2007), miR-15a, miR-16, miR-223 and 
miR-342 were elevated in NB4 cells treated with ATRA with miR-223 levels being 
elevated 5-fold. Only slight increases were detected in NB4 cells expressing hIL-3Ra 
SPl/hpc or hIL-3Ra SP2/hpc after treatment with hIL-3. The minor increases in 
miRNAs are in agreement with the partial differentiation of NB4 cells ectopically 
expressing the two hIL-3Rs induced by hIL-3. 
It has been shown that neutralizing antibodies to hIL-3, hGM-CSF and hG-CSF 
partially block ATRA-induced differentiation of NB4 suggesting a possible 
involvement of Pc receptor signaling in the ATRA-induced differentiation pathway 
(Matsui et al., 2005). However no synergistic effects between hIL-3 or hGM-CSF and 
ATRA were detected. Similarly, siRNA knockdown of hpc had no significant effect on 
NB4 differentiation induced by ATRA. Collectively these results indicate that the 
mechanisms involved in induction of differentiation via the IL-3-driven and ATRA-
induced differentiation pathways are independent in NB4 cells. 
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4.1 Introduction 
A major goal of AML treatment is the development of differentiation therapies to 
overcome the differentiation block in leukemia. The clinical use of ATRA to treat PML, 
particularly in combination with arsenic trioxide and chemotherapy, is the most 
successful differentiation therapy to date (Petrie et al., 2009). Recently, some exciting 
new findings on the differentiation of AML blasts and leukemic stem cells were 
reported which involved ligation of CD44 (Gadhoum et al., 2004). In contrast to ATRA 
treatment which is limited to PML, CD44 ligation seems to be applicable to most types 
of AML (Gadhoum et al., 2004) although the efficiency varies with the AML sub-type 
(Charrad et al., 1999). CD44-induced differentiation was very effective in reducing the 
levels of PML-RARa protein in AML3 suggesting a possible relationship with ATRA-
induced differentiation. Also, G-CSF or M-CSF mRNAs were induced in some cases 
(Charrad et al., 1999) suggesting possible links with cytokine-induced differentiation. 
Recently, it was shown that autocrine/paracrine secretion of GM-CSF is required for 
AML5 blast differentiation by ligated CD44 (Delaunay et al., 2008) suggesting the 
involvement of the Pc receptor system. 
CD44 is a cell surface transmembrane glycoprotein which is involved in normal 
hematopoiesis and in leukemia (Ghaffari et al., 1999). The CD44 gene contains 20 
exons, many of which are subject to alternative mRNA splicing resulting in a large 
number of possible transcripts. The most common form of CD44 is referred to as 
CD44H (hematopoietic) or CD44s (standard). CD44 variants contain additional exons 
referred to as variant exons (vl-vlO) (Ghaffari et al., 1999). CD44 is a receptor for 
hyaluronic acid (HA) and is involved in lymphocyte activation, recirculation and 
homing, adhesion of the extracellular matrix, angiogenesis, cell proliferation, cell 
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differentiation and cell migration (Adamia et al., 2005). CD44s (Iida and Bourguignon, 
1995) is expressed by all types of mature blood cells and the majority of mononuclear 
bone marrow precursors. The level of its expression varies according to the 
hematopoietic cell lineage and stage of differentiation. Expression of CD44 variants has 
been associated with poor prognosis and increased metastatic spread in acute leukemia 
(Bendall et al., 2000). For example, the expression of CD44v6 (CD44 isoform 
containing exon v6) has been shown to be increased in ALL (Bendall et al., 2004) and 
in AML (Legras et al., 1998) and correlates with shorter overall survival. 
CD44 is a major receptor for HA, which has been identified as a critical component of 
the hematopoietic stem cell (HSC) niche (Nilsson et al., 2003). Administration of HA to 
mice following 5-fluorouracil treatment enhanced the recovery of leucocytes and 
platelets in the peripheral blood, further suggesting that HA has important roles in vivo 
in HSC regulation (Matrosova et al., 2004). 
In primary IL-3-dependent mouse bone marrow cells, expression and activation of 
CD44 has been shown to be important for the anti-apoptotic activities of IL-3 and GM-
CSF (Lin et al., 2000). IL-3 and GM-CSF upregulate the expression of CD44v4 and 
CD44v6, and the increased CD44 expression is accompanied by elevated expression of 
IL-3Ra in activated airway eosinophils (Bates et al., 2004). However, the possible 
relationship of CD44 and the IL-3 receptor system in leukemia remains unclear. 
OPN is a secretory extracellular matrix protein that has been implicated in cancer-
associated mechanisms such as metastasis, invasion and angiogenesis and is a ligand for 
CD44. Three OPN isoforms (OPN-a, -b and -c) derived from alternative splicing are 
known to exist, but their functional specificity remains unclear (Chae et al., 2009). 
Overexpression of OPN is a feature of multiple myeloma and chronic myeloid leukemia 
through the regulation by BCR-ABL oncogene. In CML and multiple myeloma patients, 
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the expression of OPN is involved in the progression and increased aggressiveness of 
disease (Hickey et al., 2005). OPN-c is a selective marker of breast cancer (Patani et ah, 
2008). OPN has a well-documented role in bone regulation, which is vital for 
hematopoiesis both by providing a physical structure and the non-hematopoietic cellular 
and extracellular molecules that have very recently been identified as critical 
components of the HSC niche. OPN is a key molecule in the attraction, retention and 
regulation of HSC within the endosteal HSC niche (Nilsson et al., 2005). 
In the work described in this Chapter, the potential involvement of CD44 in the ATRA 
and IL-3-induced differentiation pathways was investigated by siRNA knockdown and 
the expression of CD44 and OPN isoforms in mouse myeloid differentiation models 
was studied. 
4.2 Results 
4.2.1 Expression of CD44 and osteopontin in mouse and human myeloid 
cell lines 
To evaluate the potential involvement of CD44 and its ligand OPN in IL-3-driven 
myeloid differentiation, RT-PCR was used to measure their expression in a variety of 
mouse cell lines some undergoing differentiation. DNA sequencing of cDNA clones 
was used to determine which isoforms were expressed. A similar analysis was carried 
out for the human promyelocytic leukemia line NB4. 
4.2.1.1 Expression of CD44 and osteopontin in mouse cell lines 
undergoing differentiation 
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Three differentiation models (FDCP-mix multi-potential cells, Ml leukemia cells and 
WEHI-3B D+ leukemia cells) have been used to study IL-3-induced differentiation in 
our group by ectopically expressing hIL-3 receptors in these cells (Chen et al., 2009). It 
was therefore of interest to measure the levels of CD44 and osteopontin in these cells 
during differentiation. It was found that CD44 mRNA levels were readily detectable in 
each of these cell lines (Fig.4.1). No major changes in the levels occurred when FDCP-
mix and Ml cells expressing hIL-3 receptors underwent differentiation induced by hlL-
3. Higher CD44 expression was shown in WEHI-3B D+ cells (the sub-line which 
differentiates in response to G-CSF) and lower CD44 expression in WEHI-3B D- cells 
(the non-differentiating sub-line). CD44 expression was high in the Hoxb8-
immortalized IL-3-dependent myeloid cell lines B4.1 and 5P4A and also detectable in 
the IL-3-dependent myeloid line FDCP-1. These cell lines are not capable of IL-3-
induced differentiation. Thus CD44 was expressed in the myeloid cell lines capable of 
cytokine-induced differentiation leaving open the possibility of its involvement in this 
process. CD44 mRNA expression was not detected in the B cell line CTLL-2 (Fig.4.1). 
CTLL-2 cells expressing mIL-3Ra SPl/mPiL. 3 or mIL-3Ra SP2/mp I L. 3 grown with or 
without mIL-3 and CTLL-2 expressing hIL-3Ra SPl/hpc or hIL-3Ra SP2/hpc grown 
with or without hIL-3, also did not express CD44 (data not shown). These cells are 
capable of IL-3-induced growth but not differentiation. This indicates that IL-3 receptor 
signaling has no effect on CD44 expression in CTLL-2 cells. 
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Figure 4.1: The levels of CD44 mRNA in mouse cell lines measured by RT-PCR. 
FDCP-mix, B4.1, FDCP1 were undergoing IL-3-dependent growth and CTLL-2 was 
undergoing IL-2 dependent growth. FDCP-mix and Ml cells ectopically expressing 
hIL-3Ra SP2/hpc were undergoing hIL-3-driven differentiation. RNase-free water was 
used as PCR control. P-actin was used as an internal standard. Results represent one of 
at least two independent experiments. 
OPN mRNA levels were also readily detectable in the three differentiation models 
studied (Fig.4.2). The levels did not change significantly when FDCP-mix and Ml cells 
expressing hIL-3 receptors underwent differentiation induced by hIL-3. Low OPN 
expression was found in WEHI 3B D+ cells (differentiating sub-line) and high OPN 
expression in WEHI 3B D- cells (non-differentiating sub-line). The HoxB8 
immortalized IL-3-dependent cell lines B4.1 and 5P4A, IL-3-dependent FDCP-1 and 
IL-2 dependent CTLL-2 cells do not differentiate in the presence of mIL-3. Low OPN 
expression was detected in B4.1, 5P4A and CTLL-2 cells. No OPN expression was 
detected in FDCP-1 cells (Fig.4.2). 
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Thus both CD44 and its ligand OPN were expressed in the myeloid cells undergoing IL-
3-induced differentiation making their involvement in the process plausible. A summary 
of the RT-PCR results for CD44 and OPN is given in Table 4.1. 
Figure 4.2: The levels of osteopontin mRNA in mouse cell lines measured by RT-PCR. 
FDCP-mix, B4.1 and FDCP1 cells were undergoing IL-3-dependent growth and CTLL-
2 cells were undergoing IL-2 dependent growth. FDCP-mix and Ml cells ectopically 
expressing hIL-3Ra SP2/hpc were undergoing hIL-3-driven differentiation. RNase-free 
water was used as PCR control. P-actin was used as an internal standard. Results 
represent one of at least two independent experiments. 
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Table 4.1: Summary of the levels of CD44 and OPN mRNAs in mouse cell 
lines measured by RT-PCR. 
Cell linesa CD44 OPN 
FDCP-mix + + 
FDCP-mix hIL-3 Ra SP1 / hpc (+hIL-3) + ++ 
FDCP-mix hIL-3 Ra SP2 / hpc (+hIL-3) + + 
Ml +++ +++ 
Ml hIL-3 Ra SP1 / hpc (+hIL-3) + +++ 
Ml hIL-3 Ra SP2 / hpc (+hIL-3) + +++ 
WEHI-3B D+ +++ + 
WEHI-3B D- + +++ 
B4.1 +++ +/-
5P4A +++ +/-
CTLL-2 -
FDCP-1 + . -
a Growth conditions are described in Figs 4.1 and 4.2. 
Chapter 4: Role of CD44 and osteopontin in myeloid differentiation 
4.2.1.2 Osteopontin expression in a granulocyte-macrophage progenitor 
undergoing differentiation 
SCF ER-Hoxb8 is a conditionally-immortalized granulocyte-macrophage progenitor 
and was kindly provided by Prof. Mark Kamps. Previous studies have shown that SCF 
ER-Hoxb8 neutrophil progenitors can grow in the presence of SCF with estrogen and 
undergo neutrophil differentiation after the removal of estrogen (Wang et al.l 2006). 
Interestingly, no osteopontin expression was detected in the SCF ER-Hoxb8 progenitors 
grown with estrogen in contrast with the Hoxb8-immortalized B4.1 and 5P4A cells 
(Fig.4.3). However, the expression of osteopontin mRNA was detected in the 
differentiation samples of SCF ER-Hoxb8 progenitors (Fig.4.3). Thus in SCF ER-
Hoxb8, differentiation correlates with induction of OPN expression. 
lOOObp 
850bp ^ osteopontin 
650bp V H ^ ^ ^ ^ ^ ^ ^ ^ ^ B H I ^ H i 
Figure 4.3: Osteopontin mRNA expression in the Hoxb8 immortalized myeloid 
progenitor SCF ER-Hoxb8 measured by RT-PCR. SCF ER-Hoxb8 was grown in the 
presence of SCF plus estrogen and differentiated in SCF after the removal of estrogen. 
For comparison, osteopontin expression was measured in Hoxb8-immortalized B4.1 and 
5P4A cells grown with mIL-3. P-actin was used as an internal standard. Results 
represent one of at least two independent experiments. 
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4.2.1.3 CD44 and osteopontin isoforms expressed by Ml and FDCP-mix 
cells undergoing IL-3-supported differentiation 
Because there are a number of potential isoforms for CD44 (Ghaffari et al, 1999) and 
also for OPN (Chae et al., 2009), it was of interest to determine the isoforms expressed 
and to determine any changes in isoforms between growth and differentiation. Full 
length sequencing of cDNAs for CD44 and OPN were carried out for Ml and FDCP-
mix cells expressing hIL-3Ra SPl/hpc or hIL-3Ra SP2/ hpc and grown in hIL-3. 
Six CD44 clones from each cell line were examined, and all were the standard CD44s 
isoform (Figs.4.4 and 4.5). With each cell line, only growth occurs with hIL-3Ra SP1/ 
hpc and differentiation occurs with hIL-3Ra SP2/hpc. Thus there were no changes 
detectable between cells undergoing differentiation and cells undergoing growth. One 
common amino acid substitution was detected in the cDNA clones from Ml and FDCP-
mix cells (Figs.4.4 and 4.5) compared with the reference sequence (Gtinthert, 1993). 
Similarly, six OPN cDNA clones were sequenced from Ml and FDCP-mix cells 
expressing hIL-3Ra SPl/hpc or hIL-3Ra SP2/hpc and cultured in hIL-3. All were the 
standard isoform of OPN (Craig and Denhardt, 1991) and no changes were found in the 
isoforms expressed by the differentiating cells and those undergoing growth. Seven 
common amino acid substitutions and one amino acid insertion in six clones were 
detected in Ml cells (Fig.4.6). One common amino acid substitution in six clones was 
detected in FDCP-mix cells (Fig.4.7) when compared with the reference sequence 
(Craig and Denhardt, 1991). 
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CD44_M1 hSP2hBc(+hIL-3) 
CD44M1 hSPlhBc(+hIL-3) 
CD44_M1 
standard mouse CD44 
MDKFWWHTAWGLCLLQLSLAHPHQQIDLNVTCRYAGVFHVEKNGRYSISR 50 
MDKFWWHTAWGLCLLQLSLAHPHQQIDLNVTCRYAGVFHVEKNGRYSISR 50 
MDKFWWHTAWGLCLLQLSLAHPHQQIDLNVTCRYAGVFHVEKNGRYSISR 50 
MDKFWWHTAWGLCLLQLSLAHPHQQIDLNVTCRYAGVFHVEKNGRYSISR 50 
CD44_M1 hSP2hBc(+hIL-3) 
CD44_M1 hSPlhBc(+hIL-3) 
CD44_M1 
standard mouse CD44 
TEAADLCQAFNSTLPTMDQMKLALSKGFETCRYGFIEGNWIPRIHPNAI 100 
TEAADLCQAFNSTLPTMDQMKLALSKGFETCRYGFIEGNWIPRIHPNAI 100 
TEAADLCQAFNSTLPTMDQMKLALSKGFETCRYGFIEGNWIPRIHPNAI 100 
TEAADLCQAFNSTLPTMDQMKLALSKGFETCRYGFIEGNWIPRIHPNAI 100 
CD44_M1 hSP2hBc(+hIL-3) 
CD44_M1 hSPlhBc(+hIL-3) 
CD44_M1 
standard mouse CD4 4 
CAANHTGVYILVTSNTSHYDTYCFNASAPPEEDCTSVTDLPNSFDGPVTI 150 
CAANHTGVYILVTSNTSHYDTYCFNASAPPEEDCTSVTDLPNSFDGPVTI 150 
CAANHTGVYILVTSNTSHYDTYCFNASAPPEEDCTSVTDLPNSFDGPVTI 150 
CAANHTGVYILVTSNTSHYDTYCFNASAPPEEDCTSVTDLPNSFDGPVTI 150 
CD44_M1 hSP2hBc(+hIL-3) 
CD44_M1 hSPlhBc(+hIL-3) 
CD44_M1 
standard mouse CD44 
TIVNRDGTRYSKKGEYRTHQEDIDASNIIDDDVSSGSTIEKSTPESYILH 200 
TIVNRDGTRYSKKGEYRTHQEDIDASNIIDDDVSSGSTIEKSTPESYILH 200 
TIVNRDGTRYSKKGEYRTHQEDIDASNIIDDDVSSGSTIEKSTPESYILH 200 
TIVNRDGTRYSKKGEYRTHQEDIDASNIIDDDVSSGSTIEKSTPEGYILH 200 
CD44_M1 hSP2hBc(+hIL-3) 
CD44_M1 hSPlhBc(+hIL-3) 
CD44_M1 
standard mouse CD44 
TYLPTEQPTGDQDDSFFIRSTLATRDRDSSKDSRGSSRTVTHGSELAGHS 250 
TYLPTEQPTGDQDDSFFIRSTLATRDRDSSKDSRGSSRTVTHGSELAGHS 250 
TYLPTEQPTGDQDDSFFIRSTLATRDRDSSKDSRGSSRTVTHGSELAGHS 250 
TYLPTEQPTGDQDDSFFIRSTLATRDRDSSKDSRGSSRTVTHGSELAGHS 250 
Figure 4.4: Alignment of amino acid sequences of mouse CD44 derived from Ml cells 
expressing hIL-3Ra SPl/hpc or hIL-3Ra SP2/hpc and cultured with hIL-3 and CD44 
from Ml parental cells. The full length mouse CD44 cDNA clones were isolated from 
Ml cells and the DNA sequencing was performed using the ABI Big Dye terminator 
cycle sequencing system with analysis using an ABI 3730 sequencer. 
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CD44_FDCP-mix hSP2hBC(+hIL-3) 
CD44_FDCP-mix hSPlhBc(+hIL-3) 
CD44_FDCP-mix 
standard mouse CD44 
MDKFWWHTAWGLCLLQLSLAHPHQQIDLNVTCRYAGVFHVEKNGRYSISR 50 
MDKFWWHTAWGLCLLQLSLAHPHQQIDLNVTCRYAGVFHVEKNGRYSISR 50 
MDKFWWHTAWGLCLLQLSLAHPHQQIDLNVTCRYAGVFHVEKNGRYSISR 50 
MDKFWWHTAWGLCLLQLSLAHPHQQIDLNVTCRYAGVFHVEKNGRYSISR 50 
CD44_FDCP-mix hSP2hBc (+hIL-3) 
CD44_FDCP-mix hSPlhBc (+hIL-3) 
CD44_FDCP-mix 
standard mouse CD44 
TEAADLCQAFNSTLPTMDQMKLALSKGFETCRYGFIEGNWIPRIHPNAI 100 
TEAADLCQAFNSTLPTMDQMKLALSKGFETCRYGFIEGNWIPRIHPNAI 100 
TEAADLCQAFNSTLPTMDQMKLALSKGFETCRYGFIEGNWIPRIHPNAI 100 
TEAADLCQAFNSTLPTMDQMKLALSKGFETCRYGFIEGNWIPRIHPNAI 100 
CD44_FDCP-mix hSP2hBc(+hIL-3) 
CD44_FDCP-mix hSPlhBc (+hIL-3) 
CD44_FDCP-mix 
standard mouse CD44 
CD44_FDCP-mix hSP2hBc(+hIL-3) 
CD44_FDCP-mixhSPlhBc(+hIL-3) 
CD4 4_FDCP-mix 
standard mouse CD44 
CAANHTGVYILVTSNTSHYDTYCFNASAPPEEDCTSVTDLPNSFDGPVTI 150 
CAANHTGVYILVTSNTSHYDTYCFNASAPPEEDCTSVTDLPNSFDGPVTI 150 
CAANHTGVYILVTSNTSHYDTYCFNASAPPEEDCTSVTDLPNSFDGPVTI 150 
CAANHTGVYILVTSNTSHYDTYCFNASAPPEEDCTSVTDLPNSFDGPVTI 150 
TIVNRDGTRYSKKGEYRTHQEDIDASNIIDDDVSSGSTIEKSTPESYILH 200 
TIVNRDGTRYSKKGEYRTHQEDIDASNIIDDDVSSGSTIEKSTPESYILH 200 
TIVNRDGTRYSKKGEYRTHQEDIDASNIIDDDVSSGSTIEKSTPESYILH 200 
TIVNRDGTRYSKKGEYRTHQEDIDASNIIDDDVSSGSTIEKSTPEGYILH 200 
CD44_FDCP-mix hSP2hBc(+hIL-3) 
CD44_FDCP-mix hSPlhBc(+hIL-3) 
CD4 4_FDCP-mix 
standard mouse CD44 
TYLPTEQPTGDQDDSFFIRSTLATRDRDSSKDSRGSSRTVTHGSELAGHS 250 
TYLPTEQPTGDQDDSFFIRSTLATRDRDSSKDSRGSSRTVTHGSELAGHS 250 
TYLPTEQPTGDQDDSFFIRSTLATRDRDSSKDSRGSSRTVTHGSELAGHS 250 
TYLPTEQPTGDQDDSFFIRSTLATRDRDSSKDSRGSSRTVTHGSELAGHS 250 
Figure 4.5: Alignment of amino acid sequences of mouse CD44 derived from FDCP-
mix cells expressing hIL-3Ra SPl/hpc or hIL-3Ra SP2/hpc and cultured with hIL-3 or 
FDCP-mix parental cells. The full length mouse CD44 cDNA clones were isolated from 
FDCP-mix cells and the DNA sequencing was performed using the ABI Big Dye 
terminator cycle sequencing system with analysis using an ABI 3730 sequencer. 
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OPN_MlhSP2hBc(+hIL-3) 
OPNMlhSPlhBc(+hIL-3) 
OPN_Ml 
Standard mouse OPN 
MRLAVICFCLFGIASSLPVKVTDSGSSEEKKLYSLHPDPIATWLVPDPSQ 50 
MRLAVICFCLFGIASSLPVKVTDSGSSEEKKLYSLHPDPIATWLVPDPSQ 5 0 
MRLAVICFCLFGIASSLPVKVTDSGSSEEKKLYSLHPDPIATWLVPDPSQ 5 0 
MRLAVICFCLFGIASSLPVKVTDSGSSEEK-LYSLHPDPIATWLVPDPSQ 49 
OPN_MlhSP2hBc(+hIL-3) 
OPN_MlhSPlhBc(+hIL-3) 
OPN_Ml 
Standard mouse OPN 
KQNLLAPQNAVSSEEKDDFKQETLPSNSNESHDHMDDDDDDDDDDGDHAE 100 
KQNLLAPQNAVSSEEKDDFKQETLPSNSNESHDHMDDDDDDDDDDGDHAE 100 
KQNLLAPQNAVSSEEKDDFKQETLPSNSNESHDHMDDDDDDDDDDGDHAE 100 
KQNLLAPQNAVSSEEKDDFKQETLPSNSNESHDHMDDDDDDDDDDGDHAG 9 9 
OPN_MlhSP2hBc(+hIL-3) 
OPN_MlhSPlhBc(+hIL-3) 
0PN_M1 
Standard mouse OPN 
NEDSVDSDESDESHHSDESDETFTASTQADTFTPIVPTVDVPDGRGDSLA 150 
NEDSVDSDESDESHHSDESDETFTASTQADTFTPIVPTVDVPDGRGDSLA 150 
NEDSVDSDESDESHHSDESDETFTASTQADTFTPIVPTVDVPDGRGDSLA 150 
SEDSVDSDESDESHHSDESDETVTASTQADTFTPIVPTVDVPDGRGDSLA 149 
OPN_MlhSP2hBc(+hIL-3) 
OPN_MlhSPlhBc(+hIL-3) 
OPN_Ml 
Standard mouse OPN 
YGLRSKSRSFQVSDEQYPDATYEDLTSHMKSGESKESLNVIPVAQLLSMP 200 
YGLRSKSRSFQVSDEQYPDATYEDLTSHMKSGESKESLNVIPVAQLLSMP 200 
YGLRSKSRSFQVSDEQYPDATYEDLTSHMKSGESKESLNVIPVAQLLSMP 200 
YGLRSKSRSFQVSDEQYPDATDEDLTSHMKSGESKESLDVIPVAQLLSMP 199 
OPN_MlhSP2hBc(+hIL-3) 
OPN_MlhSPlhBc(+hIL-3) 
OPN_Ml 
Standard mouse OPN 
SDQDNNGRGSHESSQLDEPSLETHSLEHSKESHESADQSDVIDSQASSKA 250 
SDQDNNGRGSHESSQLDEPSLETHSLEHSKESHESADQSDVIDSQASSKA 250 
SDQDNNGRGSHESSQLDEPSLETHSLEHSKESHESADQSDVIDSQASSKA 250 
SDQDNNGKGSHESSQLDEPSLETHRLEHSKESHESADQSDVIDSQASSKA 249 
Figure 4.6: Alignment of amino acid sequences of mouse OPN derived from Ml cells 
expressing hIL-3Ra SPl/hpc or hIL-3Ra SP2/hpc and cultured in hIL-3 or Ml parental 
cells. The full length mouse OPN cDNA clones were isolated from Ml cells and the 
DNA sequencing was performed using the ABI Big Dye terminator cycle sequencing 
system with analysis using an ABI 3730 sequencer. 
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OPN_FDCP-mix hSP2hBc(+hIL-3) 
OPN_FDCP-Mix hSPlhBc(+hIL-3) 
OPN_FDCP-mix 
Standard mouse OPN 
MRLAVICFCLFGIASSLPVKVTDSGSSEEKLYSLHPDPIATWLVPDPSQK 50 
MRLAVICFCLFGIASSLPVKVTDSGSSEEKLYSLHPDPIATWLVPDPSQK 50 
MRLAVICFCLFGIASSLPVKVTDSGSSEEKLYSLHPDPIATWLVPDPSQK 50 
MRLAVICFCLFGIASSLPVKVTDSGSSEEKLYSLHPDPIATWLVPDPSQK 50 
OPN_FDCP-mix hSP2hBc(+hIL-3) 
OPN_FDCP-Mix hSPlhBc(+hIL-3) 
OPN_FDCP-mix 
Standard mouse OPN 
QNLLAPQNAVSSEEKDDFKQETLPSNSNESHDHMDDDDDDDDDDGDHAES 100 
QNLLAPQNAVSSEEKDDFKQETLPSNSNESHDHMDDDDDDDDDDGDHAES 100 
QNLLAPQNAVSSEEKDDFKQETLPSNSNESHDHMDDDDDDDDDDGDHAES 100 
QNLLAPQNAVSSEEKDDFKQETLPSNSNESHDHMDDDDDDDDDDGDHAGS 100 
OPN_FDCP-mix hSP2hBc(+hIL-3) 
OPN_FDCP-Mix hSPlhBc(+hIL-3) 
OPN_FDCP-mix 
Standard mouse OPN 
EDSVDSDESDESHHSDESDETVTASTQADTFTPIVPTVDVPNGRGDSLAY 150 
EDSVDSDESDESHHSDESDETVTASTQADTFTPIVPTVDVPNGRGDSLAY 150 
EDSVDSDESDESHHSDESDETVTASTQADTFTPIVPTVDVPNGRGDSLAY 150 
EDSVDSDESDESHHSDESDETVTASTQADTFTPIVPTVDVPNGRGDSLAY 150 
OPN_FDCP-mix hSP2hBc(+hIL-3) 
OPN_FDCP-Mix hSP2hBc(+hIL-3) 
OPN_FDCP-mix 
Standard mouse OPN 
GLRSKSRSFQVSDEQYPDATDEDLTSHMKSGESKESLDVIPVAQLLSMPS 200 
GLRSKSRSFQVSDEQYPDATDEDLTSHMKSGESKESLDVIPVAQLLSMPS 200 
GLRSKSRSFQVSDEQYPDATDEDLTSHMKSGESKESLDVIPVAQLLSMPS 200 
GLRSKSRSFQVSDEQYPDATDEDLTSHMKSGESKESLDVIPVAQLLSMPS 200 
OPN_FDCP-mix hSP2hBc(+hIL-3) 
OPN_FDCP-Mix hSPlhBc(+hIL-3) 
OPN_FDCP-mix 
Standard mouse OPN 
DQDNNGKGSHESSQLDEPSLETHRLEHSKESQESADQSDVIDSQASSKAS 250 
DQDNNGKGSHESSQLDEPSLETHRLEHSKESQESADQSDVIDSQASSKAS 250 
DQDNNGKGSHESSQLDEPSLETHRLEHSKESQESADQSDVIDSQASSKAS 250 
DQDNNGKGSHESSQLDEPSLETHRLEHSKESQESADQSDVIDSQASSKAS 250 
Figure 4.7: Alignment of amino acid sequences of mouse OPN derived from FDCP-mix 
cells expressing hIL-3Ra SPl/hpc or hIL-3Ra SP2/hpc and cultured in hIL-3 or FDCP-
mix parental cells. The full length mouse OPN cDNA clones were isolated from FDCP-
mix cells and the DNA sequencing was performed using the ABI Big Dye terminator 
cycle sequencing system with analysis using an ABI 3730 sequencer. 
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4.2.1.4 Expression of CD44 and osteopontin in NB4 promyelocytic 
leukemia cells undergoing ATRA-induceddifferentiation 
CD44 ligation induces differentiation of AML blasts and also of NB4 cells (Charrad et 
al., 1999; Charrad et al., 2002; Song et al, 2004). It was of interest to determine the 
levels of expression of CD44 in parental NB4 cells and NB4 cells undergoing ATRA-
induced differentiation. When NB4 cells were treated with ATRA, the expression of 
CD44 mRNA at different times after induction of differentiation was determined by RT-
PCR. The expression of CD44 mRNA was readily detectable and did not change 
significantly before and after induction of differentiation by ATRA (Fig.4.8). 
Figure 4.8: The levels of CD44 mRNA in NB4 cells before and after induction of 
differentiation by ATRA were measured by RT-PCR. ATRA was dissolved in DMSO 
and included in the medium at a final concentration of 1|LIM. NB4, indicates untreated 
cells; DMSO, indicates cells treated with DMSO alone; the times of induction are 
indicated in the figure. (3-actin was used as an internal standard. Results represent one of 
at least two independent experiments. 
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Similarly, OPN mRNA expression was measured by RT-PCR in NB4 induced to 
differentiate by ATRA treatment. OPN mRNA was readily detectable with no 
significant changes in levels in NB4 cells with or without ATRA treatment (Fig.4.9). 
Figure 4.9: The levels of osteopontin mRNA in NB4 cells before and after induction of 
differentiation by ATRA were measured by RT-PCR. ATRA was dissolved in DMSO 
and included in the medium at a final concentration of ljxM. NB4, indicates untreated 
cells; DMSO, indicates cells treated with DMSO alone; the times of induction are 
indicated in the figure. P-actin was used as an internal standard. Results represent one of 
at least two independent experiments. 
4.2.1.5 Osteopontin isoforms expressed by NB4 cells undergoing ATRA-
induced differentiation 
DNA sequencing of OPN cDNA clones was carried out. Nine cDNA clones were 
sequenced from NB4 cells not undergoing differentiation and all were the standard 
isoform (Kiefer et al, 1989) denoted as OPN NB4 in Fig.4.10. Single amino acid 
substitutions (501 T—»C, aa V—>A) were detected in seven of these clones relative to the 
reference sequence (Kiefer et al., 1989). 
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There were changes in OPN isoforms in NB4 cells treated with ATRA. Two cDNA 
clones out of nine clones sequenced from NB4 cells undergoing differentiation were 
OPN-isoform C (27 aa deletion; denoted as OPN NB4+ATRA1 in Fig.4.10). One 
clone was OPN-isoform B (14 aa deletion; denoted as OPN NB4+ATRA 2 in 
Fig.4.10). Six clones were the standard isoform (Kiefer et al., 1989) and two of these 
clones had individual amino acid substitutions (815 G—>A, aa A—>T). 
OPN_NB4+ATRA_l MRIAVICFCLLGITCAIPVKQADSGSSEEK 30 
OPN_NB4+ATRA_2 MRIAVICFCLLGITCAIPVKQADSGSSEEKQLYNKYPDAVATWLNPDP— 48 
OPN NB4 MRIAVICFCLLGITCAIPVKQADSGSSEEKQLYNKYPDAVATWLNPDPSQ 50 
Standard human OPN MRIAVICFCLLGITCAIPVKQADSGSSEEKQLYNKYPDAVATWLNPDPSQ 50 
OPN_NB4+ATRA_l QNAVSSEETNDFKQETLPSKSNESHDHMDDMDDEDDDDHVDSQ 73 
OPN NB4+ATRA 2 SQKQ NLLAPQTLPSKSNESHDHMDDMDDEDDDDHVDSQ 86 
OPN_NB4 KQNLLAPQNAVSSEETNDFKQETLPSKSNESHDHMDDMDDEDDDDHVDSQ 100 
Standard human OPN KQNLLAPQNAVSSEETNDFKQETLPSKSNESHDHMDDMDDEDDDDHVDSQ 100 
OPN NB4+ATRA 1 DSIDSNDSDDVDDTDDSHQSDESHHSDESDELVTDFPTDLPATEVFTPW 123 
OPN_NB4+ATRA_2 DSIDSNDSDDVDDTDDSHQSDESHHSDESDELVTDFPTDLPATEVFTPW 136 
OPN_NB4 DSIDSNDSDDVDDTDDSHQSDESHHSDESDELVTDFPTDLPATEVFTPW 150 
Standard human OPN DSIDSNDSDDVDDTDDSHQSDESHHSDESDELVTDFPTDLPATEVFTPW 150 
OPN NB4+ATRA 1 PTVDTYDGRGDSWYGLRSKSKKFRRPDIQYPDATDEDITSHMESEELNG 173 
OPN_NB4+ATRA_2 PTVDTYDGRGDSVVYGLRSKSKKFRRPDIQYPDATDEDITSHMESEELNG 186 
OPN_NB4 PTVDTYDGRGDSWYGLRSKSKKFRRPDIQYPDATDEDITSHMESEELNG 200 
Standard human OPN PTVDTYDGRGDSWYGLRSKSKKFRRPDIQYPDATDEDITSHMESEELNG 200 
OPN_NB4+ATRA_l AYKAIPVAQDLNAPSDWDSRGKDSYETSQLDDQSAETHSHKQSRLYKRKA 223 
OPN NB+ATRA_2 AYKAIPVAQDLNAPSDWDSRGKDSYETSQLDDQSAETHSHKQSRLYKRKA 236 
OPN_NB4 AYKAIPVAQDLNAPSDWDSRGKDSYETSQLDDQSAETHSHKQSRLYKRKA 250 
Standard human OPN AYKAIPVAQDLNAPSDWDSRGKDSYETSQLDDQSAETHSHKQSRLYKRKA 250 
Figure 4.10: Alignment of amino acid sequences of human OPN derived from NB4 cells 
before and after induction of differentiation by ATRA. The full length human OPN 
cDNA clones were isolated from NB4 cells and the DNA sequencing was performed 
using the ABI Big Dye terminator cycle sequencing system with analysis using an ABI 
3730 sequencer. 
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4.2.2 Effect of siRNA knockdown of CD44 on ATRA-induced and IL-3-
induced NB4 differentiation 
Both AML blasts and NB4 cells can be induced to differentiate by CD44 ligation 
(Charrad et al., 1999; Charred et al., 2002; Song et al., 2004; Gadhoum et al., 2004). 
The antibody which is the most effective in inducing differentiation is not commercially 
available and two requests to the originator of the antibody (Charrad et al., 2002) were 
unsuccessful so direct experiments on CD44-induced differentiation was not carried out 
in these experiments. However, siRNA knockdown of CD44 was performed in order to 
see if CD44 played a critical role in the ATRA-induced or IL-3-induced differentiation 
of NB4. This cell line was considered to be the most suitable as it had been previously 
established that differentiation could be induced via CD44 (Charrad et al., 2002). 
Real-time PCR showed that siRNA treatment reduced CD44 expression to 92%, 91%, 
83% and 77% after 1 to 4 days respectively in NB4 cells (Fig.4.11). FACS analyses 
showed that the siRNA knockdown of CD44 did not significantly impair the 
differentiation of NB4 cells induced by ATRA (as evidenced by increases in CD l i b 
expression) (Fig.4.12). 
In parallel experiments with NB4 cells ectopically expressing the hIL-3Ra SPl/hpc or 
hIL-3Ra SP2/h(3c, real-time PCR showed that siRNA treatment reduced CD44 
expression to 95% and 70% at 1 day and 4 days respectively after siRNA treatment in 
NB4 cells ectopically expressing hIL-3Ra SP2/hpc and to 92% and 65% at 1 day and 4 
days respectively after siRNA treatment in NB4 cells ectopically expressing hIL-3Ra 
SPl/hpc (Figs.4.13 and 4.15). CD44 knockdown did not impair the partial 
differentiation induced by hIL-3 as evidenced by increased in CD1 lb expression (Figs. 
4.14 and 4.16). 
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Figure 4.11: The expression of CD44 mRNA in NB4 cells treated with CD44 siRNA 
and negative siRNA. siRNA knockdown of CD44 mRNA in NB4 cells by CD44 
siRNA. NB4 cells were treated with CD44 siRNA and negative siRNA control. The 
levels of CD44 mRNA in NB4 cells treated with CD44 siRNA for 1 to 4 days was 
measured by real-time RT-PCR comparison with NB4 cells treated with negative 
siRNA control. Negative control siRNA (Ambion) do not target any gene product with 
sequences. Results were verified in three independent experiments. Data are mean, error 
bars are standard deviations. *,/?<0.001; **,p<0.01 by student's t test. 
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Figure 4.12: CDllb expression in NB4 cells treated with CD44 siRNA and/or ATRA 
determined by flow cytometry. The effect of CD44 siRNA knockdown on ATRA 
induced differentiation of NB4 was measured by CDllb expression. NB4 cells were 
treated with 1 jiM ATRA and/or CD44 siRNA or negative siRNA control for 4 days. 
Results represent one of three independent experiments. 
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Figure 4.13: siRNA knockdown of CD44 mRNA in NB4 cells expressing hIL-3Ra 
SP2/hpc by CD44 siRNA. NB4 cells were treated with CD44 siRNA and negative 
siRNA control. The levels of CD44 mRNA in NB4 cells treated with CD44 siRNA for 
1 and 4 days were measured by real-time RT-PCR in comparison with NB4 cells treated 
with negative siRNA control. Results were verified in three independent experiments. 
Data are mean, error bars are standard deviations. *, p<0.001; **,/><0.01 by student's t 
test. 
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Figure 4.14: The effect of CD44 siRNA knockdown on hIL-3-induced differentiation of 
NB4 cells ectopically expressing hIL-3Ra SP2/hpc. NB4 cells expressing hIL-3Ra 
SP2/h|3c were treated with hIL-3 and/or CD44 siRNA or negative siRNA control for 4 
days. Differentiation was measured by expression of CD l i b using flow cytometry. 
Results represent one of three independent experiments. 
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Figure 4.15: siRNA knockdown of CD44 mRNA in NB4 cells expressing hIL-3Ra 
SPl/hpc by CD44 siRNA. NB4 cells expressing hIL-3Ra SPl/hpc were treated with 
CD44 siRNA and negative siRNA control. The levels of CD44 mRNA in NB4 cells 
treated with CD44 siRNA for 1 and 4 days were measured by real-time RT-PCR in 
comparison with NB4 cells treated with negative siRNA control. Results were verified 
in three independent experiments. Data are mean, error bars are standard deviations. *, 
/K0.001; **,/x0.01 by student's / test. 
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Figure 4.16: The effect of CD44 siRNA knockdown on hIL-3-induced differentiation of 
NB4 cells ectopically expressing hIL-3Ra SPl/hpc. NB4 cells expressing hIL-3Ra 
SPl/hPc were treated with hIL-3 and/or CD44 siRNA or negative siRNA control for 4 
days. Differentiation was measured by expression of CDllb determined by flow 
cytometry. Results represent one of three independent experiments. 
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4.3 Discussion 
Differentiation induction with ATRA restores granulocytic differentiation in APL 
blasts. Much progress has been made in understanding the pathogenesis of APL and in 
particular the key role of the PML-RARa oncogene (Grignani et al., 1993). However, it 
is important to note that PML-RARa alone is insufficient to cause APL. Co-operation 
with activating mutations in protein kinases such as FLT-3, which confer proliferative 
and/or survival advantages to hematopoietic stem/progenitor cells is also required 
(Sohal et al., 2003). Although degradation of PML-RARa appears to be a key part of 
the induction of differentiation by ATRA, the process is complex and incompletely 
understood. 
The demonstration that CD44 ligation can promote differentiation of a variety of AML 
blasts indicates the existence of another potential pathway for the restoration of myeloid 
differentiation in leukemia. The potential involvement of CD44 and its ligand OPN in 
myeloid differentiation was explored in the work described in this Chapter. The CD44-
induced differentiation pathway has been shown in AML blasts and NB4 promyelocyte 
leukemia cells (Charrad et al., 1999; Charrad et al., 2002; Song et al., 2004; Jin et al., 
2006) but has not yet been demonstrated in mouse cells. Also, the possible role of the 
CD44 ligand OPN in this pathway is unclear. In the work described in this Chapter, the 
expression of CD44 and OPN mRNAs was shown in each of four mouse myeloid cell 
lines undergoing differentiation so a CD44/OPN differentiation pathway is potentially 
operative also in mouse cells. The isoforms expressed were the standard isoforms in 
each case with no changes detectable between growth and differentiation. 
SCF ER-Hoxb8 progenitors are conditionally-immortalized granulocyte-macrophage 
progenitors (GMP), which retain the ability to differentiate into eosinophils, neutrophils 
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or macrophages. SCF ER-Hoxb8 progenitors can execute neutrophil differentiation in 
the absence of estrogen (Wang et al., 2006). Interestingly, we found no expression of 
the CD44 ligand OPN in SCF ER-Hoxb8 progenitors grown with estrogen, while the 
expression of OPN mRNA was detected in the differentiation samples of SCF ER-
Hoxb8 progenitors. OPN has recently been shown to be an important component of 
early cellular immune responses. The results showed that human monocyte-derived 
dendritic cells can produce OPN that enhances differentiation, maturation, and survival 
of DCs by autocrine and/or paracrine pathways (Renkl et al., 2005). The involvement of 
CD44 in SCF ER-Hoxb8 differentiation has not previously been studied. Further 
experiments are required to demonstrate the functional significance of the OPN 
induction demonstrated in the present work. 
CD44 ligation induces differentiation of AML blasts and also of NB4 cells (Charrad et 
al., 1999; Charrad et al., 2002; Song et al., 2004; Jin et al., 2006). In the work described 
in this Chapter, the expression of CD44 and OPN in parental NB4 cells and NB4 cells 
undergoing ATRA-induced differentiation was measured. The expression of CD44 and 
OPN mRNAs were readily detectable and the levels of expression did not change 
significantly before and after induction of differentiation by ATRA. 
Previous studies have shown that CD44 is a receptor for OPN and that OPN is a 
glycoprotein associated with many physiological and pathological processes including 
cell adhesion, apoptosis, and tumour metastasis (Haylock and Nilsson, 2006). Human 
OPN gene is subject to alternative splicing, which yields three distinct isoforms. OPN-A 
constitutes the full-length transcript, whereas OPN-B and OPN-C result from alternative 
splicing (Young et al., 1990; Saitoh et al., 1995; He et al., 2006). The relative 
expression of the three isoforms in human tumors and their function is not well 
characterized. While one study suggested that OPN-C was selectively expressed in 
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invasive breast cancer and more likely to support anchorage independent tumor growth 
than OPN-A (Mirza et al, 2008), another study indicated that OPN-C was less likely to 
promote cell migration and invasion than the other two OPN isoforms in mesothelioma 
cells (Ivanov et al., 2009). The role of OPN and its splice variants in acute leukemia is 
not clear. 
In the present work, DNA sequencing of OPN cDNA clones from NB4 cells revealed a 
change in OPN isoform expression after treatment with ATRA. While parental NB4 
cells solely expressed the full length OPN-A isoform, differentiating NB4 cells 
additionally expressed the OPN-C and OPN-B isoforms. The significance of this 
finding is not clear, and requires further experiments to evaluate. 
CD44 ligation is a potent stimulus for differentiation of promyelocytic leukemia blasts 
(Charrad et al., 1999) and reduces the levels of the PML-RARa protein more effectively 
than ATRA. This raises the question as to whether CD44 might be involved in ATRA-
induced differentiation. siRNA knockdown of CD44 in NB4 cells did not affect ATRA-
driven or IL-3-driven differentiation suggesting that CD44 is not a critical component of 
either of these differentiation pathways. Thus together with the work described in 
Chapter 3, these results suggest that the mechanisms involved in the induction of 
differentiation via the ATRA-driven, IL-3-driven and CD44-promoted differentiation 
pathways are independent. 
Chapter 5 
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5.1 Introduction 
IL-3, GM-CSF and IL-5 are major hematopoietic cytokines and play an important role 
in hematopoiesis associated with allergic inflammation or immune responses (Arai et 
cut, 1990). The mechanisms regulating cytokine-driven myeloid differentiation are 
poorly understood and there is a need for the development of new models of cytokine-
supported differentiation which can be subjected to detailed biochemical analysis. 
The work described in this Chapter is concerned with the mechanisms of IL-3-driven 
myeloid differentiation. IL-3 promotes both self-renewal and differentiation of early 
multipotential progenitors and is involved in inducible hematopoiesis in response to 
infections. In humans, IL-3 utilizes the 0c receptor which is shared with IL-5 and GM-
CSF. In mice, there is a shared pc (mpc) receptor but also an IL-3-specific P receptor 
(PIL-3) (Itoh et al., 1990). Recently, our group identified of a new isoform of IL-3Ra 
(designated SP2), present in mouse and human hematopoietic cells, which lacks domain 
1 of the full-length receptor (SP1) (Chen et al., 2009). The ability of the IL-3Ra SP2 
and SP1 to promote differentiation of the multi-potential hematopoietic cell line FDCP-
mix and the mouse myeloid leukemia line Ml was previously investigated. Of great 
interest is the finding that the human IL-3Ra SP2 together with hpc promotes the 
differentiation of multi-potential FDCP-mix cells into basophil-like cells in contrast to 
the IL-3Ra SP1 isoform which promotes self-renewal. Human IL-3Ra SP2 also directs 
the differentiation of the myeloblastic Ml leukemia line into monocytes whereas IL-
3Ra SP1 does not (Chen et al., 2009). How IL-3 achieves its dual signaling role of 
promoting self-renewal and differentiation has remained a mystery. The identification 
of a novel isoform of the IL-3 receptor with activity in differentiation gives a new 
insight into these processes. 
Chapter 5: IL-3-induced differentiation of the granulocyte-macrophage progenitor SCF ER-Hoxb8 
Although the ectopic expression of the human IL-3 receptor in mouse cells enabled our 
group to study the role of the human IL-3Ra isoforms in promoting differentiation, it is 
highly desirable to develop a model for studying the role of the mIL-3R in driving 
myeloid differentiation. This is because mice are the key experimental system for 
studying hematopoiesis and also for studying allergic inflammation in asthma models. 
Thus in vitro findings can potentially be tested further in vivo. 
The evaluation of three potential models for studying the mechanisms of mIL-3R-driven 
differentiation is described in the present Chapter. Initially ectopic expression of mlL-
3R subunits in the Ml leukemia line was tested as it has very low levels of endogenous 
mIL-3 receptors. Also, ectopic expression of mIL-3R subunits was tested in human NB4 
cells. Neither cells yielded satisfactory models. Subsequently SCF ER-Hoxb8 cells were 
shown to be an excellent conditional model for studying the mechanisms of IL-3-driven 
differentiation of mouse granulocyte macrophage progenitors. 
Hox oncoproteins can arrest myeloid differentiation and enforce self-renewal of factor-
dependent myeloid progenitors (Knoepfler et al., 2001). The estrogen-regulated Hoxb8 
(ER-Hoxb8) has the estrogen-binding domain of the estrogen receptor (ER) fused to the 
N-terminus of Hoxb8 so that the activity of Hoxb8 is regulated by estrogen levels in the 
medium (Wang et al., 2006). ER-Hoxb8 can immortalize neutrophil or macrophage 
progenitors which execute normal differentiation in the absence of estrogen and grow 
without differentiation in the presence of estrogen. Wang et al., (2006) reported the 
isolation of the conditionally immortalized granulocyte-macrophage progenitor line 
SCF ER-Hoxb8. This cell line grows continuously in the presence of SCF and estrogen 
but differentiates exclusively to neutrophils in the absence of estrogen. When grown in 
the presence of SCF plus GM-CSF, without estrogen, macrophages as well as 
neutrophils are formed (Wang et al., 2006). Whether this cell line responds to IL-3 was 
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not previously reported. As described below, mIL-3 alone was shown to support the 
growth and differentiation of SCF ER-Hoxb8 cells making this cell line a potentially 
valuable model for studying mIL-3-driven differentiation. Following the successful 
validation of the SCF ER-Hoxb8 model, it was used in preliminary experiments aimed 
at determining the mechanisms involved in IL-3-driven differentiation. These studies 
included determination of the IL-3Ra isoforms utilized by SCF ER-Hoxb8, 
measurement of the IL-3 signaling pathways during self-renewal and differentiation and 
determination of the transcription factors and miRNAs involved in the switch to 
differentiation. 
Transcription factors are known to play a major role in regulating hematopoietic 
differentiation and lineage commitment (Friedman, 1996). Among the master 
transcription factors for myelopoiesis are C/EBPa, PU.l, GFI1, IRFs, SCL/TAL1, and 
RUNX1/AML1. In human AML many of these transcription factors are involved in 
chromosomal translocations or contain somatic mutations (Tenen, 2003; Rosenbauer 
and Tenen, 2007). The transcription factors control lineage determination during 
differentiation in conjunction with miRNAs (microRNAs). miRNAs, a class of ~22 
nucleotide non-coding RNAs, were discovered to play important regulatory roles in 
mammalian hematopoiesis (Chen and Lodish, 2005). miRNAs regulate the translation 
and stability of specific mRNAs and are believed to significantly contribute to the 
regulation of lineage commitment and differentiation. They provide a level of control 
beyond the transcription factors and can potentially control the levels of mRNAs of 
hundreds of genes (Fatica et al., 2008). Recently, the up-regulation of miR-223 has been 
reported to be associated with up-regulation of PU. 1 and C/EBPa in steady-state blood 
cell formation (Fukao et al., 2007). It is believed that C/EBPa has a specific function in 
granulopoiesis: replacing nuclear factor I-A on the miR-223 promoter and up-regulating 
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miR-223 transcription. The increase in miR-223 levels results in down-regulation of the 
nuclear factor I-A protein and stimulation of granulocytic differentiation (Fatica et al., 
2006). Thus, it is of great interest to see if the differentiation promoted by IL-3R 
signaling, which may normally be utilized for inducible hematopoiesis in response to 
infections, may employ similar mechanisms to those involved in normal blood cell 
formation. The conditional differentiation of SCF ER-Hoxb8 allowed the investigation 
of the critical transcription factors and miRNAs induced during the onset of 
differentiation of ER-Hoxb8 progenitors. 
5.2 Results 
5.2.1 Differentiation of Ml cells ectopically expressing mIL-3Rs 
Ml is a mouse myeloblasts leukemia line which can undergo cytokine-induced 
differentiation (Smith et al., 1997). Previous studies have indicated that Ml cells 
express low levels of mIL-3Ra SP1 and very low levels of mPiL-3/ mpc (Chen et al., 
2009) suggesting the possibility that the function of the mIL-3R in differentiation could 
be investigated by ectopic expression. mIL-3 does not induce Ml to differentiate. 
Ectopic expression of hIL-3Ra SP2/hpc allows hIL-3-driven differentiation of the Ml 
cells into monocytes whereas expression of hIL-3Ra SPl/hpc does not (Chen et al., 
2009). Human GM-CSFRa/hpc expression also gives differentiation of Ml cells in the 
presence of hGM-CSF (Smith et al., 1997). 
In the present work, Western blotting together with deglycosylation of samples was 
used to investigate expression of the mIL-3Ra isoforms in Ml cells (Fig.5.1). A low 
level of mIL-3Ra SP1 was detected but no mIL-3Ra SP2. The presence of low 
endogenous levels of mIL-3Ra SP1 required care with controls, but it was considered 
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worthwhile to proceed with ectopic expression of mIL-3R subunits to evaluate the 
potential of Ml for studying mIL-3-driven myeloid differentiation. 
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Figure 5.1: Western blot analysis of the endogenous mIL-3Ra SP2 and SP1 protein 
expression in mouse Ml cells. CTLL-2 cells transfected with mSP2 or SP1 were used as 
positive controls. Proteins samples were analyzed with (+) or without (-) 
deglycosylation (dg) treatment using peptide iV-glycosidase F (PNGase F). Results 
represent one of at least two independent experiments. 
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5.2.1.1 Ectopic expression ofmIL-3Ra and p subunits in Ml cells 
mIL-3R subunits were ectopically expressed in Ml cells by stable transfection and mlL-
3Ra and p subunit expression was verified using FACS and Western blotting (Fig.5.2). 
Ectopic receptor expression was measured by flow cytometry using a 2-step antibody 
labelling procedure. Dual transfectants expressing both the mIL-3Ra together with p 
subunit were assessed by using 2-color analysis with FITC- and PE-conjugated 
secondary antibodies, respectively. The green line histograms denote non-specific 
fluorescence obtained with the isotype control antibodies and are overlaid with the red 
line histograms obtained after labelling with both the primary anti-receptor subunit 
antibody and secondary reagent. The results demonstrate good expression of the mlL-
3Ra SP1 and mPiL-3 or mpc receptor subunits (Fig.5.2A). Since the antibody used for 
detection of mIL-3Ra SP1 did not detect mIL-3Ra SP2, Western blotting was employed 
using a polyclonal antibody which detected both isoforms. The results showed high 
expression of both the mIL-3Ra SP1 and SP2 isoforms (Fig.5.2B). 
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Figure 5.2: Detection of the expression of mIL-3Ra SP1 or mIL-3Ra SP2 and mouse 
Pjl.3 or pc in Ml cells by FACS or Western blotting. A: Detection of mIL-3Ra SP1 or 
mouse Pil-3 or Pc in Ml cells by FACS. AIC2, rat anti-mouse Pil-3 /Pc monoclonal 
antibody; 5B11, rat anti-mouse IL-3Ra monoclonal antibody. B: Detection of mIL-3Ra 
SP2 expression by Western blot analysis. Mouse P-actin was used as internal protein 
loading control. Results represent one of at least two independent experiments. 
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5.2.1.2 mIL-3-driven differentiation of Ml cells ectopically expressing 
mIL-3Rs 
To detect differentiation, morphological change was examined by light microscopy after 
staining with May-Grunwald Giemsa. Ml cells were cultured using a Lab-Tek chamber 
slide system (Nalge Nunc) in growth medium for 4 days with or without mIL-3. The 
morphology of the cells was examined by light microscopy after staining with May-
Grunwald Giemsa. When mIL-3Ra SP1 or SP2 was expressed in Ml together with 
mPiL-3, mIL-3 promoted partial differentiation to about 10% monocytes (10% ±2, from 
100 cells fields counted in 3 samples) (Fig.5.3A). m(ic or mPiL-3 alone gave slight 
differentiation which is probably due to the low level of endogenous IL-3Ra SP1 which 
is present in Ml cells. In contrast, IL-3Ra SP1 or SP2 alone gave no detectable 
differentiation. mIL-3Ra SP2/mPc gave no more differentiation than mpc alone (Fig.5.3 
A, B). This is as expected, since the SP2 isoform only signals with mPiL-3 (Chen et al., 
2009). 
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Figure 5.3: Morphological changes in Ml cells expressing different mIL-3R subunits 
after 4 days culture with mIL-3. Responses to mIL-3 of Ml cells expressing the mlL-
3Ra SP1 or SP2 isoforms with and without mPiL-3 or m|3c after 4 days incubation were 
compared with responses to Ml parental cells without mIL-3. Morphological 
examination was made by light microscopy after May-Grunwald-Giemsa staining. Ml 
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B 
mIL-3Ra SP2/mPc 
mIL-3Ra SP2 Parental 
(no mIL-3) 
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cells ectopically expressing mIL-3Ra SP1/ mPiL-3 or SP2/ mPiL_3 gave partial 
differentiation to monocytes driven by mIL-3. M, monocyte. Scale bar =10 |um. Results 
represent one of three independent experiments. 
5.2.1.3 Expression of F4/80 and Mac-1 in Ml cells ectopically expressing 
mIL-3Rs in the presence of mIL-3 
The mIL-3-driven differentiation of Ml cells ectopically expressing mIL-3R subunits 
was also assessed by changes in expression of the cell surface markers F4/80 and Mac-1 
measured by flow cytometry. Ml cells expressing the different mIL-3 receptor subunits 
were incubated with or without mIL-3 for 4 days in growth medium. Control 
experiments were carried out to measure background effects from endogenous 
receptors. Ml parental cells with mIL-3 showed a significant increase in F4/80 and a 
slight increase in Mac-1 compared with parental cells without mIL-3. This suggests that 
endogenous IL-3 receptors have some background effects on F4/80 expression. mlL-
3Ra SP1 or SP2 alone gave no increase in F4/80 and Mac-1 compared with parental 
cells. Pil-3 or mpc alone gave a slight increase in F4/80 and Pil-3 alone gave a slight 
increase in Mac-1 compared with parental cells. This is consistent with the effect of a 
low level of endogenous mLL-3Ra SP1 which can signal through Pil-3 or mpc 
(Fig.5.4C). 
Differentiation was shown by increased expression of the surface markers F4/80 and 
Mac-1. Expression of mIL-3Ra SPI/PIL-3 gave an obvious increase in F4 /80 and Mac-1 
expression and expression of mIL-3Ra SP2/Pil-3 gave an obvious increase in F4/80 and 
a slight increase in Mac-1 expression compared with parental cells (Fig.5.4A). This is in 
good agreement with the observed morphological changes (Fig.5.3A). Expression of 
mIL-3Ra SP2/mPc gave a slight increase in F4/80 and Mac-1 expression compared with 
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parental cells which was quite similar to expression of mPc alone, consistent with the 
previous finding (Chen et al., 2009) that mIL-3Ra SP2 does not signal through mPc 
(Fig.5.4B). 
Although there were clear effects of the mIL-3R on differentiation, the differentiation 
was incomplete and the endogenous levels of IL-3Ra SP1 gave background effects. 
Thus Ml was not considered satisfactory as a mIL-3 differentiation model. 
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Figure 5.4: FACS analysis of expression of the surface markers F4/80 and Mac-1. Ml 
cells expressing the different mIL-3R subunits were cultured with mIL-3 for 4 days. 
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Expression of Mac-1 and F4/80 in Ml cells were measured by FACS as described in 
Methods. The following antibodies were used: F4/80- FITC, Mac-l-PE. Data were 
acquired on a FACSort cytometer and analysed using FlowJo software. Results 
represent one of three independent experiments. 
5.2.2 Differentiation of NB4 cells ectopically expressing mIL-3Rs 
NB4 is a human promyelocyte leukemia cell line which is not induced to differentiate 
by hIL-3 or hGM-CSF, but which differentiates to granulocytes in the presence of 
ATRA. The activity of the mouse 1L-3 receptor system was tested by ectopic expression 
in NB4 cells. 
5.2.2.1 Expression of mIL-3Ra and J3 sub units in NB4 cells 
Stable transfectants were prepared and the levels of expression of mIL-3Ra SP1 or SP2 
and mouse Pil-3 in NB4 cells were measured by FACS and Western blotting. mIL-3R 
subunit expression was confirmed by flow cytometry by using a 2-step antibody 
labeling procedure. The results show good expression of the mIL-3Ra SP1 and mPiL-3 
receptor subunits by FACS (Fig.5.5A). Since the expression of mIL-3 Ra SP2 could not 
be measured using the available antibody, protein expression was verified using 
Western blotting. The glycosylated SP1 and SP2 isoforms showed receptor bands of 
about 54 and 41 kDa. The results showed good expression of both mIL-3Ra SP1 and 
SP2 (Fig.5.5B). 
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Figure 5.5: Detection of the expression of mIL-3Ra SP1 or mIL-3Ra SP2 and mouse P I L - 3 
in NB4 cells by FACS or Western blotting. A: Detection of mIL-3Ra SP1 or mouse PIL-3 in 
NB4 cells by FACS. AIC2, rat anti-mouse PIL-3 /pc monoclonal antibody; 5B11, rat anti-
mouse IL-3Ra monoclonal antibody. Dual transfectants expressing both the mIL-3 Ra 
together with P subunit were assessed by using 2-color analysis with FITC- and PE-
conjugated secondary antibodies, respectively. The green line histograms denote 
nonspecific fluorescence obtained with the isotype control antibodies and are overlaid with 
the red line histograms obtained after labeling with both the primary anti receptor subunit 
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antibody and secondary reagent. B: Detection of mIL-3Ra SP2 expression by Western blot 
analysis. Mouse p-actin was used as internal protein loading control. Results represent one 
of three independent experiments. 
5.2.2.2 mIL-3-driven differentiation of NB4 cells ectopically expressing 
mIL-3Rs 
NB4 cells ectopically expressing various mIL-3R subunits were cultured in growth 
medium for 4 days with or without mIL-3. Morphological changes were examined by 
light microscopy after staining with May-Grunwald Giemsa. When mIL-3Ra SP1 or 
SP2 was expressed in NB4 together with mPiL-3, mIL-3 promoted partial differentiation. 
The majority of about 10% differentiated cells (10% ±2, from 100 cells fields counted 
in 3 samples) appeared to be monocyte-like by morphology. mIL-3Ra SP2/mpc gave no 
significant differentiation, consistent with the finding that mIL-3Ra SP2 does not signal 
through mpc (Chen et al., 2009). mIL-3Ra SPl/mpc also promoted differentiation of 
NB4 cells. However, mIL-3Ra SP1 or SP2 alone gave no differentiation (Fig.5.6A, B). 
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Figure 5.6: Morphological changes in NB4 cells expressing different mIL-3R subunits 
after 4 days culture with mIL-3. Responses to mIL-3 of NB4 cells expressing the mlL-
3Ra SP1 or SP2 isoforms with and without mPiL-3 or mpc after 4 days incubation were 
measured by changes in morphology. Morphological examination was made by light 
microscopy after May-Grunwald-Giemsa staining. Scale bar = 10 ^m. Results represent 
one of three independent experiments. 
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Differentiation was also assessed by changes in expression of the surface marker CD1 lb 
measured by flow cytometry. Expression of mIL-3Ra SPI/P1L-3 or mpc gave an obvious 
increase in CD1 lb expression in response to mIL-3. Expression of mIL-3Ra SPl/mPc 
but not mIL-3Ra SP2/mPc also promoted differentiation of NB4 cells. Judging from the 
expression of CD lib, mPiL-3 was more effective than mPc in signaling for 
differentiation via mIL-3Ra SP1 (Fig.5.7A). mIL-3Ra S P 2 / P I L - 3 gave an increase in 
CD1 lb, whereas mIL-3Ra SP2/mPc gave no increase in CD1 lb expression, as expected 
(Chen et al, 2009) (Fig.5.7B). Expression of mIL-3Ra SP1 or SP2 alone gave no 
significant increase in CDllb expression. These results are in good agreement with the 
morphological changes observed (Fig.5.6A, B). 
NB4 was not considered to be a good differentiation model for studying the 
mechanisms of mIL-3-driven differentiation as, although clear IL-3R-dependent effects 
on differentiation were observed, differentiation was incomplete. 
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Figure 5.7: FACS analysis of expression of the surface marker CD l ib . NB4 cells 
expressing the mIL-3R different subunits were cultured with or without mIL-3 for 4 
days. Expression of CD l i b in NB4 cells was measured by FACS as described in 
Methods. Data were acquired on a FACSort cytometer and analysed using FlowJo 
software. Results represent one of three independent experiments. 
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5.2.3 mIL-3-driven differentiation of the granulocyte-macrophage 
progenitor SCF ER-Hoxb8 
SCF ER-Hoxb8 and GM-CSF ER-Hoxb8 are two progenitor lines provided kindly by 
Prof. Mark Kamps which are conditionally immortalized by ER-Hoxb8 (Wang et am 
2006). Previous studies have shown that SCF ER-Hoxb8 progenitors can grow in the 
presence of SCF with estrogen and undergo neutrophil differentiation after the removal 
of estrogen. GM-CSF ER-Hoxb8 progenitors can grow in the presence of GM-CSF and 
estrogen and differentiate to macrophages in the absence of estrogen (Wang et al., 
2006). It had not previously been reported if the two cells lines can grow with mIL-3 
alone. Only the SCF ER-Hoxb8 progenitor was found to grow with mIL-3. It grows on 
mIL-3 without differentiation in the presence of estrogen and differentiates in the 
absence of estrogen. The differentiated cells arising from IL-3-driven differentiation of 
SCF ER-hoxb8 were characterized in collaboration with Dr J. Chen of our group. May-
Grunwald-Giemsa staining showed 65% of typical neutrophils and also 25% 
monocytes/macrophages (65%±4; 25%±3 from 100 cells fields counted in 3 samples) 
(Fig.5.8A). To aid the detection of basophils and mast cells, FACS was used. After 4 
days differentiation, about 5% basophils (Mar-1+, C-kit") were detected but these cells 
died rapidly and represented only about 1% of the non-adherent cells after 6 days 
differentiation. After 4 days differentiation, mast cells (Mar-1+, C-kit"1) were also 
detected. The mast cells did not rapidly die in contrast to the basophils. Transmission 
electron microscopy was used to verify the identity of the basophils and mast cells 
(Fig.5.8B). In the absence of estrogen, SCF ER-Hoxb8 was shown to differentiate to 
100% neutrophils when cultured with SCF and to 45% neutrophils and 55% 
macrophages (45%±5; 55%±5 from 100 cells fields counted in 3 samples) when 
cultured with GM-CSF (Fig.5.8A) in agreement with previously reported findings 
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(Wang et al., 2006). The non-adherent progeny were analyzed by flow cytometry 
leaving any adherent macrophages behind. FACS analysis of the differentiation surface 
markers showed an obvious increase in Mac-1 (general myeloid differentiation antigen) 
expression and an increase in Gr-1 (neutrophil differentiation antigen) in the absence of 
estrogen. F4/80 (macrophage differentiation antigen) showed no change or a slight 
decrease in the absence of estrogen (Fig.5.9). This indicates that both mIL-3 and mGM-
CSF, in the absence of SCF, support the differentiation of SCF ER-Hoxb8 progenitors. 
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Figure 5.8: Morphological analysis of SCF ER-Hoxb8 progenitor cells after culturing 4 
days without estrogen (differentiation) or with estrogen (growth). SCF ER-Hoxb8 cells 
were cultured in 1% (v/v) insect cell conditioned media containing mIL-3, mGM-CSF 
or mSCF under proliferation or differentiation conditions for 4 days. A: Analysis of 
cell morphology by light microscopy after May-Grunwald Giemsa staining. B basophil, 
N neutrophil, M macrophage, MC mast cell. Scale bar =10nm. B: Electron microscopy 
of the non-adherent SCF ER-Hoxb8 cells grown under differentiation conditions in 1% 
(v/v) insect cell conditioned media containing mIL-3 for 4 days. Results represent one 
of three independent experiments. 
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Figure 5.9: Surface marker expression of SCF ER-Hoxb8 progenitor cells after culturing 
4 days without estrogen (differentiation) or with estrogen (growth). SCF ER-Hoxb8 
cells were cultured in 1% (v/v) insect cell conditioned media containing mIL-3, mGM-
CSF or SCF under proliferation or differentiation conditions for 4 days. FACS analysis 
of Mac-1 Gr-1, F4/80 expression on cells cultured with mIL-3, mGM-CSF or SCF 
without or with estrogen. Results represent one of three independent experiments. 
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5.2.4 Endogenous expression of mIL-3 receptors in SCF ER-Hoxb8 
progenitors 
The endogenous expression of mIL-3R subunits in SCF ER-Hoxb8 progenitors was 
measured by flow cytometry in cells grown on SCF in the presence of estrogen. The 
endogenous expression of mIL-3Ra SP1 and mp receptor was verified in SCF ER-
Hoxb8 progenitors (Fig.5.10A). mIL-3Ra SP2 is not detected by the 5B11 antibody 
used in the FACS experiment. The mRNA levels of the mIL-3 receptor subunits in SCF 
ER-Hoxb8 and Hoxb8 cells (B4.1) were measured by RT-PCR. Both mpc and mPiL_3 
mRNAs were present and mRNAs for the mIL-3Ra SP1 and SP2 were detectable 
(Fig.5.10B). Also, the expression of mIL-3Ra SP2 and SP1 in SCF ER-Hoxb8 cells was 
shown by Western blotting (Fig.5.11). 
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Figure 5.10: The endogenous expression of mIL-3R subunits in SCF ER-Hoxb8 cells. 
A: Detection of mIL-3Ra SP1 and mp receptor in SCF ER-Hoxb8 cells by FACS. The 
red line histograms denote non-specific fluorescence obtained with the isotype control 
antibodies and are overlaid with the green line histograms obtained after labeling with 
5B11 (rat anti-mouse IL-3Ra monoclonal antibody) or with the blue line labeling with 
AIC2 (rat anti-mouse PiL-3/Pc monoclonal antibody) and secondary reagent. B: mRNA 
levels of the mIL-3 receptors in Hoxb8 cells by RT-PCR. Both SP1 and SP2 isoforms 
of IL-3Ra were detectable with SP1 being the major form. Results represent one of at 
least two independent experiments. 
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Figure 5.11: Analysis of mIL-3Ra SP2 and SP1 expression in mouse SCF ER-Hoxb8 
cells by Western blotting. CTLL-2 cells stably expressing mSP2 or mSPl were used as 
positive controls. Protein samples were analyzed with (+) or without (-) deglycosylation 
(dg) using peptide 7V-glycosidase F {PNGase F). Results represent one of at least two 
independent experiments. 
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5.2.5 mRNA levels of the mIL-3 and mGM-CSF receptor subunits in SCF 
ER-Hoxb8 progenitors undergoing IL-3- or GM-CSF-driven 
differentiation 
SCF ER-Hoxb8 progenitors grow continuously on IL-3 or GM-CSF without 
differentiation in the presence of estrogen and differentiate in the absence of estrogen. 
With GM-CSF supported differentiation of SCF ER-Hoxb8, levels of mGM-CSFRa and 
mpc mRNAs were increased significantly whereas mIL-3Ra SP1 mRNA levels were 
decreased. In contrast, with mIL-3-supported differentiation of SCF ER-Hoxb8, mlL-
3Ra SP1 and m0c mRNAs were decreased and mPiL-3 mRNA levels were increased 
(Fig.5.12). These changes fit well with mGM-CSFRa /m(3c involvement in GM-CSF-
driven differentiation and with mIL-3Ra SP2/mPiL-3 involvement in IL-3-driven 
differentiation as discussed below. 
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Figure 5.12: Measurement of the mRNA levels of the mIL-3 and mGM-CSF receptor 
subunits in SCF ER-Hoxb8 progenitors grown 4 days on IL-3 or GM-CSF with or 
without estrogen by RT-PCR. Results represent one of at least two independent 
experiments. 
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5.2.6 Sequencing of IL-3Ra cDNA clones isolated from SCF ER-Hoxb8 
progenitors 
cDNA clones of the mIL-3Ra isoforms were isolated from SCF ER-Hoxb8 progenitors 
cultured with mIL-3 in the presence or absence of estrogen using primers at the N-
terminal and C-terminal of the coding sequence (Fig.5.13). Nine clones were sequenced 
from SCF ER-Hoxb8 cells cultured with mIL-3 in the presence of estrogen. Four clones 
had sequences corresponding to the SP1 isoform and two clones to the SP2 isoform and 
the encoded amino acid (aa) sequences of the isoforms were identical with the reference 
sequences (Chen et al., 2009). Thus there was good expression of both IL-3Ra isoforms 
with no mutations in SCF ER-Hoxb8 cells. In addition to the canonical SP1 and SP2 
sequences, three other cDNA clones carried mutations (197 insert 90bp; 353-385base 
deletion (llaa); 199 insert 33bp). Of the cDNA clones from SCF ER-Hoxb8 cells 
cultured with mIL-3 in the absence of estrogen, two clones corresponded to the SP1 
isoform and three clones to the SP2 isoform with no mutations detected. Apart from 
these clones, three cDNAs carried point mutations (287 C—>T, aa P—>S; 836 G—>A, aa 
A->T; 620 C—»T, aa H—>Y) and one carried a deletion of 353-385 base (llaa). The 
DNA sequencing of cDNA clones from SCF ER-Hoxb8 established that there were 
good levels of mRNAs encoding normal mIL-3Ra SP1 and SP2 isoforms during both 
growth and differentiation. 
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mIL-3RaSP2 MAANLWLILGLLASHSSDL 19 
mIL-3Ra SP1 MAANLWLILGLLASHSSDLAAVREAPPTAVTTPIQNLHIDPAHYTLSWDP 50 
REF mIL-3Ra SP1 MAANLWLILGLLASHSSDLAAVREAPPTAVTTPIQNLHIDPAHYTLSWDP 50 
REF mIL-3Ra SP2 MAANLWLILGLLASHSSDL 19 
mIL-3Ra SP2 19 
mIL-3Ra SP1 APGADITTGAFCRKGRDIFVWADPGLARCSFQSLSLCHVTNFTVFLGKDR 100 
REF mIL-3Ra SP1 APGADITTGAFCRKGRDIFVWADPGLARCSFQSLSLCHVTNFTVFLGKDR 100 
REF mIL-3Ra SP2 19 
mlL-3Ra SP2 : DGDHEAAAQDLRCWVHEGQLSCQWERGPKATGDVHYRM 57 
mIL-3Ra SP1 AVAGSIQFPPDDDGDHEAAAQDLRCWVHEGQLSCQWERGPKATGDVHYRM 150 
REF mIL-3Ra SP1 AVAGSIQFPPDDDGDHEAAAQDLRCWVHEGQLSCQWERGPKATGDVHYRM 150 
REF mIL-3Ra SP2 DGDHEAAAQDLRCWVHEGQLSCQWERGPKATGDVHYRM 57 
mIL-3Ra SP2 FWRDVRLGPAHNRECPHYHSLDVNTAGPAPHGGHEGCTLDLDTVLGSTPN 107 
mIL-3Ra SP1 FWRDVRLGPAHNRECPHYHSLDVNTAGPAPHGGHEGCTLDLDTVLGSTPN 200 
REF mIL-3Ra SP1 FWRDVRLGPAHNRECPHYHSLDVNTAGPAPHGGHEGCTLDLDTVLGSTPN 200 
REF mIL-3Ra SP2 FWRDVRLGPAHNRECPHYHSLDVNTAGPAPHGGHEGCTLDLDTVLGSTPN 107 
mIL-3Ra SP2 SPDLVPQVTITVNGSGRAGPVPCMDNTVDLQRAEVLAPPTLTVECNGSEA 157 
mIL-3RaSPl SPDLVPQVTITVNGSGRAGPVPCMDNTVDLQRAEVLAPPTLTVECNGSEA 250 
REF mIL-3Ra SP1 SPDLVPQVTITVNGSGRAGPVPCMDNTVDLQRAEVLAPPTLTVECNGSEA 250 
REFmIL-3RaSP2 SPDLVPQVTITVNGSGRAGPVPCMDNTVDLQRAEVLAPPTLTVECNGSEA 157 
mIL-3Ra SP2 HARWVARNRFHHGLLGYTLQVNQSSRSEPQEYNVSIPHFWVPNAGAISFR 207 
mIL-3Ra SP1 HARWVARNRFHHGLLGYTLQVNQSSRSEPQE YNVS I PHFWVPNAGAI S FR 300 
REF mIL-3Ra SP1 HARWVARNRFHHGLLGYTLQVNQS SRSEPQE YNVS I PHFWVPNAGAI S FR 300 
REF mIL-3Ra SP2 HARWVARNRFHHGLLGYTLQVNQSSRSEPQEYNVSIPHFWVPNAGAISFR 207 
Figure 5.13: Amino acid sequences of mIL-3Ra isoforms encoded by cDNA clones 
derived from SCF ER-Hoxb8 cells grown for 4 days with mIL-3 and with and without 
estrogen. REF mIL-3Ra SP1 and SP2 (Chen et al., 2009) are the previously reported 
reference sequences for these receptor subunits. 
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5.2.7IL-3 signaling pathways during self-renewal and differentiation in 
SCF ER-Hoxb8 progenitors 
5.2.7.1 Utilization ofIL-3Ra isoforms by SCF ER-Hoxb8 
In other research in our group, a mIL-3 mutant has been characterized which has near 
wild type activity with the IL-3Ra SP1 isoform and no activity with the SP2 isoform 
(Mirza et al., 2010). This mutant, mIL-3 E23A, provides a test for the critical utilization 
of the SP2 isoform. In collaboration with S. Mirza of our group, the utilization of the 
IL-3Ra SP2 isoform by SCF ER-Hoxb8 was measured using mIL-3 E23A. 
Interestingly, SCF ER-Hoxb8 grew very poorly on mIL-3 E23A in comparison with the 
IL-3-dependent cell line Ba/F3 (Fig.5.14). mIL-3 E23A also did not effectively drive 
differentiation of SCF ER-Hoxb8. This is despite IL-3Ra SP1 being the major isoform 
expressed in these cells. Since the levels of IL-3Ra SP1 expressed in Ba/F3 and SCF 
ER-Hoxb8 are similar, it is likely that a specific mechanism is present in SCF ER-
Hoxb8 blocking signaling via IL-3Ra SP1. This could facilitate differentiation signaling 
via IL-3Ra SP2 in GM progenitors. 
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Figure 5.14: Growth assay of cells cultured with wild type mIL-3 or mIL-3 E23A. A: 
SCF ER-Hoxb8 cells grown with estrogen; B: Ba/F3 cells. Cells were grown in media 
supplemented with various percentages (v/v) of insect cell conditioned media containing 
either wild type mIL-3 or mIL-3 E23A as indicated for 2 days, and percentage of 
growth was measured in triplicate by [3H]-thymidine incorporation. Results represent 
one of at least two independent experiments. 
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5.2.7.2 IL-3 signaling pathways during growth and differentiation in 
SCF ER-Hoxb8 
Studies of the signaling pathways linked to the mIL-3R have primarily been carried out 
with cell lines like Ba/F3 which don't differentiate. It was of interest to compare the 
known IL-3 signaling pathways during growth and differentiation and to use mIL-3 
E23A to test mIL-3Ra SP1 utilization. 
SCF ER-Hoxb8 progenitors were allowed to grow or differentiate by culturing with 
mIL-3 for 4 days with or without estrogen and the non-adherent cells were collected. 
The cells were starved of IL-3 and then stimulated for 10 minutes with mIL-3 or mIL-3 
E23A and then lysed. The lysates were subjected to SDS-PAGE and immunoblotted 
using phosphospecific and total protein antibodies to Jak2, STAT5, Erkl/2, Akt. IL-3 
signaling pathways in the SCF ER-Hoxb8 progenitors during growth or differentiation 
were compared with those in the IL-3-dependent cell line Ba/F3 during growth. The 
janus activated kinase (Jak) /signal transducer and activator of transcription (STAT) 
pathway plays a critical role for cytokine receptor-mediated intracellular signaling and 
hematopoietic cell development (Nosaka and Kitamura, 2000). The extracellular signal-
regulated kinase 1/2 (Erkl/2), is a serine/threonine kinase that appears to be one of the 
key regulators of cell proliferation and differentiation (McCubrey et ah, 2000; Lee and 
McCubrey, 2002). Akt is a protein serine/threonine kinase and the major effector of the 
PI3-K pathway. It was found that Jak2/STAT5, Akt and Erkl/2 were activated 
efficiently in SCF ER-Hoxb8 progenitors treated with mIL-3, but not in cells treated 
with mIL-3 E23A. 
In agreement with the growth data presented above (Fig.5.14), Ba/F3 cells showed no 
measurable differences in Jak2 and Erkl/2 signaling when stimulated with wild-type 
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mIL-3 or mIL-3 E23A. In contrast, SCF ER-Hoxb8 cells showed a dramatic reduction 
in Jak2 and Erk activation when stimulated with mIL-3 E23A. This indicates that IL-3 
signaling in SCF ER-Hoxb8 is predominantly via IL-3Ra SP2 whereas IL-3Ra SP1 is 
utilized by Ba/F3 cells (Fig.5.15). Interestingly, the differentiated progeny cells could 
utilize IL-3Ra SP1 for signaling via Erkl/2 (Fig.5.15C). 
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Figure 5.15: Activation of Jak2, STAT5, AKT and Erkl/2 signaling in Ba/F3 and SCF 
ER-Hoxb8 cells by wild-type and mIL-3 E23A. BaF/3 cells and SCF ER-Hoxb8 cells 
cultured in 1% (v/v) insect cell conditioned media containing wild type mIL-3 or SCF 
respectively were starved for 4 h before stimulation with wild-type mIL-3, mIL-3 E23A 
, or no (-) mIL-3 for 10 min. The differentiated SCF ER-Hoxb8 cells were cultured in 
1% (v/v) insect cell conditioned media containing wild type mIL-3 without estrogen for 
4 days. Western blots were performed to detect phospho-Jak2 (Tyr 1 0 0 7 1 0 0 8 ) , total Jak2, 
phospho-STAT5 (Tyr 6 9 1), total STAT5, phospho-Akt (Ser 4 7 3), total Akt, phospho-
169 
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Erkl/2 (Thr^/Tyr 2 0 4 ) and total Erkl/2. Results were verified in at least three 
independent experiments. 
5.2.8 The expression of the G-CSFR andM-CSFR in differentiating SCF 
ER-Hoxb8 cells 
Deficiency of the cytokines IL-3, IL-5 or GM-CSF or their receptors has minimal 
effects on steady state blood cell formation. In contrast, they are required for inducible 
hematopoiesis and allergic inflammation (Murphy and Young, 2006). Deficiency of G-
CSF or M-CSF or their receptors gives reductions in steady-state levels of neutrophils 
and macrophages respectively (Lieschke et al., 1994; Liu et al., 1996; Dai et ah, 2002). 
To test for possible induction of expression of these receptors during cytokine-driven 
differentiation of SCF ER-Hoxb8 progenitors their expression levels were measured by 
RT-PCR. Interestingly, the expression of the G-CSF-R was increased significantly in 
differentiating SCF ER-Hoxb8 cells stimulated with IL-3 or SCF and the expression of 
the M-CSF-R was increased significantly in differentiating Hoxb8 cells stimulated with 
GM-CSF (Fig.5.16). The patterns of expression of the G-CSFR and M-CSFR fits well 
with the role of these receptors in the steady state differentiation pathways to 
granulocytes and monoctyes. 
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Figure 5.16: Measurement of expression of the G-CSF receptor and M-CSF receptors in 
SCF ER-Hoxb8 progenitors cultured with mouse IL-3, GM-CSF or SCF for 4 days with 
and without estrogen using RT-PCR. Results represent one of at least two independent 
experiments. 
Chapter 5: IL-3-induced differentiation of the granulocyte-macrophage progenitor SCF ER-Hoxb8 
5.2.9 Involvement of transcription factors and miRNAs in the switch 
between proliferation and differentiation 
5.2.9.1 Induced changes in transcription factor expression 
Transcription factors are known to play a major role in regulating hematopoietic 
differentiation and lineage commitment. Expression of transcription factors in SCF ER-
Hoxb8 cells cultured with mIL-3, mGM-CSF, SCF for 4 days without and with estrogen 
was measured by quantitative real time RT-PCR with HPRT (hypoxanthine-guanine 
phosphoribosyl transferase) as a control (Figs.5.17-5.19). Significant induction of the 
transcription factors C/EBPe, C/EBPp, PU.l and GATA-1 was observed when the SCF 
ER-Hoxb8 progenitors growing on mIL-3 were released from self-renewal. In addition, 
the transcription factors GATA-2, c-Myb, and Gfi-1 were decreased when the cells 
differentiated (Fig.5.17). In cells stimulated to differentiate with mGM-CSF, mRNA 
levels of the transcription factors PU.l, C/EBPs and C/EBPP, were increased and those 
for c-Myb were decreased (Fig.5.18). In cells stimulated to differentiate with SCF, up-
regulation of C/EBPs, PU.l and GATA-1 and down-regulation of GATA-2, c-Myb, and 
Gfi-1 was observed (Fig.5.19). A comparison was also made of the changes of 
transcription factors using non-adherent or adherent cells stimulated to differentiate with 
IL-3 or GM-CSF for 2 days. C/EBPe was elevated significantly in non-adherent cells 
with IL-3 (Table 5.2). 
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Figure 5.17: Expression of transcription factors in SCF ER-Hoxb8 cells cultured with 
mIL-3 for 4 days without and with estrogen by real time RT-PCR. Expression of each 
component is presented as the fold expression ratio of the level in differentiated cells 
(without estrogen) over the level in self-renewing cells (with estrogen). Results were 
verified in three independent experiments. Data are mean, error bars are standard 
deviations. *,/?<0.0001; **,/?=0.0005; ***,/?=0.0054 by student's / test. 
Chapter 5: IL-3-induced differentiation of the granulocyte-macrophage progenitor SCF ER-Hoxb8 
Figure 5.18: Expression of transcription factors in SCF ER-Hoxb8 cells cultured with 
mGM-CSF for 4 days without and with estrogen by real time RT-PCR. Expression of 
each component is presented as the fold expression ratio of the level in differentiated 
cells (without estrogen) over the level in self-renewing cells (with estrogen). Results 
were verified in three independent experiments. Data are mean, error bars are standard 
deviations. *,/?<0.001; **,p<0.001 by student's t test. 
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Figure 5.19: Expression of transcription factors in SCF ER-Hoxb8 cells cultured with 
SCF for 4 days without and with estrogen by real time RT-PCR. Expression of each 
component is presented as the fold expression ratio of the level in differentiated cells 
(without estrogen) over the level in self-renewing cells (with estrogen). Results were 
verified in three independent experiments. Data are mean, error bars are standard 
deviations. *,/><0.0001; **,p<0.01 by student's / test. 
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Table 5.2: Relative fold changes in transcription factor expression in ER-Hoxb8 cells 
cultured with IL-3, GM-CSF or SCF for 4 days or 2 days without estrogen (adherent, 
non-adherent or total cells) and with estrogen. Expression of each component is 
presented as the fold expression ratio of the level in differentiated cells (without 
estrogen) over the level in self-renewing cells (with estrogen). 
Transcription 
factor 
IL-3 (4d) 
Total 
Fold change 
IL-3 (2d) 
Non-adherent 
Fold change 
GM-CSF (4d) 
Total 
Fold change 
GM-CSF (2d) 
Adherent 
Fold change 
SCF (4d) 
Total 
Fold change 
C/EBPe 38.6447 31.0506 11.7732 4.7672 33.7742 
PU.1 7.0758 2.7715 16.4308 3.6718 7.3387 
GATA-1 16.2507 3.5774 2.2830 5.5170 4.1363 
C/EBPa 0.5080 1.2588 0.1623 0.5485 0.1597 
C/EBPp 10.5095 0.4772 5.6356 1.5390 0.3829 
C/EBP5 1.7985 0.7868 0.9755 1.1779 0.3199 
Id 1 0.8831 1.8357 5.3135 1.4727 4.8688 
NFI-A 0.2694 0.4354 0.6807 0.8703 0.8079 
Gfi-1 0.0314 0.9490 0.1068 0.7702 0.2343 
GATA-2 0.0657 0.2280 0.3962 0.2402 0.0004 
c-Myb 0.0886 0.6685 0.0452 0.3878 0.0999 
AML1 1.0622 2.2618 2.2373 
NFYA 2.0542 1.5695 0.2865 
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5.2.9.2 Induced changes in expression ofmiRNAs 
miRNAs regulate the translation and stability of specific mRNAs and are believed to 
significantly contribute to the regulation of lineage commitment and differentiation 
(Fatica et al., 2008). Initially, the levels of 11 miRNAs known to be involved in the 
regulation of differentiation and hematopoiesis were measured by real-time PCR in SCF 
ER-Hoxb8 cells triggered to differentiate. In cells undergoing differentiation supported 
by either IL-3, GM-CSF or SCF, miR-223 was highly induced. The changes in miR-223 
during the time course of differentiation supported by IL-3 showed that miR-223 
increased gradually from 1 day to 4 days in the absence of estrogen (Fig.5.21). This is in 
agreement with a number of reports implicating miR-223 in the functional maturation of 
granulocytes (Fazi et al., 2005; Fatica et al., 2006; Johnnidis et al., 2008). In contrast, 
the levels of miR-155, miR-181a and miR-292 were decreased in differentiating cells 
grown in IL-3 or GM-CSF and miR-155 was decreased in differentiating cells grown in 
SCF (Figs.5.20, 5.22 and 5.23). 
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Figure 5.20: Expression of miRNAs in ER-Hoxb8 cells cultured with mIL-3 for 4 days 
without and with estrogen by real time RT-PCR. Expression of each component is 
presented as the fold expression ratio of the level in differentiated cells (without 
estrogen) over the level in self-renewing cells (with estrogen). Results were verified in 
three independent experiments. Data are mean, error bars are standard deviations. *, 
p<0.0001 by student's t test. 
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Figure 5.21: Time course of expression of miR-223 in SCF ER-Hoxb8 cells cultured 
with mIL-3 without and with estrogen. The fold expression of all samples is relative to 
the control RNA which is labelled "0". Results were verified in at least two independent 
experiments. Data are mean, error bars are standard deviations. *, p<0.05; **, p<0.01; 
***, /X0.001 by student's t test. 
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Figure 5.22: Expression of miRNAs in ER-Hoxb8 cells cultured with mGM-CSF for 4 
days without and with estrogen by real time RT-PCR. Expression of each component is 
presented as the fold expression ratio of the level in differentiated cells (without 
estrogen) over the level in self-renewing cells (with estrogen). Results were verified in 
three independent experiments. Data are mean, error bars are standard deviations. *, 
/?<0.0001 by student's t test. 
Chapter 5: IL-3-induced differentiation of the granulocyte-macrophage progenitor SCF ER-Hoxb8 
< z ci 
2 Jo 
u. U C/3 
£ P bo 
50 
30 
10 
0 
1 I R B ? ! 
1-T! 
% ^ % % \ \ V \ \ \ % \ \ % 
\ v<r % % \ % % 
Figure 5.23: Expression of miRNAs in ER-Hoxb8 cells cultured with SCF for 4 days 
without and with estrogen by real time RT-PCR. Expression of each component is 
presented as the fold expression ratio of the level in differentiated cells (without 
estrogen) over the level in self-renewing cells (with estrogen). Results were verified in 
three independent experiments. Data are mean, error bars are standard deviations. *, 
£><0.0001 by student's / test. 
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5.2.10 MiRNA-mediated molecular circuitries in granulocytic 
differentiation 
Analysis of miRNA expression is an important step in elucidating miRNA function. The 
Affymetrix miRNA microarray platform was also used to compare the expression of 
mouse miRNAs in SCF ER-Hoxb8 cells cultured with mIL-3 for 2 days without and 
with estrogen to detect changes occurring early in differentiation. Non-adherent cells 
were collected after SCF ER-Hoxb8 was cultured with mIL-3 for 2 days without 
estrogen and the adherent cells (macrophages) when SCF ER-Hoxb8 cultured with 
mGM-CSF for 2 days without estrogen. The results are presented as fold change of 
miRNA expression with respect to its control. Greater than 2-fold changes in miRNA 
expression in the differentiating cells were considered significant. In addition to miR-
223, miR-15a, miR-210 and miR-338-5p were highly up-regulated and miR-708 and 
miR-324-3p highly down-regulated the differentiated cells cultured with mIL-3 (Table 
5.3). Whereas miR-210, miR-139-3p, miR-423-5p and miR-200 were highly up-
regulated and miR-466-5p, miR-421 and miR-708 highly down-regulated in 
macrophages cultured with mGM-CSF (Table 5.4). miR-210, miR-223, miR-339-5p 
were up-regulated and miR-708, miR-181d were down-regulated both in the cells 
differentiated with mIL-3 and macrophages differentiated with mGM-CSF. 
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Table 5.3: Relative fold expression of miRNAs in ER-Hoxb8 cells cultured with mIL-3 
for 2 days without and with estrogen. Affymetrix miRNA microarray analysis of the 
expression of 609 mouse miRNAs. Raw data were normalized after background 
subtraction using global median of the intensities. In the histograms, the results are 
presented as above 2-fold change of miRNA expression with respect to the control 
(growth with estrogen). 
Upregulated Downregulated 
microRNA Fold microRNA Fold 
(-estrogen/+estrogen) change (-estrogen/+estrogen) change 
mmu-miR-15a-star 10.0813 mmu-miR-708 -14.9411 
mmu-miR-210 7.41527 mmu-miR-324-3p -7.01336 
mmu-miR-338-5p 6.76612 mmu-miR-146b-star -4.51752 
mmu-miR-223 6.74026 mmu-miR-139-3p -4.45189 
mmu-miR-466a-3p 4.13576 mmu-miR-669a -4.43455 
mmu-let-7b-star 3.50846 mmu-miR-301b -4.35723 
mmu-miR-488 3.04903 mmu-let-7g-star -4.10465 
mmu-miR-297a 2.92813 mmu-let-7d-star -4.03176 
mmu-miR-494 2.90112 mmu-miR-146a -3.87895 
mmu-miR-16-star 2.77259 mmu-miR-30e -3.79337 
mmu-miR-883b-3p 2.74271 mmu-miR-34b-3p -3.5051 
mmu-miR-466j 2.63969 mmu-miR-155 -3.23504 
mmu-miR-148a-star 2.44478 mmu-miR-27a-star -3.14742 
mmu-miR-615-5p 2.41843 mmu-miR-330-star -3.14452 
mmu-miR-325-star 2.41275 mmu-miR-877 -3.11208 
mmu-miR-15b 2.33739 mmu-miR-467g_st -3.06459 
mmu-miR-133b 2.29989 mmu-miR-181 a-1 -star -2.96668 
mmu-miR-669h-3p 2.29897 mmu-miR-295-star -2.96263 
mmu-miR-92a-star 2.28157 mmu-miR-194 -2.93591 
mmu-miR-192 2.27768 mmu-let-7f -2.92428 
mmu-miR-483-star 2.25807 mmu-miR-296-5p -2.87554 
mmu-miR-504 2.23538 mmu-miR-1192 -2.66171 
mmu-miR-322 2.22399 mmu-miR-181d -2.66007 
mmu-miR-335-5p 2.20422 mmu-miR-486 -2.655 
mmu-miR-151-3p 2.17377 mmu-miR-467e-star -2.62041 
mmu-miR-199b-star 2.15404 mmu-miR-378-star -2.61495 
mmu-miR-466f-3p 2.10006 mmu-miR-345-5p -2.34548 
mmu-miR-302b-star 2.09659 mmu-miR-503 -2.24069 
mmu-miR-374-star 2.0833 mmu-miR-487b -2.17616 
mmu-miR-153 2.07073 mmu-miR-712-star -2.10372 
mmu-miR-342-3p 2.04919 mmu-miR-140-star -2.0355 
mmu-miR-339-5p 2.01439 mmu-miR-200b-star -2.01638 
mmu-miR-677 2.01046 mmu-miR-345-3p -2.00294 
mmu-miR-16 2.00164 mmu-miR-874 -2.00089 
mmu-miR-770-3p_ 2.00078 
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Table 5.4: Relative fold expression of miRNAs in ER-Hoxb8 cells cultured with mGM-
CSF for 2 days without and with estrogen. 
Upregulated microRNA 
(-estrogen/+estrogen) 
Fold 
change 
Downregulated microRNA 
(-estrogen/+estrogen) 
Fold 
change 
mmu-miR-210 67.1135 mmu-miR-466f-5p -38.8015 
mmu-miR-139-3p 24.9937 mmu-miR-421 -38.0426 
mmu-miR-423-5p 11.9852 mmu-miR-708 -37.113 
mmu-miR-200c 11.6448 mmu-miR-29a -30.7649 
mmu-miR-700 7.34154 mmu-miR-669c -24.4433 
mmu-miR-339-5p 6.47265 mmu-miR-1187 -18.8575 
mmu-miR-149 6.11887 mmu-miR-27b-star -18.7192 
mmu-miR-320 5.63614 mmu-miR-183 -15.7939 
mmu-miR-744 4.60775 mmu-miR-181 d -12.4855 
mmu-miR-503 4.53228 mmu-miR-466c-5p -12.4426 
mmu-miR-351 4.34515 mmu-miR-466f -12.1067 
mmu-miR-877 4.24376 mmu-miR-706 -8.98144 
mmu-miR-324-5p 4.24234 mmu-miR-674-star -8.91225 
mmu-miR-411 3.91161 mmu-miR-466j -8.7236 
mmu-miR-330-star 3.82128 mmu-miR-34a -8.68018 
mmu-miR-197 3.71742 mmu-miR-466h -8.62144 
mmu-miR-140-star 3.64369 mmu-miR-19a -8.48764 
mmu-miR-423-3p 3.6305 mmu-let-7g -7.61579 
mmu-miR-298 3.59883 mmu-miR-466c-3p -6.52831 
mmu-miR-484 3.55326 mmu-miR-155 -6.34483 
mmu-miR-702 3.54145 mmu-miR-15a -5.90134 
mmu-miR-185 3.51897 mmu-miR-669b -5.84019 
mmu-miR-223 3.39345 mmu-miR-466b-3p -5.8078 
mmu-miR-182 3.08227 mmu-miR-1224 -5.01183 
mmu-miR-674 2.94435 mmu-miR-467c -4.79775 
mmu-miR-106b-star 2.47348 mmu-miR-425-star -4.31763 
mmu-miR-296-3p 2.45936 mmu-miR-345-3p -4.18605 
mmu-miR-103 2.42065 mmu-miR-93-star -4.06823 
mmu-miR-467e-star 2.41869 mmu-let-7i -3.83814 
mmu-miR-17-star 2.40776 mmu-let-7f -3.71558 
mmu-miR-652 2.35986 mmu-miR-466e-3p -3.54537 
mmu-miR-27a-star 2.18406 mmu-miR-20b -3.43348 
mmu-miR-215 2.13602 mmu-miR-27b -3.37576 
mmu-miR-532-5p 2.13554 mmu-miR-25 -3.29103 
mmu-miR-720 2.01579 mmu-miR-714 -3.16664 
mmu-miR-297a -3.13486 
mmu-miR-467a -2.95292 
mmu-miR-378-star -2.92468 
mmu-miR-183-star -2.70655 
mmu-let-7a -2.56126 
mmu-miR-19b -2.52892 
mmu-miR-466a-3p -2.50725 
mmu-miR-106a -2.42859 
mmu-miR-194 -2.36924 
mmu-miR-15a-star -2.16935 
mmu-miR-140 -2.15724 
mmu-miR-574-5p -2.07455 
mmu-miR-181 a-1 -star -2.06184 
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5.3 Discussion 
As part of a search for a model to study mIL-3 -driven myeloid differentiation, three 
differentiation models were investigated. Ectopic expression of mIL-3R subunits in Ml 
mouse myeloblasts leukemia cells or NB4 human promyelocyte leukemia cells gave 
only partial differentiation in response to mIL-3. A far superior model was SCF ER-
Hoxb8 progenitors which grow on mIL-3 or mGM-CSF without differentiation in the 
presence of estrogen and differentiate essentially completely in its absence. The SCF 
ER-Hoxb8 progenitor line therefore provides an excellent model to study the 
mechanisms controlling differentiation and self-renewal. 
Deficiency of G-CSF or M-CSF or their receptors gives reductions in steady-state 
levels of neutrophils and macrophages respectively (Lieschke et al., 1994; Liu et at, 
1996; Dai et al., 2002). Thus these receptors are involved in steady state hematopoiesis 
and the steady state differentiation pathway. It was therefore of interest to see if these 
receptors were expressed during the cytokine-induced differentiation of SCF ER-Hoxb8 
progenitors. The results showed that the G-CSFR is induced during differentiation in 
IL-3 and SCF and the M-CSFR is induced during differentiation with GM-CSF. This 
represents an additional similarity between the cytokine-induced and steady state 
myeloid differentiation pathways. 
Our group has recently discovered a new isoform of the IL-3Ra (designated SP2), 
which is expressed by mouse and human hematopoietic cells (Chen et al., 2009). Recent 
structure-function studies have shown there are distinct epitopes on IL-3 and the p 
receptors which are utilized by mIL-3Ra SP1 and SP2 isoforms (Mirza et al., 2010). It 
seems likely that that the two high affinity complexes involve different relative 
orientations of the receptor subunits resulting in different signaling properties. An IL-3 
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mutant, mIL-3 E23A, has been characterized by our group which supports IL-3 growth 
signaling via the IL-3Ra SP1 isoform but not via the SP2 isoform. In the work 
described in this Chapter it was shown that SCF ER-Hoxb8 progenitors did not grow 
with the mutant mIL-3. This indicates that the cell line predominantly uses the IL-3Ra 
SP2 isoform for mIL-3 signaling. Sequencing analysis and Western blotting showed 
that both IL-3Ra SP1 and SP2 isoforms are expressed in SCF ER-Hoxb8. Indeed the 
SP1 isoform is the major form and flow cytometry confirmed good levels on the surface 
of the SCF ER-Hoxb8 cells. Thus there appears to be a mechanism in SCF ER-Hoxb8 
progenitors that suppresses IL-3 signaling via IL-3Ra SP1. It seems likely that this 
mechanism promotes signaling via the SP2 isoform which may be optimal for IL-3-
induced differentiation of GM progenitors. Recent experiments in our group with 
normal mouse bone marrow cells have confirmed that the SP2 isoform is utilized for the 
normal differentiation of GM progenitors (J. Chen and I. Young, unpublished). 
Cytokines regulate various hematopoietic cell functions through the activation of signal 
transduction pathways. IL-3 is known to activate many signaling cascades including the 
Ras/MAPK/Erk pathway, PI3 kinase/Akt pathway and Jak/STAT pathway. In the 
present work, the IL-3 signaling pathways in SCF ER-Hoxb8 progenitors were 
compared with those in the widely studied IL-3-dependent cell line Ba/F3. Jak2, Stat5, 
Erkl/2 and Akt were activated in SCF ER-Hoxb8 progenitors treated with mIL-3. The 
signaling was shown to be dependent on the IL-3Ra SP2 isoform by using mIL-3 E23A. 
After lineage maturation, neutrophils again efficiently utilized the SP1 isoform of IL-
3Ra for IL-3 signaling. The IL-3 signaling pathways in differentiating SCF ER-Hoxb8 
progenitors were very similar to those in Ba/F3 cells which don't differentiate, except 
for the mIL-3Ra isoform utilized. Clearly, further work is required to elucidate the 
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critical links between IL-3R signaling and differentiation which are not reflected in the 
IL-3 signaling pathways as they are currently known. 
Although specific transcription factors are believed to control lineage determination 
during myeloid differentiation they appear to function in conjunction with miRNAs 
which provide an additional level of control (Zhu and Emerson, 2002; Fatica et al., 
2008). In the present work, the levels of miRNAs and the mRNAs for relevant 
transcription factors were measured in SCF ER-Hoxb8 progenitors comparing cytokine-
driven differentiation and proliferation. Significant induction of miR-223, and up-
regulation of transcription factors such as C/EBPs, C/EBPp, PU.l and GATA-1 were 
shown in differentiating cells. miR-223 is up-regulated in myeloid differentiation and is 
a critical inducer of differentiation in human promyelocytic NB4 cells which have been 
induced to differentiate by ATRA (Fazi et al., 2005). C/EBPp and PU.l have been 
linked to the up-regulation of miR-223 (Fukao et al., 2007). 
The upregulation of C/EBPP and C/EBPe in differentiating SCF ER-Hoxb8 progenitors 
is particularly interesting. The C/EBP family of transcription factors plays important 
roles in myeloid differentiation. C/EBPa is expressed in the earliest myeloid cells and 
required for production of GM progenitors (Zhang et al., 2002). Subsequently, 
C/EBPp and C/EBPe are induced during granulocytic differentiation (Scott et al., 1992; 
Radomska et al., 1998). In acute promyelocytic leukemia, there is a marked decrease in 
C/EBPa DNA binding activity and treatment of PML cells with ATRA results in 
induction of first C/EBPp and then C /EBPE as granulocytic differentiation is restored 
(Park et al., 1999; Duprez et al., 2000; Duprez et al., 2001). Interestingly, when 
C/EBPa ''' cells are stimulated with the IL-3 and GM-CSF, but not with ATRA, 
granulocytic differentiation is also restored with induction of C/EBPP and C/EBPs 
(Zhang et al., 2002). Thus, the pathways of steady state granulocytic differentiation, 
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restoration of differentiation of PML cells with ATRA and IL-3-driven differentiation 
have a number of features in common. It seems likely that, while the mechanisms 
involved in the induction of differentiation via these pathways are independent, they 
share common mechanisms for promoting differentiation. 
The miRNA array data suggests that a broader investigation of the miRNAs whose 
levels are changed with the onset of differentiation is warranted and that IL-3, GM-CSF 
and SCF signaling may generate unique miRNA profiles consistent with their different 
differentiation outcomes. Time did not permit further more detailed studies of the 
miRNA circuits involved using functional approaches such as ectopic expression and 
antagomirs (Krutzfeldt et al., 2005; Fatica et al., 2008). More detailed understanding of 
the mechanisms controlling cytokine-driven differentiation are critical for the 
development of new treatments for allergic inflammation and to improve our 
understanding of the pathogenesis of AML. 
Chapter 6 
Final discussion 
Chapter 6: Final Discussion 
Blood cell formation involves proliferation of hematopoietic stem cells coupled with 
progressive maturation and lineage commitment. There is a critical requirement to 
maintain stem cell numbers by self-renewal which involves replication without 
differentiation. Leukemic stem cells with abnormal self-renewal capacity are believed to 
be the critical tumour initiating cells in acute leukemias and appear to arise from normal 
stem cells or from later progenitors (Passegue et al., 2003; Hope et al., 2004). Although 
there has been progress on the action of oncoproteins and the genes involved in self-
renewal, the mechanisms which control both differentiation and the balance between 
self-renewal and differentiation are poorly understood. 
The focus of this thesis is on myeloid differentiation. Four myeloid differentiation 
pathways have been recognized: (1) steady state myeloid differentiation, which 
maintains the normal levels of mature myeloid cells, (2) cytokine-driven or inducible 
myelopoiesis which generates additional myeloid effector cells during infections or 
allergic responses, (3) ATRA-induced differentiation of PML cells and (4) CD44-driven 
differentiation of AML blasts. The aim of the work described in this thesis was to gain a 
better understanding of IL-3-driven myeloid differentiation and to establish an in vitro 
model for studying mouse myeloid differentiation so that findings can be verified by in 
vivo studies. 
Optimal differentiation models for in vitro studies should be conditional or inducible so 
that the onset of differentiation is controlled and detailed studies of the mechanisms can 
be carried out. It is difficult to establish steady-state differentiation models in vitro since 
it is not possible to accurately reproduce the normal signals provided by the bone 
marrow niche for self-renewal versus differentiation and when progenitors are 
maintained in vitro on a cocktail of cytokines they rapidly mature. However, knock-out 
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mice have been useful in giving information on the role of transcription factors in 
steady-state myeloid differentiation (Coffer et al., 2000; Rosenbauer and Tenen, 2007; 
Dey et al., 2010). Zhang et al., (2002) derived cell lines resembling immature myeloid 
progenitors from C/EBPa mice. Conditional expression of C/EBPa induced the 
C/EBP family members C/EBPp and C/EBPs and subsequent granulocytic 
differentiation. Interestingly, similar results were obtained when C/EBPa cells were 
stimulated with IL-3 and GM-CSF, but not with all-trans retinoic acid, supporting the 
concept of an independent cytokine-induced myeloid differentiation pathway involving 
C/EBPp and C/EBPs but not C/EBPa. These findings are in good agreement with the 
studies of IL-3-induced differentiation of SCF ER-Hoxb8 progenitors discussed below. 
Two main differentiation models were used in the work described in this thesis: (1) SCF 
ER-Hoxb8, a conditionally immortalized granulocyte-macrophage progenitor used for 
studying mIL-3-driven differentiation and (2) NB4 PML cells, a model for ATRA-
induced differentiation. SiRNA knockdown experiments were carried out to explore 
possible overlap between the steady-state, cytokine-induced, ATRA-induced or CD44-
driven differentiation pathways. 
The dysfunctionality of IL-3-driven differentiation in AML is supported by the 
observation that over 80% of AML blasts have high affinity IL-3 receptors but IL-3 
does not induce their differentiation (Hsu et al., 1996; Alexandera et al., 2001). Thus, 
both the cytokine-driven and steady-state differentiation pathways may commonly be 
blocked in AML. In the work described in Chapter 3, the IL-3R system was investigated 
in NB4 cells. NB4 is a human promyelocytic leukemia cell line which is not induced to 
differentiate by hIL-3 or hGM-CSF like a normal promyelocyte (Hsu et al., 1996). 
However, NB4 differentiates to neutrophils in the presence of ATRA (Lee et al., 2002). 
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The NB4 cell line carries the t (15; 17) translocation resulting in the joining of the PML 
oncogene to the gene encoding the RARa (Lanotte et al., 1991). 
The data showed that the IL-3R subunits were expressed at a low level in NB4 cells but 
were otherwise normal suggesting that the block in IL-3-induced differentiation was 
likely to be downstream of the IL-3R. When the levels of the hIL-3R (hpc with either 
hIL-3Ra SP1 or SP2) were elevated by ectopic expression, hIL-3-driven differentiation 
was restored, without ATRA, as shown by morphological analysis and surface marker 
expression. However, the differentiation achieved was only partial, presumably due to 
the inhibitory effect of the PML-RARa protein. Although ATRA treatment elevated 
miR-223 about 5-fold, only a small increase was achieved with IL-3 alone. MiR-223 is 
a key member of a regulatory circuit involving C/EBPa and NFI-A which is believed to 
control granulocytic differentiation in ATRA-treated APL cell lines (Fazi et al., 2005). 
It has been shown that neutralizing antibodies to hIL-3, hGM-CSF and hG-CSF 
partially block ATRA-induced differentiation of NB4 suggesting a possible 
involvement of 0c receptor signaling in the process (Matsui et al., 2005). However no 
synergistic effects between hIL-3 or hGM-CSF and ATRA were detected. Similarly, 
siRNA knockdown of hpc had no significant effect on NB4 differentiation induced by 
ATRA. Collectively these results indicate that the mechanisms involved in the induction 
of differentiation via the IL-3-driven and ATRA-induced differentiation pathways are 
independent in NB4 cells. 
A CD44-induced myeloid differentiation pathway has been shown in AML blasts and 
NB4 promyelocyte leukemia cells (Charrad et al., 1999; Charrad et al., 2002; Song et 
al., 2004; Jin et al., 2006) although little is known of the mechanisms involved. The 
potential involvement of CD44 and its ligand OPN in myeloid differentiation was 
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explored in the work described in Chapter 4. The CD44-induced differentiation pathway 
has not been defined in mouse cells. The expression of CD44 and OPN mRNAs was 
shown in each of four mouse myeloid cell lines undergoing IL-3-induced 
differentiation. The isoforms expressed were the standard isoforms in each case with no 
changes detectable between growth and differentiation. In conditionally-immortalized 
mouse SCF ER-Hoxb8 progenitors no expression of the CD44 ligand OPN was detected 
in growing cells but the expression of OPN mRNA was detected during differentiation. 
Further experiments are required to demonstrate the functional significance of the OPN 
induction demonstrated in the present work. 
The expression of CD44 and OPN in NB4 cells undergoing ATRA-induced 
differentiation was also measured. The expression of CD44 and OPN mRNAs were 
readily detectable and the levels of expression did not change significantly before and 
after induction of differentiation by ATRA. Human OPN has three distinct isoforms. 
OPN-A constitutes the full-length transcript, whereas OPN-B and OPN-C result from 
alternative splicing (Young et al., 1990; Saitoh et al, 1995; He et al, 2006). DNA 
sequencing of OPN cDNA clones from NB4 cells showed a change in OPN isoform 
expression after treatment with ATRA. While parental NB4 cells solely expressed the 
full length OPN-A isoform, differentiating NB4 cells additionally expressed the OPN-C 
and OPN-B isoforms. The significance of this finding is not clear, and requires further 
investigation. 
CD44-induced differentiation is as effective as ATRA for the differentiation of 
promyelocyte leukemia blasts (Charrad et al, 1999). The possible involvement of 
CD44 in the ATRA-induced and IL-3-induced differentiation pathways was tested by 
siRNA knockdown of CD44. Neither ATRA-driven nor IL-3-driven differentiation was 
affected by siRNA knockdown of CD44 in NB4 cells suggesting that CD44 is not a 
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critical component of these differentiation pathways. Collectively, the results presented 
in the thesis work suggest that the mechanisms involved in the induction of 
differentiation via the ATRA-driven, IL-3-driven and CD44-induced differentiation 
pathways are independent. 
The results presented in Chapter 5 show that SCF ER-Hoxb8 progenitors are an 
excellent model for studying the mechanisms controlling mIL-3-driven differentiation. 
G-CSF and M-CSF are critical for steady state production of neutrophils and 
macrophages respectively (Lieschke et al., 1994; Liu et al., 1996; Dai et al., 2002). The 
work in Chapter 5 showed that the G-CSFR is induced during differentiation in IL-3 
and SCF and the M-CSFR is induced during differentiation with GM-CSF. This is an 
interesting similarity between the cytokine-induced and steady state differentiation 
pathways to granulocytes and macrophages. 
Our group has recently shown the existence of a second isoform of IL-3Ra (designated 
SP2) which has distinctive binding and signaling properties (Chen et al., 2009; Mirza et 
al., 2010a) relative to the originally described isoform (designated SP1). An important 
issue is to define the biological roles of the two isoforms. The studies reported in 
Chapter 5 revealed a specific role for the mIL-3Ra SP2 isoform in the differentiation of 
the SCF ER-Hoxb8 progenitors. Recent structure-function studies in our group have 
shown there are distinct epitopes on IL-3 and the p receptors which are utilized by mlL-
3Ra SP1 and SP2 isoforms (Mirza et al., 2010a). It seems likely that that the respective 
high affinity complexes have different relative orientations of the receptor subunits 
resulting in different signaling properties. An IL-3 mutant, mIL-3 E23A, has been 
characterized which is only active with the IL-3Ra SP1 isoform and can be used to 
demonstrate dependence on IL-3 signaling via the SP2 isoform. In the work described in 
Chapter 5 it was shown that SCF ER-Hoxb8 progenitors did not grow with mIL-3 
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E23A. This indicates that these cells predominantly use the IL-3Ra SP2 isoform for 
mIL-3 signaling. Interestingly, however, sequencing analysis and Western blotting 
showed expression of normal IL-3Ra SP1 in SCF ER-Hoxb8. In fact the SP1 isoform is 
the major form and flow cytometry confirmed good levels on the surface of the SCF 
ER-Hoxb8 cells. Thus there appears to be a novel mechanism in SCF ER-Hoxb8 
progenitors that suppresses IL-3 signaling via IL-3Ra SP1. This suggests that IL-3 
signaling via IL-3Ra SP2 is required for optimal differentiation of GM progenitors. 
Recent experiments with normal mouse bone marrow cells have confirmed that the SP2 
isoform is also utilized for the optimal differentiation of GM progenitors from bone 
marrow (J. Chen and I. Young, unpublished). 
Interestingly, autocrine IL-3 production occurs reasonably commonly in mouse 
leukemias arising from the expression of oncoproteins. For example, Hoxb8 expression 
in bone marrow cells allows the ready isolation of IL-3-dependent cell lines which are 
blocked in differentiation (Perkins and Cory, 1993). Some of the spontaneous leukemias 
arising from Hoxb8 expression are autocrine for IL-3 and simultaneous over-expression 
of both Hoxb8 and IL-3 rapidly yields a transplantable myeloid leukemia (Perkins et al., 
1990). 
In human AML, IL-3Ra is overexpressed on leukemic stem cells and blasts and plays a 
potential role in the pathogenesis of this disease. It is currently being developed as a 
target for anti-leukemia therapy (Testa et al., 2004). It was recently reported that an 
anti-IL-3Ra chain (CD123)-neutralizing antibody (7G3) targeted AML-LSCs, impairing 
homing to bone marrow (BM) and activating innate immunity of nonobese diabetic/ 
severe-combined immunodeficient (NOD/SCID) mice. 7G3 treatment profoundly 
reduced AML-LSC engrafhnent and improved mouse survival (Jin et al., 2009). In view 
of the specific role revealed for IL-3Ra SP2 in mouse myeloid differentiation it will be 
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of interest to see if this also is true of human GM progenitors and whether there are any 
derangements in AML. 
IL-3 is known to activate the Ras/MAPK/Erk, PI3 kinase/Akt and Jak/Stat signaling 
pathways. Definition of the IL-3 signaling pathways has resulted from work with IL-3-
dependent lines like Ba/F3 which grow continuously on IL-3 but do not differentiate. In 
the present work, the IL-3 signaling pathways in SCF ER-Hoxb8 progenitors 
undergoing IL-3-driven self-renewal or differentiation were compared with those in 
Ba/F3. It was shown that Jak2, Stat5, Erkl/2 and Akt were activated in SCF ER-Hoxb8 
progenitors treated with mIL-3. The signaling was shown to be dependent on the IL-
3Ra SP2 isoform using mIL-3 E23A. The IL-3 signaling pathways in differentiating 
SCF ER-Hoxb8 progenitors were very similar to those in Ba/F3 cells, except that these 
cells specifically signaled via the mIL-3Ra SP2 isoform whereas the Ba/F3 cells clearly 
utilized mIL-3Ra SP1. Further work is required to elucidate the critical links between 
IL-3R signaling and differentiation which are not reflected in the IL-3 signaling 
pathways as they are currently known. 
Recently, Doulatov et al., (2009) reported evidence that the transcription factor PLZF is 
a critical regulator of myeloid differentiation restricting proliferation and differentiation 
of myeloid progenitors. PLZF represses transcription factors involved in myeloid 
differentiation including GFI-1, C/EBPa and LEF1. Induction of MEK1/2 by IL-3 leads 
to nuclear export and inactivation of PLZF which augments mature cell production. 
Future investigation of the role of PLZF and of the mIL-3Ra isoforms in regulating IL-
3-driven myeloid differentiation would be of great interest. 
Transcription factors are believed to control lineage determination during myeloid 
differentiation and appear to function in conjunction with miRNAs (Zhu and Emerson, 
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2002; Fatica et al., 2008). A common myeloid precursor gives rise to mature 
granulocytes and monocytes and their production depends on the activity of several 
transcription factors. A crucial role in the initial steps of myelopoiesis is played by 
C/EBPa and PU. 1. These two factors are responsible for the transcriptional activation of 
miR-223 and miR-424 respectively that down-regulate the common target NFI-A. NFI-
A counteracts the differentiation of both granulocytes and monocytes, thus its down-
regulation is important for myelopoiesis to proceed. An interesting autoregulatory loop 
appears to control granulocytic differentiation of APL cells: C/EBPa activation 
produces the displacement of NFI-A from the miR-223 promoter and its up-regulation. 
In cascade, miR-223 acts by repressing NFI-A thus removing it from the competition 
with C/EBPa and maintaining sustained levels of miR-223 expression (Fazi et al., 
2005). In the present work, the levels of miRNAs and the mRNAs for relevant 
transcription factors were measured in SCF ER-Hoxb8 progenitors comparing self-
renewal with cytokine-driven differentiation. With the onset of differentiation, 
significant induction of miR-223, and up-regulation of transcription factors such as 
C/EBPs, C/EBPp, PU.l and GATA-1 was observed. 
The data in Chapter 5 showed upregulation of C/EBPp and C/EBPe in differentiating 
SCF ER-Hoxb8 progenitors. In steady state myeloid differentiation, C/EBPa is 
expressed in the earliest myeloid cells and required for production of GM progenitors 
(Zhang et al., 2002). Subsequently, C/EBPp and C/EBPe are induced during 
granulocytic differentiation (Scott et al., 1992; Radomska et al., 1998). Similarly, 
treatment of promyelocytic leukemia cells with ATRA gives induction of first C/EBPp 
and then C/EBPe as granulocytic differentiation is restored (Duprez et al., 2000; Duprez 
et al., 2001; Park et al., 1999). Also, when C/EBPa " myeloid progenitors are 
stimulated with IL-3 and GM-CSF, granulocytic differentiation is restored with 
Chapter 6: Final Discussion 
induction of C/EBPP and C/EBPe (Zhang et al., 2002). Thus, although the mechanisms 
leading to induction of differentiation via the pathways of steady state granulocytic 
differentiation, ATRA-induced differentiation of PML cells and IL-3-driven 
differentiation are independent they have in common the induction of C/EBPp, C/EBPe 
and miR-223 suggesting common mechanisms for the later steps. 
Previous studies have shown different roles for C / E B P P and C/EBPe in myeloid 
differentiation. Yamanaka et al., (1997) reported C/EBPe is required for the terminal 
differentiation and maturation of granulocytes from studies of C/EBPe-deficient 
(C/EBPE LG mice. Recently, it has been shown that, in the absence of C/EBPe, there is 
not only incomplete differentiation of granulocytes, but myelopoiesis is disrupted with 
the appearance of an intermediate cell type with monocyte and granulocyte features, and 
the neutrophils have abnormal chemotaxis (Halene et al., 2010). C/EBPe mice also 
has defective eosinophil differentiation (Bedi et al., 2009). C/EBPp is upregulated 
during differentiation of myeloid cells (Natsuka et al., 1992; Scott et al., 1992), but no 
defects in granulopoiesis are apparent in C/EBPp mice (Screpanti et al., 1995). 
However, C/EBPp is essential in granulopoiesis specifically in conditions of stress, in 
which various factors, including cytokines and pathogens, stimulate the mobilization of 
granulocyte progenitors (Hirai et al., 2006). 
The miRNA array data in Chapter 5 suggests that a broader investigation of the 
miRNAs whose levels are changed with the onset of differentiation is warranted. It 
appears that IL-3-, GM-CSF- and SCF-driven differentiation may generate unique 
miRNA profiles consistent with the different composition of mature cell types that are 
produced by the three pathways. More detailed studies of the miRNA circuits involved 
in IL-3-driven differentiation using functional approaches such as ectopic expression 
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and antagomirs (Krutzfeldt et al., 2005; Fatica et al., 2008) is also required. 
Antagomirs, a novel class of chemically engineered oligonucleotides, are powerful tools 
to silence specific miRNAs in vivo and may represent a therapeutic strategy for 
silencing miRNAs in disease (Krutzfeldt et al., 2005). Recently, it has been shown that 
antagonism of miRNA-126 suppresses the effector function of Th2 cells and the 
development of allergic airways disease in mice (Mattes et al., 2009). The work 
described in Chapter 5 provides the foundation for future studies which could lead to 
miRNA directed strategies for controlling allergic inflammation. More detailed 
understanding of the mechanisms controlling cytokine-driven differentiation may also 
improve our understanding of AML. 
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